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Abstract 
Campylobacter jejuni is an important food-borne pathogen, and a major cause of 
bacterial gastroenteritis. Despite this, relatively little is known regarding the way 
in which C. jejuni colonises hosts, causes disease or survives in the environment 
during transmission between hosts. C. jejuni responds to a number of biological 
molecules found in the human intestinal environment such as bile salts leading to 
the induction of Campylobacter invasion antigens (Cia), and norepinephrine in 
response to which the bacterium shows increased virulence. In this study we 
investigated the response of C. jejuni to mammalian pancreatic α-amylase. The 
results of this study show that C. jejuni responds to pancreatic α-amylase with 
production of a mucoid colony phenotype that results from increased secretion of 
extracellular polysaccharide (EPS) identified as an α-dextran, further to this it 
was found that the amount of extracellular protein produced by C. jejuni was also 
increased, the proteins where identified using liquid chromatography mass 
spectrometry (LC-MS), a number of proteins associated with virulence were 
identified in the samples grown in the presence of α-amylase. In response to 
pancreatic α-amylase C. jejuni forms significantly increased biofilm and exhibits 
increased virulence in the Galleria mellonella and Caco-2 epithelial cell models. 
Furthermore C. jejuni pre exposed to amylase show significantly increased 
colonisation of chickens and increased resistance to stresses. It is also shown 
that C. jejuni is able to utilise α-amylase as a nutrient source, this was 
determined by growing the bacterium on a defined minimal media with the α-
amylase as the only source of carbon present. The ability of C. jejuni to respond 
pancreatic amylase was shown to require proteolytic activity of Cj0511. 
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Chapter 1: Introduction 
1.1 Campylobacter historical perspectives and 
background 
 
In the early part of 1906, Sir John McFadyean and Sir Stewart Stockman, two 
British veterinary surgeons, isolated an unknown spiral-shaped organism from 
the aborted foetuses of sheep (McFadyean and Stockman, 1913; Zilbauer et al., 
2008).  The majority of cells observed were shaped like a comma, however some 
cells were described as being long and spiral. These cells were determined as 
actively motile; inoculation into liquid agar that was subsequently allowed to 
solidify exhibited a band of growth corresponding with growth at a region of 
reduced oxygen tension.  
 
Figure 1.1. John McFadyean and Stewart Stockman's photographs of Campylobacter 
species (A) in smears of uterine exudate from an infected ewe. (B) and a culture of 
Campylobacter species in liquid agar which had then been allowed to solidify (Skirrow, 
2006).   
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However, Campylobacter was likely to have been isolated approximately 20 
years prior to the McFadyean and Stockman study. In 1886, Theodor Escherich 
had published a series of articles in the Weekly Munich Medical Review after 
making observations from examining the stool samples of 72 children suffering 
from intestinal diseases and found spiral-shaped bacteria in 35 of them. 
However, it was thought that this spiral-shaped bacterium played no role in 
causation of the disease (Butzler, 2004, Skirrow, 2006). The Escherich articles 
that were written and published in German remained unknown for nearly a 
century until the Third International Campylobacter Workshop held in Ottawa in 
1985 and Manfred Kist presented Escherish’s findings (Kist, 1985) 
Further to the veterinary study of McFadyean and Stockman, in 1919 Theobald 
Smith investigated infectious abortions in cattle in the USA and isolated a 
bacterium that he described as spirillum. This organism was initially described as 
a Vibrio fetus, due to its spiral morphology, and was cultured on a medium 
constituted of agar, gelatin, and serum (Smith, 1919). And in 1931 Jones et al. 
credited winter dysentery in calves to an infection caused by what they called 
Vibrio jejuni (Jones et al., 1931).  
The first well-documented outbreak of human campylobacteriosis was in 1938 
and took place in the US state of Illinois, where 355 inmates of 2 neighboring 
penitentiaries were affected (Levy, 1946). The outbreak was milk-borne and an 
organism resembling Vibrio jejuni was isolated from some of the infected. Then in 
1947 Vinzent et al. isolated V. fetus from the blood of 3 pregnant women 
suffering from illness of unknown origin (Vinzent et al., 1947). The illness 
persisted for approximately a month; consequently 2 of the women suffered an 
abortion. A decade later Elizabeth King observed similar findings to the Vinzent 
et al. (1947) study and called the organism a related Vibrio, although at that time 
there were only a handful of cases describing what we now know as 
campylobacteriosis King postulated that the true number was much higher and 
highlighted the importance of developing a suitable culturing method, to grow the 
bacterium (King, 1957). 
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This breakthrough came in 1968 when Dekeyser at the National Institute of 
Veterinary Research, Brussels, Belgium in collaboration with Buztler at the St 
Peter University Hospital, New Brunswick, Canada developed a method involving 
filtration of stool samples through 0.64 μm membrane filter and inoculation of the 
filtrates onto agar (Dekeyser et al., 1968).  In 1977 a much simpler method of 
culturing both C. jejuni and C. coli was developed by Skirrow who described a 
method of directly culturing faeces onto blood agar containing trimethoprim, 
polymyxin and vancomycin (Skirrow, 1977). The growth condition were defined 
as 43°C in microaerobic conditions constituted of 5 % (v/v) oxygen 10 % (v/v) 
carbon dioxide and 85 % nitrogen (v/v) 
1.2 Campylobacter taxonomy 
The taxonomy of Campylobacter has changed considerably since the inception 
of the Campylobacter genus by Sebald and Veron in 1963, the name meaning 
‘twisting bacteria’ in Greek.  Under the original classification the genus contained 
only 2 taxa, the first being C. fetus and C. bubulus   (Sebald and Veron, 1963). 
The science of taxonomy comprises of 3 disciplines, identification, classification 
and nomenclature. Traditionally bacterial classification was based on cell 
morphology, growth requirements and biochemical tests. As mentioned before, 
Campylobacter was originally classified in the genus Vibrio, a genus which pre-
1963 was very diverse and contained true Vibrio spp. such as V. cholerae. In 
1963 Sebald and Veron discovered that V. fetus and V. bubulus were indeed 
different to other Vibrio spp. this discovery made when they applied the Hugh 
and Liefsen fermentation test as well as looking at the G+C ratio of genomic DNA 
(Sebald and Veron, 1963). Advancements in technology have allowed 
considerable progress in the methods used for bacterial classification, such as 
using 16S RNA sequencing. C. jejuni is today classified as belonging to the 
epsilon class of proteobacteria, order Campylobacteriales; this order also 
includes Helicobacter and Wolinella, these two combined with Campylobacter 
form a genus group known as the rRNA superfamily VI. The Campylobacter 
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genus contains 20 species, and 8 subspecies (Bergey's Manual of Systematic 
Bacteriology, 2005) 
1.3 Epidemiology 
 
Today, C. jejuni is one of the leading causes of bacterial gastroenteritis in the 
world, and a principal cause of diarrhoeal disease in England and Wales. 
According to the Health Protection Agency (HPA) there were 64, 608 reported 
cases of Campylobacter spp. infections in 2011 as in figure 1.2(HPA, 2012). In 
addition to this, the fact that the majority of C. jejuni infections do not require 
hospitalization means many cases go unreported and so the actual incidence is 
presumed to be considerably higher.  
 
Figure 1.2. Incidence of Campylobacterioses per year in England and Wales from 2000 
to 2011 (HPA. 2012). 
The statistics show that by age group, ages 15-44 are the most affected with 
Campylobacteriosis, persons aged between 45-64 are the second most 
frequently infected. Furthermore the number of infections in this group has risen 
25% in the last decade with 14, 355 cases in 2001 to 19,949 cases in 2011. (Fig 
1.3. HPA, 2012). 
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Figure 1. 3. Incidence of Campylobacterioses per age group in England and Wales from 
2000 to 2011 (HPA, 2012). 
 
Campylobacter  spp. infections are present throughout the year but peak in the 
summer months (HPA. 2012) The Department for Environment Food & Rural 
Affairs (DEFRA) state that the economic impact of Campylobacteriosis is 
significant, due to affected individuals being unable to work. In 2009 the Food 
Standards Agency (FSA) conducted a survey of retail-bought chickens and 
reported that 66 % of all chickens sold in retail across the UK are infected with 
Campylobacter spp. (FSA. 2013). 
The Centres for Disease Control and Prevention (CDC) in the United States of 
America report that approximately 13 cases are diagnosed per 100,000 people. 
However, they do estimate that over 2.4 million people are affected every year 
with the vast majority of cases are unreported. They also report that organism is 
isolated more regularly in males than females and predominantly in infants and 
young adults. It is thought that approximately 124 persons with Campylobacter 
infections die each year (CDC. 2012) 
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Campylobacterioses is also a problem in developing countries and primarily 
affects children under the age of 5 years old, as an example the isolation rate is 
17.7 % in Algeria 11% in Egypt and 13% in Bangladesh. C. jejuni infection in 
developing countries does not show seasonal variation as it does in developed 
countries. 
1.4 The gastrointestinal tract 
 
C. jejuni host environment is the human GI tract which consists of its own unique 
intestinal microflora, hometo a vast and diverse bacterial biomass of 
approximately 1014 bacterial almost 10 times the number of eukaryotic cells 
present in the human body, with an estimated 300-500 species (Simon and 
Gorbach, 1984). 
In utero the intestine is sterile, immediately after birth the colonisation of the 
gastrointestinal tract begins; depending on the method of delivery different 
bacteria are acquired, from the maternal birth canal bifidobacteria and 
lactobacilli. If delivery occurs by caesarean section initial colonisation occurs by 
bacteria acquired from the ambient environment, this can affect the overall 
composition of the microflora (Borriello,1986). 
Initial colonisation by pioneer bacteria influence the expression of genes in host 
epithelial cells and create an environment conducive to their own requirements, 
this in turn can result in the prevention of colonisation by bacteria the are 
introduced to the gastrointestinal tract later in life. Therefore this process of initial 
colonisation can have an impact on the permanent flora present throughout the 
lifetime of a person (Bengmark, 1998). 
Babies who are fed formula milk have been shown to contain bacteriodes, 
clostridia and enteric bacteria in comparison to breast fed babies whose 
microflora is comprised of bifidobacteria and lactobacilli. Once the child begins 
on solid food the microbial intestinal composition begins to converge and the 
beginning of the complex permanent adult flora is formed, Gram negative 
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bacteria predominate and a wider range of genera are observed (Bengmark, 
1998). 
In fully grown adults the vast majority of bacteria are contained in the large 
intestine with up to 1012 cells/g of luminal content, this forms a highly dense and 
complex ecosystem. In comparison, the stomach and small intestine contains 
relatively fewer bacteria that adhere to the epithelial cell this is due to the 
conditions created in the upper section of the tract by bile and pancreatic 
secretion which do not allow ingested bacteria to persist. Furthermore, peristalsis 
that propels movement towards the ileum hinders colonisation by bacteria. 
1.4 Pathogenesis 
 
The infective dose of C. jejuni for humans is considered low, approximately 500 
bacteria, compared to another Gram-negative enteric pathogen, Vibrio cholerae 
which requires between 103 to 108 cells for successful infection of the human 
host (Schmid-Hemple and Frank, 2007).  
The onset of disease after ingestion of C. jejuni requires an incubation period of 
24-72 hours, after which symptoms begin to present. Clinical symptoms include 
abdominal pain and diarrhoea that can be mild, non-inflammatory and non-
bloody in some cases, and severe bloody diarrhoea in others. Disease is more 
severe in developed countries in comparison to developing countries. In 
developed countries disease is characterised by fever and abdominal pain 
accompanied with bloody diarrohea, in developing countries the disease is 
characterised by again fever and abdominal pain but the diarrhoea is non-bloody 
accompanied by vomiting and dehydration, in some cases the disease outcome 
can be more severe in developing countries because patients are often 
malnourished (Coker et al., 2002). Furthermore in developing countries infants 
suffer from multiple infections which are followed by increasingly asymptomatic 
disease in older children and adults (Coker et al., 2002).   
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For C. jejuni to cause an infection, the bacterium must first circumvent the 
barriers provided by the GI tract, be they mechanical or immunological. C. jejuni 
corkscrew morphology and high motility allow it to pass through the mucus layer 
of the GI tract which is the first line of defence; another feature which aids this 
process is the short O-side chain of its LOS which reduces non-specific binding 
to mucins (McSweegan et al., 1986). 
Once this initial barrier has been penetrated the bacterium is able to it interact 
with epithelial cells using adherence mechanisms. A constituent of bile, sodium 
deoxycholate stimulates the production of Campylobacter invasion antigens or 
Cia proteins, the secretion of these proteins is not initiated until the bacterium is 
at the site of long-term colonisation (Malik-Kale et al., 2008). Some studies have 
suggested that C. jejuni is able to invade epithelial cells with intracellular bacteria 
being found in patient serum (Rivera-Amill et al., 2001) 
Typically, in healthy individuals, infection is self-limiting and lasts up to 7 days. 
Antibiotics are only recommended to those with severe or prolonged symptoms 
and the antibiotic most commonly prescribed is erythromycin (Al-Abri et al., 2005, 
Zilbauer et al., 2008). Erythromycin has been the drug of choice for treatment of 
most C. jejuni gastrointestinal infections (Al-Abri et al., 2005). This agent is 
characterised by low toxicity, a narrow spectrum of activity and low cost (Allos 
and Blaser, 1995).  The resistance of C. jejuni to erythromycin is less than 5% 
with little change in this resistance rate (Allos and Blaser, 1995)  
In rare cases, patients can develop a serious complication as Guillain–Barré 
syndrome (GBS) and its variant variant Miller-Fisher syndrome (MFS). GBS is an 
autoimmune disorder resulting in paralysis of the peripheral nervous system. 
Approximately 66 % of all GBS patients have had C. jejuni intestinal infection one 
to three weeks prior to the onset of GBS, therefore C. jejuni is thought to be the 
fundamental predisposing factor associated with development and onset of GBS 
(Prendergast et al., 1998). With the decline of polio, GBS has now become the 
principal cause of acute neuromuscular paralysis, with an annual incidence of 1-2 
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cases per 100 000 in many parts of the world (Blaser et al., 1997; Buzby et al., 
1997; Nachamkin, 1997; Wassenaar et al., 2000).   
Clinical features of GBS can include loss of tendon reflexes and symmetrical 
weakness that usually affects the lower limbs and progresses in an ascending 
fashion, and loss of proprioception. GBS can also affect the lower cranial and 
thoracic nerves that can result in respiratory difficulties. The majority of patients 
require hospital treatment and approximately one in three require treatment for 
respiratory failure (Schmidt-Ott et al., 2006). Features such as fluctuations bowel 
function, blood pressure and heart rate can also be observed (Hahn, 1998, 
Hadden and Gregson, 2001). 
 
A number of studies have stated that specific serotypes of C. jejuni are 
associated with the onset of GBS, (Kuroki et al., 1991). Studies by Kuroki et al. 
(1993) and Fujimoto et al. (1992) found C. jejuni O:19 to be predominant 
amongst Japanese patients suffering from GBS.  
 
1.5 Virulence factors 
1.5.1 Capsular Polysaccharides  
 
It has been postulated that virtually every virulence factor associated with 
bacterial pathogenesis is secreted or positioned on the cell surface (Finlay and 
Falkow, 1997). Surface polysaccharides represent the predominant structures on 
all bacterial cell surfaces, and they are often important in the interactions 
between pathogens, their hosts and the environment 
Capsular polysaccharide (CPS) plays an integral role in bacterial survival in the 
environment as well as contributing to virulence and pathogenesis.  CPS is found 
on the surface of many bacteria, and can contribute to pathogenesis by providing 
structural variation, imitating host antigens and resisting phagocytosis and 
complement-mediated killing (Guerry and Szymanski, 2008). A significant 
20 
 
proportion of the C. jejuni genome is dedicated to polysaccharide synthesis as 
much as one-tenth of the genome might be devoted to carbohydrate synthesis 
(Mclennan et al., 2008).  
C. jejuni has a high molecular weight capsular polysaccharide, whose synthesis 
is dependent on the kps gene cluster (Karlyshev et al., 2000; Parkhill et al., 
2000). The CPS is a means of determining the Penner serotype, and has been 
shown to be phase variable (Karlyshev et al., 2001; Bacon et al., 2001). Bacon et 
al. (2001) showed that a non-capsulated C. jejuni 81-176 kpsM mutant showed a 
significant decrease in the ability to infect INT407 cells and reduced virulence in 
a diarrhoeal disease ferret model. Based on such evidence, CPS is considered 
one of the definite factors associated with virulence (Guerry and Szymanski, 
2008). 
1.5.2  Lipo-oligosaccharides  
 
C. jejuni expresses a second surface carbohydrate, a lipo-oligosaccharide (LOS) 
which is anchored into the membrane by a segment of lipid A which is attached 
to an extracellular-positioned short oligosccahride unit via 2-keto-3-deoxy-
octulosonic acid (KDO). The LOS is hyper-variable, consistent with a function in 
avoiding host immune action. The hyper variability arises from homopolymeric 
tract variation in genes, cgtA and wlaN, the former encodes an N-
acetylgalactosaminyltransferase, and the latter encoding a β-1,3 
galactosyltransferase (Linton et al., 2000; Guerry et al., 2002).  Mutations in gene 
cgtA have been shown to increase resistance to normal human serum and 
intestinal epithelial cell invasion (Guerry et al, 2002; Guerry et al, 2000). 
C. jejuni LOS are distinct from other bacterial LOS as they are able to imitate the 
structure of human gangliosides. This ability to imitate causes antibodies 
targeted against the C. jejuni LOS ganglioside to react with host gangliosides 
resulting in the development of autoimmune neuropathies such as GBS (Guerry 
and Szymanski, 2008). 
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1.5.3 Flagella  
 
C. jejuni possesses either uni-polar or bi-polar unsheathed flagella providing the 
bacterium with a high degree of motility. Motility is required to overcome the 
peristalsis present the gut and is criterion for entry into the mucous layer and 
subsequent colonization of host tissue (Wassenaar et al., 1993). Flagella also 
play a role in chemotactic motility: C. jejuni exhibits chemotaxis towards amino 
acids that are present in abundance in the gastrointestinal tract of the host 
(Young et al., 2007).  
Mutation in the response regulator that controls flagellar rotation CheY, exhibit 
decreased virulence in the ferret mode (Yao et al.,1997) The function of the 
flagellar apparatus is not restrained only to motility; constituents of the flagellar 
apparatus are used to export certain proteins. The flagellar export apparatus is 
used not only for the export of flagellin subunits but also for the export of other 
proteins, the so-called Campylobacter invasion antigens (CiaA-H) that are 
required for adhesion to and invasion of epithelial cells  (Konkel et al., 2004).  
These antigens are produced during coculture with INT407 epithelial cells, 
insertional mutagenesis of the ciaB gene resulted in a significant reduction in C. 
jejuni invasion (Konkel et al, 1999). However, Novik et al (2010) found that a 81-
176 ciaB mutant did not exhibit any measurable deficiency in its ability to invade 
T84 epithelial cells (Novik et al., 2010) 
Genes flgB, flgC and flgE2 are involved flagellar filament assembly and 
mutations in these genes resulted in the inability to secrete protein CiaB, 
demonstrating a function in flagellar assembly and export. To successfully 
secrete CiaB either FlaA or FlaB are required, additionally in vitro cell invasion of 
INT407 cells is dependent on secretion of these Cia antigens and motility. 
(Konkel et al., 2004). 
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1.5.4 Cytolethal distending toxin (CDT) 
 
Other bacterial species, such as Escherichia coli and Helicobacter hepaticus, 
produce a CDT that is related to that of C. jejuni. CDT functions by causing 
eukaryotic cells to stop in the G1/S or G2/M transition cell cycle preventing them 
from entering the mitotic cell cycle (Whitehouse, et al., 1998). 
CDT is composed of 3 subunits known as CdtA, CdtB and CdtC, which are 
membrane-associated proteins and are required for the induction of IL-8 (Lara-
Tejero and Galan., 2000).  Transfection with CdtB into host cell leads to the 
same outcome as seen with complete CdtABC complex suggesting that CdtB is 
the toxic component of the of the 3 subunits, furthermore CdtB has been shown 
to share homology with mammalian DNase I (Lara-Tejero and Galan., 2000). 
CdtB causes damage to DNA by phosphorylating protein H2AX, which 
contributes to the structure of DNA by nucleosome formation. 
It has been suggested that CdtA and CdtC play a pivotal role in delivering CdtB 
to the host cell nucleus to allow the protein to operate as a DNase (Lara-Tejero 
and Galan, 2001). However the complete role of CDT in the pathogenesis of C. 
jejuni disease remains undetermined. 
 
1.5.5 Glycosylation Pathways 
 
C. jejuni posses both O-linked and N-linked glycosylation pathways. The N-linked 
system is responsible for post-translational modification of proteins by modifying 
asparagine residues.  The system is encoded by a single gene cluster termed the 
protein glycosylation locus (pgl). N-linked glycosylation is an important virulence 
factor (Hendrixson and DiRita, 2004; Young et al., 2002). Karlyshev et al. (2004) 
reported that a pglH mutant was unable to glycosylate numerous proteins, 
showed a reduced ability to adhere to and invade human epithelial cells, and was 
unable to colonize chicks. 
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O-linked glycosylation functions by modifying serine or threonine residues on 
flagellin, the flagellin proteins are O-glycosylated and this is essential for 
successful construction of flagella. The importance of flagella for motility and the 
flagellar export apparatus for the secretion of the Cia proteins means that O-
linked glycosylation has a direct impact on motility and ultimately affects 
adhesion, invasion and virulence (Guerry et al., 2006). 
 
Figure 1.4. The Campylobacter jejuni glycome and surface structures. Showing 
flagellum, capsule and LOS (Young et al., 2007)  
 
1.5.6 Adherence mechanisms 
 
In order to successfully colonise the host microbial pathogens must first adhere 
to host surfaces.  In many Gram-negative and Gram-positive bacteria this 
adherence is supported by appendage like structures known as pili. Essentially 
there are 2 types of bacterial adherence mechanisms the first being fimbriae or 
pilus, and the second being afimbrial adhesins. C. jejuni has no genetic 
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homologues for genes encoding pilus-like structures (Finlay and Falkow., 1997; 
Parkhill et al., 2000) 
Although C. jejuni does not possess any specific adhesion organelles it does 
produce a number of adhesins, one these is JlpA a surface exposed lipoprotein 
which binds Hsp90 resulting pro-inflammatory responses by activation of NF-κB. 
Mutants of jlpA showed markedly reduced adherence to Hep-2 cells when 
compared to the wild-type strains (Jin et al, 2001). CapA is another lipoprotein 
thought to be an adhesin, mutants lacking CapA have shown reduced 
colonisation in a chick model and reduced adherence to in vitro Caco-2 cells, 
indicating its role in adhesion (Ashgar et al., 2007). 
C. jejuni synthesises a 37 kDa outer membrane protein termed CadF which binds 
to a constituent of the extracellular matrix of human colonic tissue known as 
fibronectin. Mutants unable to synthesize CadF exhibited significantly reduced 
colonization of a chicken model, and reduced adherence and invasion in vitro 
(Monteville et al., 2003; Konkel, 2005). A study by Flanagan et al. (2009) showed 
that fibronectin-like protein A (FlpA) promotes binding of C. jejuni to host epithelia 
and plays a role in the colonistaion of chickens (Flanagan et al., 2009).   
The peb1A a periplasimic gene product acts as an adhesin and is required for 
adherence to HeLa cells  and also colonisation of mice. Peb1 has been shown to 
be an L-glutamate and L-asparagine binding protein component of an ABC-
transporter, it is required to metabolise these amino acids and strains mutations 
in peb1A are unable to grow if these amino acids are the major constituents of 
growth media (Leon-Kempis et al., 2006).  
 
1.6 Biofilms 
Bacteria can exist either as planktonic cells or as a biofilm. Bacteria favour 
growing after attachment to a surface, then form an enclosed microbial 
community within a matrix known as a biofilm (Jenkinson and Lamont, 2005). 
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Microbial biofilms where first described in 1936 by Zobell and Anderson who 
studied the multiplication of bacteria in sea water. 
There are a number of hypotheses as to why bacteria form biofilms. The primary 
reason is defence. The microorganisms inside the biofilm matrix are able to avoid 
antimicrobial agents; in some cases a 100-fold increase in antibiotic 
concentration has been shown to be required to kill the biofilm organisms 
compared with that required to kill the same microbes in planktonic form 
(Jefferson, 2004). Existing as a biofilm also allows organisms to withstand host 
immune responses such as phagocytosis and as a community they can endure 
changes in pH and starvation of nutrients (Jenkinson and Lamont, 2005).  
The best characterised bacterial biofilms are oral biofilms. If we look at the 
mechanism of biofilm formation in the oral cavity we see that the process begins 
when a pioneer organism forms a primary colony on salivary pellicle after 
attaching to specific surface receptors. In the oral cavity this pioneer organism 
may one of a number of Streptococci, and the surface they preferentially adhere 
to is tooth enamel (Petersen et al., 2006).  
After this initial step, the primary colonising bacteria form a link for other species 
of bacteria such as Actinomyces and Fusobacterium to attach, subsequent 
growth and expansion allows other species that are present as planktonic 
bacteria to attach and form a diverse species biofilm (Jenkinson and Lamont, 
2005). 
Another reason for biofilm formation specifically in the mouth, is that it is a 
favourable site for bacteria to grow as it has a constant supply of nutrients and 
exhibits surfaces which are ideal for growth and survival as well as inevitable 
multiplication. Therefore growing as biofilm is preferential to remaining an 
attached community (Jefferson, 2004) 
It has been hypothesised that in natural habitats bacteria are predominantly 
found in mixed species biofilms rather than planktonic cells, and are therefore 
multi-cellular organisms. Bacteria in biofilms do exhibit behaviour similar to a 
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multi-cellular organism. For example, bacteria in biofilms develop architecture, 
they are built with various species, providing numerous micro-environments in 
which they can interact with their surroundings. This enables them to adjust their 
metabolic processes to maximize the use of available substrates and to protect 
themselves from detrimental conditions (Jenkinson and Lamont, 2005).  
The gastrointestinal tract is covered with a layer of mucus which is produced by 
goblet cells that are present within the intestinal epithelium, they also produce 
and secrete mucins which form the thick gel-like properties of the mucus layer 
and vary in thickness from 48 to 273 µm. In healthy individuals, this mucus layer 
provides protection so the host cells are never exposed to luminal content. 
(Pullan et al., 1994).  
C. jejuni 81-176 has been shown to form microcolonies and biofilms on human 
intestinal tissue, and it has been suggested that biofilm formation on the intestine 
is prerequisite for causing diarrhoea in humans (Haddock et al., 2010). 
Joshua et al. (2006) showed that C. jejuni is able to form both attached and 
unattached biofilm.  These unattached aggregates of biofilm known as ‘flocs’ are 
more resistant to environmental stresses and are thought to be important in 
survival and pathogenesis of the organism.  Further to this, C. jejuni has the 
ability to form attached biofilm on the surfaces of domestic and farming watering 
supplies and these attached bacteria could potentially act as an active reservoir 
of infection for humans and domestic animals (Reeser et al ., 2007).  
Biofilm-forming ability of C. jejuni is decreased in the presence of nutrient rich 
media, concurring with the idea that it is a stress response. Reeser et al. (2007) 
reported that biofilm formation is significantly decreased when C. jejuni is grown 
in nutrient-rich media. They also found that motility is an important factor for 
optimal biofilm formation; flaAB mutants, which are deficient in a motile flagellum, 
and luxS mutants, which are deficient in a quorum sensing signal molecule called 
autoinducer-2 (AI-2), showed significantly decreased ability to form biofilm 
(Reeser et al., 2007).   
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One of the major withstanding questions with regards to C. jejuni biofilms is the 
composition of the extracellular polymeric matrix or EPM. The EPM is what holds 
the biofilm together, providing structure and strength; for most bacterial biofilms 
the EPM is constituted of polysaccharide. However in the case of C. jejuni 
biofilms, the best characterised polysaccharide, the CPS, is not involved in 
biofilm formation as shown by Joshua et al. (2006) who reported no reduction in 
the biofilm forming capacity of a C. jejuni NCTC 11168 kpsM mutant (CPS 
deficient). 
1.7 Metabolism of C. jejuni 
 
The metabolism of C. jejuni is not yet fully understood. It is an asaccharolytic 
organism unable to metabolise exogenous sugars as a carbon source due to a 
deficiency of phosphofructokinase, a glycolytic enzyme which acts upon fructose 
6-phosphate (Hofreuter et al., 2008). 
 
Instead, C. jejuni metabolises amino acids as a carbon source, with a preference 
for apartate, serine, glutamate and proline (Leach et al., 1997; Guccione et al., 
2008). The organism only has a limited number of catabolic enzymes which 
utilise the above named amino acids as well as asparagine and glutamine 
(Velayudhan et al., 2004).  
 
1.7.1 Serine 
 
The L-isomer of serine is preferentially utilised by C. jejuni as it is able to convert 
L-serine into pyruvate, this conversion occurs when serine is transported into the 
cell via SdaC a serine transporter and  after which protein SdaA an active serine 
deaminase  which converts L-serine to pyruvate.  (Mendz et al., 1997). Pyruvate 
is a major metabolic intermediate that allows the utilisation of amino acids for 
energy generation through biosynthetic pathways (Mendz et al., 1997). C. jejuni 
metabolises pyruvate through the citric acid cycle and pyruvate:flavodoxin 
oxidoreductase (Guccione et al., 2008). 
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Inhibition of SdaA and SdaC synthesis resulted in complete impairment of chock 
colonistaion, showing that metabolistaion of L-serine is essential for colonisation 
(Velayudhan et al., 2004). 
1.7.2 Proline 
 
Proline which is a constituent of mucins and is abundant in the gastrointestinal 
tract has been found by Wright et al. (2009) to be a less favoured in comparison 
aspartate, glutamine and serine metobilisation. Proline is utilised through two 
proteins PutA a bifunctional proline dehydrogenase/delta-1-pyrroline-5-
carboxylatedehydrogenase and PutP is a sodium/proline symporter. PutAP 
proteins are homologues to ones seen in both E. coli and Helicobacter spp and 
PutA has been to be a key a factor for its motility and subsequent stomach 
colonisation (Krishnan et al., 2008; Nakajima et al., 2008). 
1.7.3 Asparagine 
 
It has been suggested that asparagine metabolisation plays a role in tissue 
specific colonisation; this conclusion is based on mutation in gene ansB, a 
asparaginease, resulting in decreased colonisation of the liver in mice however 
this reduction in colonisation was not observed in the murine intestine (Hofreuter 
et al., 2008).  
Although C. jejuni possess an asparaginase, many strains do not possess a 
functioning asparagine transporter, and are unable to ultilise asparagine. Strains 
such as 81-176 have an extended ansB gene by approximately 40 bp which 
encodes a Sec dependent signal peptide and this peptide allows the AnsB 
protein to transported from cytoplasm where it is generally found to  the 
periplasm, where it can function by deaminating asparagine to aspartate 
(Hofreuter et al., 2008). 
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1.7.4 Glutamine 
 
Some C. jejuni strains such as 81-176 synthesis γ-glutamyltranspeptidase (GGT) 
which enables them to directly utilise glutamine as a principal nutrient source 
(Hofreuter et al., 2006). However, Hofreuter et al. (2008) showed that strain C. 
jejuni NCTC11168 does not utilise glutamine as a source of carbon despite 
having a complete functional glutamine uptake system. 
This uptake system contains components of amino acid ABC transporter PaqP 
and PaqQ, glutamatehydrogenase encoded by gltBD which converts glutamine 
and 2-oxoglutarate into glutamate and a glutamine synthase encoded by glnA 
which catalyses the process of converting glutamate back into glutamine. 
1.7.5 Short chain fatty acids 
 
C. jejuni is also able to metabolise short chain fatty acids acetate and lactate 
which are abundant in the gastrointestinal tract of humans.  When other primary 
metabolites are exhausted C. jejuni switches to acetate and lactate metabolism, 
acetate that is a by-product of the metabolism of L-serine. No acetate transporter 
has been documented in C.jejuni except for an annotated acetate permease 
encoded by actP in C. jejuni subsp. doylei (Parker et al., 2007). Wright et al. 
(2009) showed that acetate can be used as a primary source of carbon in vitro. 
Lactate, a product of carbohydrate fermentation by gut microflora is produced in 
profuse quantities but is taken up by many gastrointestinal bacteria keeping the 
overall concentration of lactate in the colon reasonably low. Lactate is 
transported into the cell via a L-lactate permease encoded by lctP, however 
lactate transport is not completely dependent on lctP a mutation in in this gene 
resulted in decreased lactate metabolisation leading to the proposition that 
another yet unidentified transporter and/or mechanism is involved (Thomas et al., 
2011). 
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Once lactate has been transported into the cell it converted in pyruvate by a 
number of methods. The first involves three genes, Cj0073c, Cj0074c, and 
Cj0075c (lldEFG/lutABC) encode a non-flavin iron–sulfur containing 
oxidoreductase, and convert s L-lactate to pyruvate through deamination. The 
second a flavin and iron–sulfur containing enzyme Cj1585c (Dld) also shows L-
acetate dehydrogenase activity. C. jejuni has also been shown to utilise the D-
isomer of lactate (Thomas et al., 2011). 
 
 
Figure 1.5: The predicted amino acid transport and catabolism pathways in C. jejuni 
NCTC11168. Dashed arrows represent pathways of importance under oxygen-limited 
conditions. Solid arrows represent predicted functions of pathways under microaerobic 
conditions (Guccione et al., 2008). 
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1.8 Models for the study of C. jejuni virulence and 
colonisation 
 
Despite the advances in the study of C. jejuni virulence, the mechanisms by 
which C. jejuni colonises the host and causes disease are still relatively poorly 
understood. A major reason for this the lack of a practical animal model to study 
Campylobacterioses.  
A variety of animal models have been proposed for study of C. jejuni-mediated 
disease these include; the ferret model which was used by Bacon et al. (2001) to 
elucidate that the phase-variable Capsular polysaccharide (CPS) was a 
significant virulence factor. Other models such as the rabbit ileal loop method 
have been used, this particular model was first used by Everest et al. (1993) to 
examine pathological changes in rabbit ileal tissue after C. jejuni infection. 
Primates such as infant rhesus macaques (Macaca mulatta) and the New World 
monkey Aotus nancymae have also been used (Russell et al., 1993; Jones et al., 
2006). However ethical concerns and inadequate representation of human 
campylobacterioses has prevented the widespread application of these models. 
1.8.1 Chicken 
 
Campylobcater jejuni is able to colonise the avian gastrointestinal tract, and the 
contamination of broiler chicken meat is a principle source of 
Campylobacterioses. However, this colonisation is asymptomatic and is 
considered to be a commensal association with the host (Newell, 2001).   With 
the problems and limitations of the models described above, the chicken 
colonisation model has become a frequently used colonisation model.  
Campylobcater jejuni predominantly colonises the caecum of chicken, generally 
between 106 to 108 cfu/g (Beery et al., 1988). This ability to successfully colonise 
the chicken gastrointestinal tract is a multifactorial process;  the model has been 
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used to elucidate genes and mechanisms that are vital for colonisation of, and 
survival within the host. 
Chicken colonisation models for C. jejuni are categorised into 2 groups, the first 
uses chicks that are up to 2 days old and the second group use chickens 
between 14 and 16 days. Although the model does not provide a true 
representation of human disease, the model has been used to determine 
colonisation factors such as motility, chemotaxis, two-component regulatory 
systems and Oxidative and nitrosative stress response among many others (Lin 
et al., 2003; Raphael et al., 2005: Karlyshev et al., 2002; Bras et al., 1999; Atack 
and Kelly, 2009). 
1.8.2 Galleria mellonella 
 
In 2010 Champion et al, reported that the larvae of Galleria mellonella or Greater 
Wax Moth can be successfully infected by C. jejuni and this model can be utilised 
to screen for genes involved in virulence.  
Insect models of infection have been used as alternatives to mammalian models 
due to their cost effectiveness and non-requirement of ethical consent. The most 
commonly used invertebrate for infection is the nematode species 
Caenorhabditis elegans, it has been used to study marine bacteria such as 
Shewanella frigidimarina and Aeromonas hydrophila. However the limitations of 
the C. elegans model are its inability survive at 37°C they also lack functional 
homologues of the mammalian immune system such as phagocytic cells. Using 
insect larvae overcomes these disadvantages because they can survive at 37°C 
and have structures known as hemocytes which function in a similar fashion as 
components of the human innate immune system (Champion et al., 2010).  
Senior et al. (2011) used the model to show that C. jejuni can survive within G. 
mellonella causing significant damage to the gut of these larvae. 
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1.8.3 Murine model  
 
The mouse model is a useful tool for the study of bacterial pathogenicity.  
However murine models for the study of C. jejuni infection, have disadvantages 
including sporadic colonization and absence of clinical manifestations of disease; 
this is partially due to mice which have a normal commensal microflora exhibiting 
colonisation resistance against C. jejuni (Friedman et al., 2000). Therefore 
germfree mice, which have a restricted gut microflora, have been an attractive 
model and have been used with success (Hodgson et al., 1998). Chang and 
Miller (2006) used the limited flora murine colonisation model to characterise 
virulence determinants required for colonisation and described the model as a 
tractable, reproducible tool which they used to define host responses to 
colonisation (Chang and Miller, 2006). Furthermore, a number of studies have 
induced clinical manifestations of disease such as bloody diarrhea, and humoral 
immune responses in isolator-raised germfree mice (Yrios and Balish, 1986a; 
Yrios and Balish, 1986b; Jesudason et al., 1989; Youssef et al., 1987). 
However, germfree mice have abnormal gut lymphoid tissue development and 
therefore lack a complete innate immune system (Shroff and Cebra, 1995). Mice 
lacking MyD88 an innate immunity adaptor protein, which plays an essential role 
in Toll-like receptor (TLR) signalling, were colonised by C. jejuni but did not 
develop intestinal inflammation, a key clinical symptom (Watson et al., 2007). 
Furthermore, the outcomes of C. jejuni infection vary between genetically 
engineered mice; this highlights the lack of a robust, reproducible mouse model 
(Mills et al., 2012) 
1.8.4 Intestinal cell invasion model 
 
As an alternative to using live animals to model Campylobacterioses in vitro 
epithelial cells are utilised. Cell lines used to study C. jejuni infection include the 
INT407 cell line, a human embryonic intestinal cell line, and the Caco-2 human 
colon adenocarcinoma line (Friis et al., 2009). 
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These cells are used to assess the ability of C. jejuni to adhere to the 
extracellular cell surface of the epithelial cells and the ability to invade the 
epithelial cells. Of the two cell lines the Caco-2 cell line is considered favourable 
to study including columnar shape, become polarised and form tight junctions 
and express microvilli (Bak et al., 1999). 
It has been shown that data obtained from in vitro cell lines accurately mimics 
that obtained using animal models of infection, for example mutations of genes 
cheY and kpsM in strain 81-176 exhibited reduced virulence in a ferret disease 
model these results corroborated with the findings of cell culture results showing 
reduced adherence and invasion (Yao et al., 1997; Bacon et al., 2001). 
1.9 Aims of study  
 
C. jejuni has evolved to respond to a number of biological molecules found in the 
host intestinal environment. The bacterium responds to human bile salts (sodium 
deoxycholate) leading to the induction of Campylobacter invasion antigens (Cia), 
which are required for host cell invasion (Malik-Kale et al., 2008). C. jejuni also 
responds to norepinephrine, a neurotransmitter which has been found to spill 
over into the intestine. When grown in iron-limited medium in the presence of 
norepinephrine, C. jejuni shows an increased growth rate, motility and ability to 
invade epithelial cells (Cogan et al., 2009). 
Therefore it is possible that C. jejuni has evolved to respond to other biological 
molecules specific to the host intestinal environment. The pancreas is the 
predominant digestive gland in the human body; it is a dual functioning gland 
possessing both endocrine and exocrine features. This exocrine function plays a 
major role in digestion of carbohydrates, proteins and lipids (Farges et al., 1996). 
Pancreatic α-amylase functions by cleaving the α1-4 glycosidic bonds of 
polysaccharides to generate dextrin, maltose or maltotriose. Also, hyperamylasia 
has been reported in clinical cases of severe campylobacterioses (Tositti et al., 
2001; Peterson and Besendorfer, 2012). 
35 
 
 
The aims of this study are to determine whether C. jejuni is able to recognise and 
respond to mammalian pancreatic α-amylase. Furthermore, to characterise how 
the responses of C. jejuni to pancreatic α-amylase affects the virulence of the 
organism by assessing changes in colony morphology through secretion of exo-
polymers, subsequent biofilm formation and resistance to stresses. Furthermore, 
the effects of α-amylase on growth rate, virulence and colonisation as well as 
elucidating the molecular basis of the response. 
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Chapter 2: Materials and methods 
2.1 Growth media and reagents 
All the media and supplementary components used for bacterial growth are 
summarized below. 
2.1.1 Media 
Table 2.1. Bacterial growth medium. 
Medium name Components and Source 
Luria-Bertani Broth (LB) As supplied by Oxoid 
 
Mueller Hinton Broth (MHB)                                                        Oxoid 
 
Charcoal Mueller Hinton Agar (CMHA)                                                 MHB
1.5 % bacteriological agar (Oxoid) 
0.4 % Charcoal (BDH) 
 
Minimum Essential Media-α (MEM-α) 
agar   
MEM-α (Sigma) 
20 mM sodium pyruvate  
1.5 % bacteriological agar (Oxoid)  
 
Brucella Broth (BB)                                                              Beckton Dickinson 
  
Columbia Blood Agar (CBA) Oxoid 
Typical formula: 
2.3% w/v Special peptone    
0.1%  w/v Starch    
0.5% w/v Sodium chloride    
1% w/v Agar  
 
 
7% sterile defibrinated horse blood (E 
& O Laboratories) 
 
Nutrient Agar Oxoid 
 
Dulbecco’s modified essential media 
(DMEM) 
Gibco 
Super Optimal broth with Catabolite 
repression (SOC)  
Promega 
 
Standard American Petroleum Institute KCl     3.35 mM 
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(SAPI) medium  
 
KH2PO4   1.84 mM 
MgSO4  1.01 mM 
NH4NO3  6.25 mM 
Tris   50 mM 
FeSO4  10 μM 
 
pH adjusted to 7.5 using HCl. 
1.5 % bacteriological agar 
Starch Agar Nutrient agar (Oxoid 
 0.4 % (v/v) starch (Sigma-S9765) 
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2.1.2 Supplementary components  
Table 2.2. Supplementary components. 
Supplementary Component Source 
α-amylase from hog pancreas 
(powder)  
Sigma-Aldrich (cat no. 10080) 
α-amylase from Aspergillus oryzae 
(aqueous solution) 
Sigma-Aldrich (cat no. A8220) 
Trypsin from porcine pancreas 
(powder)  
Sigma-Aldrich (cat no. T7409) 
Mucin from porcine stomach (powder)
  
Sigma-Aldrich (cat no. M2378) 
Albumin from bovine serum (BSA)  
(powder) 
Sigma-Aldrich (cat no. A2153) 
Bile from porcine extract (powder) Sigma-Aldrich (cat no. B8631) 
Protease inhibitor cocktail Sigma-Aldrich (cat no. P8465) 
Azocasein solution  Sigma-Aldrich (cat no. A2765) 
Lugol iodine solution  Sigma-Aldrich (cat no. L6146) 
Starch Sigma-Aldrich (cat no. S9765). 
Live/Dead BacLight stain  Invitrogen (L-7012) 
Foetal bovine serum  Sigma-Aldrich (cat no. F6178) 
Non-essential amino acids Sigma-Aldrich (cat no. M7145) 
Penicillin streptomycin solution Sigma-Aldrich (cat no. P4333) 
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2.2 Bacterial strains, plasmids and culture conditions  
 
The bacterial strains and plasmids used in this study are listed in Table 2.3.  
Table 2.3. Strains and plasmids used in this study. 
Strains and plasmids Characteristics                   Reference 
C. jejuni 11168H 
Hypermotile variant of C. 
jejuni NCTC 11168  
Karlyshev et al. (2002) 
 
C. jejuni 81-176 
 
Clinical isolate from 
human diarrhoeal 
sample 
 
Korlath et al. (1985) 
C. jejuni 11168H 
kpsM::aphA3 
Mutation of gene 
encoding ABC 
transporter involved in 
capsule assembly, by 
insertion of Kanr gene 
aphA-3 resulting in 
inability to express CPS 
Karlyshev et al. (2001) 
 
C. jejuni 11168H 
waaF::aphA3 
Mutation of gene 
encoding 
heptosyltransferase II  by 
insertion of Kanr  gene 
aphA-3 resulting in a 
truncated core 
oligosaccharide 
 
Campylobacter 
Resource Facility 
 
C. jejuni 11168H 
waaC::aphA3 
Mutation of gene 
encoding 
heptosyltransferase I by 
insertion of Kanr  gene 
aphA-3 resulting in the 
expression of a severely 
truncated LOS 
 
Campylobacter 
Resource Facility 
 
C. jejuni 11168H 
spoT::aphA3 
 
 
Mutation of gene that 
governs stringent 
response by insertion of 
Kanr  gene aphA-3 
resulting. Resulting 
mutant is unable to 
express and increased 
level of CFW-binding 
polysaccharide 
 
This study 
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C. jejuni 11168H 
Cj0511::aphA3 
 
 
Mutation of gene 
encoding for secreted 
carboxyl-terminal 
protease. 
Campylobacter 
Resource Facility 
 
11168H Cj0511::aphA3 
pWJ4 
 
 
Complemented strain 
containing Cj0511 gene 
and  Camr inserted into 
pseudogene Cj0046 
This study 
E. coli JM109 Cloning host 
(F¢ (traD36, proAB+ 
lacIq, D(lacZ)M15) 
endA1 recA1 
hsdR17(rk-, mk+) mcrA 
supE44 l- gyrA96 relA1 
D(lacproAB) thi-1) 
 
Promega 
Plasmids 
pJMK30  pUC19 derivative 
carrying C. coli Kanr  
gene aphA-3 
 
van Vliet et al. (1998) 
 
pGEM-T-Easy Cloning vector enables 
TA cloning  
 
Promega 
pWJ1 pGEM-T-Easy derivative 
with C. jejuni 11168H 
spoT gene  
 
 
This study 
pWJ2 pWJ1derivative with 
aphA3 inserted into spoT 
gene at the BglII site 
 
This study 
pET151/D-TOPO 
 
Protein expression 
vector  containing T7 
promoter, lac 
operator,ribosome 
binding site, 
Initiation ATG, and  
polyhistidine region 
 
Invitrogen 
pWJ3 
 
pET151D-TOPO 
derivative with C. jejuni 
Cj0511cloned 
downstream of ribosome 
binding site. 
 
This study 
pC46fdxA 
 
 pC46 derivative with  
fdxA promoter, Camr 
selection marker. 
 
Institute of Food 
Research 
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pWJ4 
 
Derivative of pC46fdxA 
containing Cj0511 
 
This study 
 
 
All C. jejuni strains were stored at -70 °C in Brucella broth supplemented with 
15 % (v/v) glycerol. Bacteria were revived by plating on CBA and grown at 37 
°C in an atmosphere of 5 % (v/v) CO2 for 48 hours.  
2.2.1 Antibiotic selections  
 
The antibiotics used in this study are listed in Table 2.4. Stock solutions were 
prepared at 1000x concentration.  
Table 2.4. Antibiotics used for culture of C. jejuni and E. coli. 
Antibiotic  Diluent  Final concentration 
(μg/ml)  
Ampicillin (Amp)  Filtered dH2O  100  
Chloramphenicol (Cam)  Ethanol  20  
Kanamycin (Kan)  Filtered dH2O  40 
 
2.3 α-Amylase Agar 
α-Amylase powder from hog pancreas, were all made into a suspension using 
distilled water and added into the respective media at a final concentration of 
5 µg/ml (100 nM). To improve visualization of C. jejuni colonies, 0.4 % (w/v) 
charcoal was used. 
2.4 DNA Techniques 
2.4.1 Plasmid purification  
Plasmid preparation from E. coli and C. jejuni was performed by using the 
Spin column plasmid miniprep kit (NBS Biologicals) according to the 
manufacturer’s instructions.  
2.4.2 Genomic DNA extraction 
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C. jejuni genomic DNA was extracted using the Promega Wizard Genomic 
DNA Purification Kit according to the manufacturer’s instructions. 
2.4.3 Agarose gel electrophoresis 
DNA fragments were separated by electrophoresis in 0.8 % (w/v) agarose 
(Sigma-Aldrich) in 1× Tris-Acetate-EDTA (TAE) buffer (40 mM Tris-acetate 
and 1 mM EDTA, pH 8.3) containing 0.1g/ml ethidium bromide. Samples were 
run in 1×loading buffer (0.05 % (w/v) bromophenol blue, 5 % (v/v) glycerol in 
dH2O at 80-100 V for 1 h. The 1 kb plus DNA ladder (New England Biolabs) 
was included as a size marker. The DNA bands were detected under 
ultraviolet light at 302 nm using an Alpha Innotech Alpha Imager. 
2.4.4 DNA purification from gel or solution 
PCR amplified DNA fragments were purified by using Qiagen PCR purification 
columns. Gel purified DNA fragments were excised from agarose gels and 
purified using a Qiagen Gel Purification Kit.  
2.4.5 PCR protocol 
Where amplicons were to be used for TA cloning, amplification was carried 
out using a 1:4 mix of VentR
® DNA polymerase and Taq DNA polymerase 
(New England Biolabs); otherwise PCR used VentR
® DNA polymerase or Taq 
DNA polymerase. The primers used for PCR are listed in Table 2.5 
Table 2.5. Primers for PCR amplification. 
Primer name                         Sequence (5’>>>3’) 
WJ1 TATTGCTTGAACAATTAATCG 
WJ2 TCTTTAGCATATTCATAAAGC 
WJ3 TTGGCGTATAACATAGTATCG 
WJ10F GTCGTCTCACATGTTGAAAACAAAACG 
WJ10R GTCGTCTCACATGTTATTGTCCTTGTTTG 
WJ11 GGAACACAGCAGAGCACTTG 
WJ12 CCTGGAGAAGTATTAGATAGTAGCG 
CJ1AF CACCAAAGTTGATCAAAAAGAAGAGC 
CJ1AR CTATTGTCCTTGTTTGATATTTAA 
PfdxAF GTAAATTTTTGATTATCAAAATTTACATTATTTAAG 
43 
 
 
Reaction mix  
Qiagen PCR buffer                            1×                  
dNTPs                                                                                 0.2 mM 
Forward primer                                                                0.5 µM  
Reverse primer                                                                0.5 µM 
Template DNA                                                                ~0.2 ng /µl                                                 
VentR
®/Taq DNA polymerase                                          0.05 unit /µl 
 
Reaction conditions: 
Pre-amplification denaturation                   96 °C             2 min 
Denaturation                                              94 °C             30 s 
Annealing                                                  Tm – 5 °C        30 s            35 cycles 
Extension                                                   72 °C             1min/kb 
Final extension                                           72 °C             7 min 
Pause                                                         4 °C               ∞ 
 
2.4.6 Restriction Digestion 
Restriction endonucleases were purchased from New England Biolabs, and 
digests performed according to the manufacturer’s guidelines for each 
enzyme.  
 
2.4.8 Ligation 
Prior to ligation, the concentrations of vector and DNA fragments were 
determined using a NanoDrop 1000 spectrophotometer (NanoDrop), and the 
molar concentration ratio of vector / inserts was calculated. A 1:3 molar ratio 
of vector / insert was used in ligation reactions with T4 DNA ligase (New 
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England Biolabs), and performed according to manufacturer’s 
recommendations.  
2.5 Electrocompetent Cells Preparation 
C. jejuni 11168H was inoculated onto CBA plates and incubated at 37 °C with 
5 % CO2 for 24 hours. The growth was harvested into 1 ml cold 
electroporation buffer (EPB: 272 mM sucrose, 15% (v/v) glycerol, 2.43 mM 
K2HPO4, 0.57 mM KH2PO4, pH 7.4). After centrifuging at 13,200 rpm for 8 min 
at 4 °C in a microcentrifuge (Eppendorf), the supernatant was discarded and 
the pellet was resuspended in 1 ml cold EPB. This wash step was repeated 3 
times, after which cells were suspended in 1 ml EPB and used immediately. 
2.6 Electroporation 
Approximately 3 μg of plasmid DNA was mixed with 150 μl of 
electrocompetent cells, followed by incubation on ice for 20 min. This mixture 
was then transferred into a pre-chilled 0.2 cm electroporation cuvette (Bio-
Rad). Electroporation of cells was performed with a Bio-Rad Gene Pulser 
system at 2.5 kV, 200 Ω, and 25 mF. Immediately after electroporation, 100 μl 
of SOC medium was added to the cuvette. The contents of the cuvette were 
then plated on CBA and grown for 24 hours at 37 °C in microaerobic 
conditions. 
For selection of kanamycin resistant (kanr) colonies, growth was removed 
from the CBA plates and suspended in 1 ml MHB, this was then plated onto 
CBA supplemented with 40 μg/ml kanamycin, and grown for 48 hours in 
microaerobic conditions at 37 °C.  
2.7 Growth curve 
C.jejuni 11168H was revived from frozen stock on to CBA and grown for 48 
hours. A single colony was inoculated into 10 ml Brucella broth (Oxoid) and 
grown overnight at 37 °C in an atmosphere of 5 % CO2 with shaking at 50 
rpm.  The overnight culture (OD600 = 0.5-0.7) was diluted into 40 ml Brucella 
broth with or without 100 nM of amylase to OD600 = 0.1 and incubated at 37 °C 
in an atmosphere of 5 % CO2 with shaking at 50 rpm. The optical density at 
600 nM (OD600) was recorded hourly. 
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2.8 EPM Purification 
The growth was removed from 4 MH agar plates with or without 100 nM hog 
pancreatic α-amylase and suspended in 5 ml phosphate buffered saline (PBS; 
Sigma-Aldrich). For proteomics analysis, the preparation was done in the 
presence and absence of 1 µl protease inhibitor cocktail (Sigma) prepared 
according to the supplier’s instructions and then diluted 1 in 10. The 
suspension was washed at 200 rpm on a rotary platform for 1.5 hours at 30 ºC 
then vortexed for 15 min and washed at 200 rpm for a further 1.5 hours at 
room temperature. The bacteria were removed by centrifugation at 1,800 x g 
for 15 min and the material in the supernatant was precipitated by addition of 
4 volumes of ice cold acetone which was left at 4 °C overnight. The precipitate 
was recovered by centrifugation at 450 x g for 5 min, washed in water and 
dried in a Speedvac SPD1010 (Thermo Scientific). Finally, the pellet was 
dissolved in 1 ml of distilled water and, if not used immediately, was stored at -
70°C. 
 
2.9 Carbohydrate Assay 
Total carbohydrate was measured using the phenol-sulphuric acid assay 
(Dubois et al., 1956) with glucose as the standard. 
 
2.10 Protein Assay 
The acetone-precipitated material was assayed for protein using a Micro BCA 
Protein Assay Kit (Pierce, Thermo Scientific) according to the manufacturer’s 
instructions. 
2.11 Carbohydrate characterisation 
Crude EPM samples were dissolved in doubly-distilled water (20 mL) and 
small sugars were removed by dialysis (14K MWCO) for 72 hours at 4 oC, 
against three changes of distilled water per day. The contents of the dialysis 
bag were freeze dried and the resulting polysaccharide was characterised 
using a combination of NMR spectroscopy (Laws et al., 2008), monomer 
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analysis (Gerwig et al., 1978) and linkage analysis (Stellner et al., 1973). For 
comparison, the same experiments were performed with a commercial -
dextran standard (Sigma-Aldrich). Details of the experimental procedures 
used to characterise the EPM samples have been reported elsewhere (Laws 
et al., 2008).  
2.12 Proteomics 
 
An equal volume of 2 x sample buffer [0.5M Tris-HCl pH 6.8, 1.0 M 
dithiothreitol 5% (w/v) SDS (sodium dodecyl sulfate), 0.02% bromophenol 
blue, 20 % glycerol] was added to each sample and heated for 5 min at 90 ˚C. 
The samples were electrophoresed in a 10% SDS-PAGE gel at 100 V in 
running buffer [25 mM Trizma, 192 mM glycine, 0.1 % (w/v) SDS]. After 
electrophoresis, the gels were fixed in 2% (v/v) acetic acid, 40% (v/v) 
methanol at room temperature for 1 hour and stained in 16% Colloidal 
Coomassie Brilliant Blue (Sigma), 20 % (v/v) methanol for 2 hours at room 
temperature on a rotary platform shaker at 30 rpm.  The gel was rinsed in 5% 
(v/v) acetic acid, 25 % (v/v) methanol for 2 minutes at room temperature, 
destained in 25 % (v/v) methanol on a rotary platform shaker 30 rpm and 
stored in water in sealed acetate at 4˚C. For LC/MS/MS, the bands were 
excised from the gel, digested with trypsin and analysed by LC-MS/MS 
according to standard methods. MS data were used to interrogate the Cj 
database using Bioworks version 3.2 hits are listed according to the 11168H 
database. 
2.13 Autoagglutination assay 
 
The autoagglutination assay is based on the phenomenon that bacterial cells 
which strongly agglutinate do not remain in the aqueous phase resulting in the 
reduction of OD600. The method is based upon that described by Misawa and 
Blaser (2000). Briefly, bacteria were harvested from MH agar which was 
supplemented with and without 100 nM (5 µg/ml) hog pancreatic α-amylase 
and suspended in Brucella broth to an OD600 of 1.0; 1 ml of this suspension 
was left to stand in a cuvette at room temperature. The OD600 was measured 
at 6, 12, 24 and 48 hours.  
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2.14 Azocaesin assay 
 
Total proteolytic activity was determined using the azocaesin hydrolysis 
method (Tomarelli., et al 1949). Briefly, 2.5 ml 2.50% (w/v) azocasein solution 
(Sigma-A2765) was mixed with 1.5 ml 60 µM sodium bicarbonate buffer 
(NaHCO3), pH 8.3 at 37°C. To this 1 ml of the protease (trypsin or 
recombinant Cj0511) was added and incubated for 30 minutes at 37°C. The 
reaction was stopped by the addition of 4 ml 5.0 % (v/v) trichloroacetic acid 
and filtered through a 0.45 µm filter, before being added to 3 ml 500 mM 
sodium hydroxide solution. The OD440 was recorded. Blanks (test tubes 
without samples) were run in all cases and trypsin was used as a control. The 
following formula was used to determine A440 nm: ΔA440nm = A440nm Test - 
A440nm Blank. The absorbance was plotted against increasing 
concentrations of protein.  
 
2.15 Starch-iodine assay of amylase degradation by 
recombinant Cj0511 
 
Starch agar plates were made by incorporating nutrient agar (Oxoid) with 0.4 
% (v/v) starch (Sigma-Aldrich). Once the agar had set, five equal sized wells 
were cut into the agar using the rim of a sterile 200 µl pipette tip. Next 1, 2, 3 
and 4 mg of recombinant Cj0511 were incubated with 5 µg hog pancreatic α-
amylase in volume of 1 ml at 37 ˚C in a water bath for 6 hours, after which 100 
µl of each sample was loaded into the plate and incubated aerobically 
overnight at 37 ˚C. As a control 5 µg/ml hog pancreatic α-amylase alone was 
loaded into a well. The plate was flooded with Lugol iodine solution (Sigma) 
and resulting halos which indicate α-amylase activity were viewed over a white 
light. 
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2.16 Galleria mellonella killing assay 
Galleria mellonella larvae (Cornish Crispa Co., England) were stored in a 
breathable container on wood chips at 11°C. Killing assays were done as 
described by Champion et al (2010). G. mellonella larvae weighing between 
0.2 and 0.3 g were selected. C. jejuni strains grown in the presence and 
absence of 100 nM (5 µg/ml) hog pancreatic α-amylase on MH agar were 
harvested in PBS and the OD600 was adjusted to 0.6  (~1×10
6 CFU/ml). 
Infectious doses were confirmed by viable counts on CBA supplemented with 
7% horse blood. The larvae were placed in a petri dish and put on ice for 5 
min, then 10 µl of the inoculum was injected into the right foreleg of the larvae 
using PBS as the negative control. Survival after 24 hours was assessed by 
stimulating the underside of the larvae; an absence of a response was 
recorded as dead.  
2.17 Interaction of GFP- C. jejuni with G. mellonella 
 
Green fluorescent protein (GFP)-tagged C. jejuni 11168H was cultured under 
microaerobic conditions at 37 °C on MH agar with and without 100 nM 
amylase. Growth was harvested in PBS and the OD600 was adjusted to 0.6 
(~1×106 CFU/ml). Infectious doses were confirmed by viable counting CBA 
supplemented with 7% horse blood.10 µl of inoculum was injected into the 
right foreleg of G. mellonella larvae weighing between 0.2 and 0.3 g. The 
larvae were incubated at 37 °C and removed at 3 hours and 6 hours before 
being chilled on ice for 5 min. Next the larvae were swabbed with 70% ethanol 
prior to the aseptic removal of the bottom 2 mm of the body and the 
haemocoel was drained into an eppendorf. To pellet the haemocytes, the 
haemocoel was centrifuged at 200 rpm for 5 min and 10 µl of the supernatant 
was dropped onto a slide. Slides were examined using a Bio-Rad confocal 
microscope attached to Olympus BX51 upright microscope. 
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2.18 Biofilm assay 
Biofilm formation was determined on borosilicate glass test tubes using crystal 
violet as described previously by Mclennan et al. (2008) and Reuter et al. 
(2010).  Briefly, a single colony of each strain was inoculated into Brucella 
broth and grown for 16 hours at 37°C in an atmosphere of 5% CO2 with 
shaking at 50 rpm. The overnight cultures were diluted to an OD600 = 0.1 and 
2 ml of this culture was added to each test tube. To test biofilm growth in the 
presence of amylase, 100 nM (5 µg/ml) hog pancreatic α – amylase (Sigma-
Aldrich) was supplemented to one set of test tubes and incubated for 48 hours 
at 37°C in 5% CO2 with agitation. For crystal violet (CV) staining, tubes were 
washed with distilled water and dried for 30 min at 45°C.  0.1% (w/v) CV 
(Sigma, UK) was added for 5 min. Each tube was washed with dH2O and 
dried at 45°C. Bound CV was solubilised with 80% ethanol-20% acetone, and 
OD600 measured.  . 
2.19 Biofilm formation for confocal microscopy 
 
A single colony was inoculated into 10 ml Brucella broth (Beckton Dickinson) 
and grown with shaking at 50 rpm for 16 hours at 37°C in 5% CO2. The culture 
was diluted to OD600 = 0.1 and 4 ml added to each well of a 6-well tissue 
culture plate (Sarstedt). To test the effect of α-amylase on biofilm formation 
100 nM was supplemented into one set of wells. Two glass coverslips were 
immersed in the broth in each well and placed upright against each other and 
incubated for 48 hours at 37 °C with 5% CO2 with shaking at 5 rpm. For 
confocal microscopy, the coverslips were removed from the culture, washed 
gently in PBS, stained with Live/Dead BacLight stain (Invitrogen) according to 
the manufacturer’s instructions and visualised with Bio-Rad confocal 
microscope attached to Olympus BX51 upright microscope. 
 
2.20 Kinetics of biofilm formation 
 
A single colony of (GFP)-tagged C. jejuni 11168H was inoculated into 10 ml 
Brucella broth (Beckton Dickinson) and grown with shaking at 50 rpm for 16 
hours at 37°C in 5% CO2. The culture was diluted to OD600 = 0.1 and 4 ml 
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added to each well of a 6-well tissue culture plate (Sarstedt). To test the effect 
of α-amylase on biofilm formation 100 nM was supplemented into one set of 
wells. Two glass coverslips were immersed in the broth in each well and 
placed upright against each other and incubated for 48 hours at 37 °C with 5% 
CO2 with shaking at 5 rpm. To observe the changes during formation of the 
biofilm, at time points 3, 6, 12, 24 and 48 hours, the slides were removed, 
washed three times with sterile PBS and visualised using a confocal 
microscope. 
 
2.21 Scanning electron microscopy (SEM) of 5-day old 
biofilms 
To validate the CV staining data, SEM was used to visualize biofilms of 
reference strain 11168H in the presence and absence of 100 µM α-amylase at 
the ultra-structural level. Bacterial biofilms were grown microaerobically at 
37°C on 0.2 µm polycarbonate filter disks (Millipore) placed on MHA plates the 
disks were removed and placed on fresh plates every 24 hours for a total of 5 
days. The sample was processed as shown in Table 2.6. 
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Table 2.6. SEM sample preparation 
 Chemical Temperature Time  Repetitions 
Primary 
fixation 
2.5% 
glutaraldehyde in 
distilled water 
room or 0-
4°C 
16 hours 1 
Wash  distilled water room or 0-
4°C 
5-10 
minutes  
3-5 
Secondary 
fixation 
1-4% osmium 
tetroxide in 
distilled water 
room or 0-
4°C 
20 
minutes 
1 
Wash distilled water room or 0-
4°C 
5-10 
minutes  
3-5 
Dehydration 25% ethanol 
50% ethanol 
70-75% ethanol 
90-95% ethanol 
100% ethanol 
room or 0-
4°C 
5 
minutes  
5 
minutes  
5 
minutes  
5 
minutes  
5-10 
minutes  
1 
1 
1 
1 
2  
Place porous container in small amount of 100% ethanol in petri dish 
Critical point dry 
Coated with gold 
 
Images were obtained using JEOL JSM 5410 LVSEM at 5.0 kV 
 
2.22 Preparation of extract from chicken pancreas 
A crude extract from twenty chicken pancreases that had been stored at -70ºC 
for four months was prepared using methods adapted from Madhusudhan et 
al., (1987). The pancreases were partially thawed at room temperature, 1 ml 
of buffer added (0.05 M Tris, 0.9% (w/v) NaCl, 0.05 M CaCl2, pH 8.0) and 
homogenised using a Ultra-Turrax T8 (IKA Labortechnik). The homogenate 
was centrifuged at 1,000 x g for 20 min, the supernatant recovered and the pH 
adjusted to 8.0 with NaOH. The amount of amylase present in the extract was 
determined using a starch iodine agar assay (see above) using the purified 
hog pancreatic α-amylase preparation from Sigma as a standard.  An 
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appropriate volume of pancreatic extract was used in the biofilm assay to give 
a final concentration of 1 µM of α-amylase. 
2.23 Resistance to Environmental stress 
 
For determining resistance to environmental stress, cultures were grown 
microaerobically on MHA with and without 100 nM pancreatic α-amylase for 
48 hours. The growth was removed and suspended in PBS to OD600 of 2.0.  
To determine survival at low temperature, 5.0 ml of this suspension was left at 
4 °C and aliquots removed every 2 days for viable counting on CBA. To 
determine survival under ambient conditions, bacteria were harvested and 
OD600 adjusted to 2.0 in 5 ml Mueller-Hinton broth this was left in a screw cap 
tube on the bench and aliquots removed every 2 days for viable counting on 
Columbia blood agar plates. To determine survival at high temperature, 1.0 ml 
of the suspension was incubated at 65 °C and aliquots removed every 3 min 
for viable counting. To determine survival at low pH, the bacteria were 
collected OD600 adjusted to 2.0 in 1 ml PBS. The bacteria were then pelleted 
using a bench-top centrifuge (13,200 rpm), and the supernatant removed. 
Next the pellets were resuspended in 1 ml PBS (pH 2 or 4 adjusted using 
HCL). The suspensions were then incubated at 37 °C and aliquots removed 
every 15 min for viable counting. 
 
2.24 Interaction and invasion of Caco-2 cells 
 
Human colon cancer cells (Caco-2) were stored in liquid nitrogen and cultured 
in 5% CO2 at 37°C in Dulbecco’s modified essential media (DMEM) 
supplemented with 10 % (v/v) foetal bovine serum (FBS), 1 % (v/v) non-
essential amino acids, 100 µg/ml streptomycin and 100 U/ml penicillin. To a 
confluent monolayer of approximately 106 epithelial cells, 108 bacteria were 
added (multiplicity of infection (MOI) of 100:1). Infected monolayers were 
incubated at 37°C in 5% CO2 for 3, 6 and 24 hours. For determination of the 
total numbers of interacting bacteria, the monolayers were washed three times 
with PBS and the cells were lysed by adding 0.2 % (v/v) Triton X-100. 
Dilutions were performed and plated on CBA for determination of viable 
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counts.  To determine the numbers of bacteria having invaded the Caco-2 
cells, the monolayers were incubated with DMEM containing gentamicin (150 
µg/ml) for 2 hours to kill extracellular bacteria. The monolayers were washed 
three times with PBS, lysed by the addition of 0.2 % (v/v) Triton X-100, and 
the bacteria were enumerated by viable counting on Columbia blood agar.  
2.25 Interaction with T84 epithelial cells 
 
T84 epithelial cells were grown in complete DMEM/F12 HAM media in rat 
collagen pre-coated transwell dishes until the transepithelial electrical 
resistance (TEER) measurement was > 800 Ω to ensure formation of tight-
junctions in the monolayer (usually >14 days). Co-culture studies were 
performed at an MOI of 10 in DMEM/F12 HAM + 10% FBS for either 6 hours 
or 24 hours. CFU counts were subsequently performed by serial dilution and 
plating on BA plates. IL-8 levels were determined from the supernatant of the 
apical surface at 24 hours post-infection by ELISA (eBioscience). TEER 
measurements were conducted at 24 hours post-infection. 
2.26 Infection of chickens 
 
Day old broiler chickens were obtained from a commercial supplier and 
housed in biosecure housing. The study was performed under UK Home 
Office licence and approval by the local ethical review committee.  Birds were 
fed a commercial diet, had constant access to food and water and had a 
gradual increase and decrease in light at the beginning and end of each day, 
as part of a 12 hour light and 12 hour darkness cycle. When the birds were 21 
days old, groups of 30 were infected by oral gavage with a 105 cfu dose of C. 
jejuni strain 11168H or the Cj0511 mutant grown on agar with or without 100 
µM amylase and resuspended in MH broth. Fifteen birds were euthanased at 
4 and 7 days post infection (d.p.i) and ileum and liver samples removed for the 
culture of Campylobacter. Ileum samples were serially diluted and spread 
plated on to modified charcoal cefoperazone deoxycholate agar 
(mCCDA;Oxoid Ltd) and these plates were incubated at 37oC for 48 hours 
under microaerobic conditions of 2% H2, 10% CO2, 5% O2 in N2. Liver 
samples were homogenised and enriched in modified Exeter broth incubated 
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with minimal headspace at 37oC for 48 h followed by plating on to mCCDA.  
Differences in the number of birds colonised were assessed using a Chi-
square test. Differences in the number of bacteria found at each site were 
analysed using a Kruskal-Wallis test with Dunn’s multiple comparison test.  
2.27 Statistical Analysis 
 
Statistical analysis was conducted on data using Minitab 15 statistical 
software (Minitab). The statistical test used was the 2 paired students T-test, 
equal variance was assumed. For environmental stress analysis, one way 
ANOVA was used in SPSS 16.0 and again equal variance was assumed. In 
both cases, p values <0.05 were considered significant and p values <0.001 
were considered highly significant. 
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Chapter 3: Exposure to pancreatic α-amylase 
induces exo-polymers 
3.1 Introduction 
Campylobacter jejuni is one of the most common causes of gastroenteritis in 
the developed world, with a predicted 500,000 cases per year in the United 
Kingdom, and 2.5 million cases per year in the United States of America 
(Blaser, 1997). The consensus is that the vast majority of cases are 
transmitted through either handling or consumption of contaminated 
undercooked poultry (Friedman et al., 2004). The infective dose of C. jejuni for 
humans is considered low, approximately 500 bacteria, compared to another 
Gram-negative enteric pathogen, Salmonella typhimirium which requires >105 
cells for successful infection of the human host (Kothary and Babu, 2007).  
 
The onset of disease after ingestion of C. jejuni requires an incubation period 
of 24-72 hours, after which symptoms develop. Clinical symptoms include 
abdominal pain and diarrhoea which can be mild, non-inflammatory and non-
bloody, in some cases and severe, inflammatory and bloody in others. 
Disease is more severe in developed countries in comparison to developing 
countries (Smith et al., 2002). In developed countries, disease is characterised 
by fever, abdominal pain and sometimes accompanied by bloody diarrhoea; in 
developing countries the disease is characterised again by fever and 
abdominal pain but the diarrhoea is often non-bloody accompanied by 
vomiting and dehydration. In some cases the disease outcome can be more 
severe in developing countries because patients are often malnourished 
(Smith et al., 2002). 
 
Typically, in healthy individuals, infection is self-limiting and lasts up to 7 days 
(Zilbauer et al., 2008). In some cases, patients can develop serious 
complication as Guillain–Barré syndrome (GBS) and its variant Miller-Fisher 
syndrome (MFS). These syndromes are is autoimmune neuropathies of the 
peripheral nervous system, which are characterized by acute flaccid paralysis. 
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Despite the prevalence of C. jejuni infections in humans, the understanding of 
the pathogenesis of disease at the molecular level is still insufficient in 
comparison to other enteric pathogens such as Escherichia coli, Salmonella 
spp., Shigella spp. and Yersinia spp. (Young et al., 2007). This lack of 
understanding of pathogenesis and thus lack of any specific control measures 
can be attributed in part to the absence of a suitable, reproducible small-
animal model system to study C. jejuni host interactions (Dorrell and Wren, 
2007).  
 
A number of animal models have been proposed but all have major 
disadvantages. Models using mammalian hosts such as ferrets and rhesus 
monkeys have been shown to accurately imitate human disease (Bell and 
Manning, 1990; Russell et al., 1993). Nevertheless, drawbacks include the 
cost of facilities required to house and handle such animals, the lack of host 
genetic manipulation techniques and the ethical issues surrounding the use of 
primates as disease hosts. Furthermore the long generation time for the 
animals renders them impractical for use in the majority of laboratories.  
 
The natural host of C. jejuni are chickens and a number of studies have used 
chicks and chickens to study C. jejuni colonisation, however they are unable 
to truly replicate human campylobacteriosis (Hendrixson and Di Rita 2004). 
 
The model most commonly used is the mouse which was first used 30 years 
ago (Blaser et al., 1983). The results obtained from mouse models have 
differed significantly from severe diarrhoea to non-colonisation which has been 
explained by differences in the mouse strains used and the routes of 
inoculation (Baqar et al., 1996; Blaser et al., 1989). Knockout mouse models, 
deficient in expressing pro-inflammatory cytokines, and mice with limited 
enteric flora have all been studied, but the results of C. jejuni infections in 
these models vary between genetically engineered mice. This clearly shows 
that there is no robust, accurate and reproducible model for the in vivo study 
of C. jejuni (Mansfield et al., 2007). 
 
The lack of a model has led to the use of tissue culture assays as an 
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alternative. Studies have shown that C. jejuni is able to both adhere to, and 
invade, a number of intestinal epithelial cell lines such as INT 407 (Konkel et 
al., 1992), Caco-2 (Everest et al., 1992) and T-84 cells (Monteville and Konkel 
2002). However, the reported interactions of C. jejuni with intestinal epithelial 
cells in vitro are frequently low, with invasion being reported at less than one 
per cent. This is not considered accurate when compared to clinical data (Friis 
et al., 2005).  
 
A rational explanation for this is that these experiments are conducted in 
conditions which are not truly representative of the gastrointestinal (GI) tract of 
humans. The human GI tract extends from the mouth to the anus, and 
includes the stomach, large and small intestines. It is home to a plethora of 
microorganisms making up the human intestinal microflora, a vast and diverse 
bacterial biomass of approximately 1014 bacterial cells, almost 10 times the 
number of eukaryotic cells present in the human body, with an estimated 500-
1000 species (Xu and Gordon, 2003). 
 
The pH and oxygen concentration of the GI tract vary greatly.  Therefore, 
bacteria travelling through the GI tract will encounter aerobic, microaerophilic 
and anaerobic conditions. The pH of the stomach is between 1.5 to 3.0 and 
changes quickly to approximately pH 6.0 in the duodenum, the pH then 
progressively increases to approximately pH 7.4 in the ileum and then 
decreases to 5.7 in the caecum, and again gradually increases to pH 6.7 in the 
rectum (Fallingborg, 1999).  
 
Altering the oxygen concentrations when conducting in vitro assays results in 
changes in virulence. A microaerophilic environment increases the ability of E. 
coli to invade Caco-2 cells when compared to experiments conducted under 
aerobic conditions (Pietzak et al., 1998).  A study by Cottet et al. (2002) 
involved co-culture of epithelial cells with Helicobacter pylori under aerobic 
conditions at the basolateral surface and microaeropilic conditions at the 
apical surface using a device called the vertical diffusion chamber (VDC). The 
results showed an increase in expression of virulence factor CagA and a 
significant increase in bacterial adherence under microaerophilic conditions 
(Cottet et al., 2002). 
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A similar model was utilised for the first time for C. jejuni, by Mills et al. (2012). 
The results showed significantly increased interaction with epithelial cells 
complemented by greater basolateral secretion of proinflammatory interleukin-
8 (IL-8) highlighting the necessity to perform experiments in conditions that 
replicate in vivo conditions as closely as possible to elucidate the pathogenic 
mechanisms of C. jejuni (Mills et al., 2012). 
 
Bacteria travelling through the GI tract encounter numerous secretions and 
compounds from organs in the gut. Secretions such as saliva which contains 
mucus and salivary amylase, gastrin in the stomach, bile and pancreatic juices 
composed of numerous enzymes and hormones in the small intestine. 
 
Enteric pathogens have been shown to react to specific intestinal compounds 
such as gastrin, a peptide hormone secreted by G cells in the antrum of the 
stomach, small intestine and pancreas.  Gastrin at physiological 
concentrations promotes growth of H. pylori in vitro in a dose-dependent 
manner and the effects were specific to gastrin and not stimulated by 
cholecystokinin, somatostatin and pentagastrin (Chowers et al., 1999).  
 
C. jejuni also responds to a constituent of gastrointestinal secretions, such as 
bile. Bile performs a pivotal role in the dispersion and absorption of lipids; it is 
composed of ~ 50% bile acids produced by the liver from cholesterol.  Bile 
acids include cholates and deoxycholates (DOC) (Elliot, 1985). Studies have 
shown that bile stimulates expression of virulence factors by Vibrio 
parahaemolyticus (Pace et al., 1997) and Shigella spp. (Pope et al., 1995). 
Furthermore, Yang et al. (2013) showed that bile stimulated virulence cascade 
in V. cholerae through periplasmic cysteine oxidation. Malik-Kale et al. (2008) 
showed that culturing C. jejuni with DOC stimulates an increase in epithelial 
cell invasion; the study concluded that interaction with DOC prepares the 
bacterium to invade cells though activating the production of Cia proteins.  
Furthermore, microarray analysis showed an increase in the expression of 
virulence genes ciaB, cmeABC (multidrug efflux pump), dccR (two-component 
signal transduction system), and tlyA (hemolysin A) when C. jejuni is grown in 
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the presence of DOC (Malik-Kale et al., 2008). 
 
The human GI tract also has a nervous system component consisting of 
approximately 100 million neurones and norepinephrine (NE) is the main 
neurotransmitter in this system (Hansen, 2003). It has been shown that NE 
levels in the gut of rats are increased in response to sepsis by increasing 
expression of tyrosine hydroxylase, a catecholamine biosynthetic enzyme 
(Zhou et al., 2004). A number of Gram-negative pathogens such as 
Pseudomonas aeruginosa and Yersinia enterolitica have been shown to 
respond to catecholamines by increasing growth rate (Lyte and Ernst, 1992). 
Furthermore E. coli O157 also responds to NE by increasing virulence factor 
expression as well as adherence to epithelial cells in vivo in a bovine intestinal 
loop model (Walters and Sperandio, 2006; Vlisidou et al., 2004). 
 
When C. jejuni was cultured with NE in iron limited media, growth rate, motility 
and invasion of Caco-2 cells were increased in comparison with cultures 
grown in the absence of NE. Additionally, C. jejuni exposed to NE produced 
extensive breakdown of tight junctions in cell monolayers, indicating that this 
may contribute to the epithelial destruction that is characteristic of severe 
campylobacteriosis (Cogan et al., 2007). 
 
The mucus layer which is present in the GI tract provides protection to 
mucosal epithelial cells against mechanical, chemical, microbial and 
enzymatic damage. The main components of the mucus are glycoproteins 
known as mucins (Neutra and Forstner, 1987; Strugala et al., 2003). C. jejuni 
has shown significant chemotaxis towards mucin and it has been 
demonstrated that the bacteria is able to bind to mucin (Hugdahl et al., 1988; 
Szymanski et al., 1995)  
 
Of all mucins, MUC2 is the most common and is secreted by goblet cells in 
the small intestine and colon (Allen et al., 1998).  Tu et al. (2008) examined, 
using RT-PCR, the expression of 20 virulence genes in response to MUC2 
and showed that genes encoding cytolethal distending toxin protein (cdtABC), 
vacuolating cytotoxin (vacB), C. jejuni lipoprotein (jlpA), Campylobacter 
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invasion antigen B (ciaB) and the multidrug efflux system (cmeAB) were all 
increased.  It was concluded that C. jejuni utilizes MUC2 as an environmental 
signal to control expression of genes with functions that include colonization 
and pathogenicity (Tu et al., 2008). 
 
Further research on the response of C. jejuni to mucins has shown C. jejuni to 
possess a genomic island (Cj0480c–Cj0490) that is up-regulated in the 
presence of both L-fucose and mucin and allows L-fucose to be used as a 
substrate for growth. When a fucose permease (Cj0486) was mutated, this 
resulted in loss of the ability to utilise L-fucose and consequently the mutant 
showed decreased colonisation of the piglet model of human 
campylobacterioses (Stahl et al., 2011). 
 
3.1.2 Mucoid bacteria 
Bacteria such as Burkholderia cepacia (Bartholdson et al., 2008), 
Streptococcus pneumoniae (Allegrucci and Sauer, 2007) and Pseudomonas 
aeruginosa (Friedl et al., 1992) all have the ability to express mucoidy. Some 
bacteria such as B. cepacia and P. aeruginosa express mucoidy through 
secretion of an exopolymeric material or EPM (Bartholdson et al., 2008; Tielen 
et al., 2010). These EPM can consist of either polysaccharide, extracellular 
proteins, DNA and lipids, in some cases the EPM can be a combination of all 
these substrates (Costerton et al., 1995).   
 
In nature, bacteria persist in organised microbial communities which are 
encapsulated in an EPM known as a biofilm. These communities exhibit a 
number of advantages over unicellular growth, including increased survival in 
harsh conditions (Davey et al., 2003). Biofilms often exhibit increased 
antimicrobial resistance and protection against predation, dehydration and 
phagocytosis (Davey et al., 2003). 
 
Biofilm formation commences when planktonic bacteria irreversibly attach to 
biotic or abiotic surfaces. Once in the biofilm mode of growth, bacteria assume 
a biofilm-specific phenotype, drastically different from that expressed in 
planktonic cells (Mah and O’Toole, 2001). Bacteria within biofilms assume 
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specific changes in protein expression particularly proteins associated with 
resistance to oxidative damage, exopolysaccharide production, phospholipids 
synthesis and membrane transport. Furthermore, biofilm-specific phenotype 
can trigger mechanisms responsible for antimicrobial resistance, enhanced 
virulence and persistence (Costerton et al., 1995).   
 
Joshua et al. (2005) showed that C. jejuni is able to form both attached and 
unattached biofilms. These unattached aggregates of biofilm known as ‘flocs’ 
are more resistant to environmental stresses and are thought to be important 
in survival and pathogenesis of the organism. Further to this, C. jejuni has the 
ability to form attached biofilm on the surfaces of domestic and farming 
watering supplies and these attached bacteria could potentially act as an 
active reservoir of infection for humans and domestic animals (Reeser et al ., 
2006). 
 
3.1.3 C. jejuni EPM 
 
One of the major outstanding questions with regards to C. jejuni biofilms is the 
composition of the EPM. The EPM is what holds the biofilm together, providing 
structure and strength. In the case of C. jejuni biofilms, the best characterised 
polysaccharide, the CPS, is not involved in biofilm formation as shown by 
Joshua et al., (2005) who reported no reduction in the biofilm forming capacity 
of a C. jejuni NCTC 11168 kpsM mutant. KpsM consists of six putative trans-
membrane regions and is situated in the inner membrane, and functions as a 
component of an ABC transporter involved in capsule transport through the 
inner membrane (Karlyshev et al., 2000). 
 
Another polysaccharide produced by C. jejuni is a calcoflour white (CFW)- 
reactive polysaccharide. CFW is a fluorescent stain which binds β1-3 and β1-4 
sugar linkages (McLennan et al., 2008). These authors showed that a C. jejuni 
biofilm produces a CFW-reactive polysaccharide.  They also found biofilm 
formation is up-regulated in the absence of the stringent response, a stress 
response generally triggered by nutrient deprivation, which is controlled by 
SpoT. When spoT was mutated, an increase in the level of CFW-binding 
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polysaccharide and in the amount of biofilm was observed. Furthermore, there 
is evidence that LOS and N- and O-linked glycoproteins are not involved in 
biofilm formation. McLennan et al. (2008) tested a gne mutant and found no 
defect in biofilm formation. The gne gene encodes a bifunctional UDP-
GlcNAc/Glc 4 epimerase involved in the synthesis of CPS, LOS, and N-linked 
carbohydrates (Bernatchez et al., 2005).  
 
3.1.4 Hypothesis 
 
As highlighted above C. jejuni has evolved to respond to a number of 
biological molecules found in the host intestinal environment including bile 
salts and norepinephrine. Initial data showed that supplementation of charcoal 
MHA (CMHA) or MEM-α with pancreatin (a commercial preparation of 
porcine pancreatic enzymes used for the treatment of pancreatic deficiency), 
results in C. jejuni exhibiting a mucoid morphology. The hypothesis examined 
in this chapter is that C. jejuni can also detect and respond to specifically 
mammalian pancreatic α-amylase, and this enzyme is responsible for the 
mucoid morphology seen upon pancretin supplementation.  
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3.2 Results 
3.2.1 Pancreatic α-amylase induces a colony morphology change in C. 
jejuni 
When hog pancreatic α-amylase was incorporated into charcoal MHA (CMHA) 
or MEM, a change in colony morphology was observed. Figure 1 shows the 
typical colony morphology observed on charcoal MHA with and without 100 
µM hog pancreatic α-amylase. The colonies on pancreatic α-amylase 
supplemented CMHA plates (panel A) are larger and more mucoid than the 
colonies on CMHA without amylase (panel B). This response is specific to hog 
pancreatic amylase and was not evident in response to amylase from 
Aspergillus oryzae or human salivary amylase. Other C. jejuni strains were 
tested (81-176, 81116, G1, X), all showing a similar response however the oral 
bacterium Campylobacter rectus did not show this response (Table 3.1). 
Further to this, porcine mucin, porcine bile, porcine pancreatic trypsin and 
bovine serum albumin (BSA) were tested at a range of concentrations and no 
change in phenotype was observed (Table 3.1). No difference was observed 
between strains in the degree of mucoidy in response to enzyme 
supplementation. Furthermore to identify the lowest concentration of amylase 
at which mucoidy was induced, varying concentrations of amylase were 
incorporated into CMHA. The results showed that the lowest concentration at 
which mucoidy was visible was at 100 µM (Figure 3.1). The hog α-amylase 
preparation was shown to contain only pancreatic α-amylase and no other 
proteins, see Appendix 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) B) 
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Figure 3.1. C. jejuni 11168H streaked on CMHA (panel A) and CMHA with 100 µM 
hog pancreatic α-amylase (panel B). 
 
 
 
Table 3.1: Appearance of mucoidy in response to medium supplementation with 
pancreatic enzymes of all strains tested and the respective response to the individual 
components tested. All results were tested on CMHA and MEM-α with identical 
results. Mucoidy was marked on a scale +++ being very mucoid and – being non-
mucoid 
 
 
 
 
3.2.2 Determining the carbohydrate content of C. jejuni exposed to α-
amylase  
 
To determine if the mucoid phenotype observed in the presence of α-amylase 
is a result of increased carbohydrate secretion, the EPM was prepared from 
bacteria (for methods see Chapter 2 section 2.9) grown on increasing 
concentrations of α-amylase and the carbohydrate content determined (Figure 
2). The results showed that carbohydrate secretion significantly increased at 
100 nM of α-amylase, the estimated physiological concentration. The increase 
in carbohydrate secretion was not dose dependent and no further increase 
was observed when concentrations above 100 nM were tested. 
Strain pancreatic 
α-amylase 
α-amylase 
from  A. 
oryzae 
human 
salivary  α-
amylase 
BSA Trypsin Mucin Bile 
 
11168H +++ - - - - - - 
81-176 +++ - - - - - - 
Strain X +++ - - - - - - 
G1 +++ - - - - - - 
81116 +++ - - - - - - 
C. rectus - - - - - - - 
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Figure 3.2. Graph showing the amount of extracellular carbohydrate produced by 
11168H grown on MHA supplemented with increasing concentrations of hog 
pancreatic α-amylase. Data shown is the mean and standard deviation from three 
independent experiments. 
 
3.2.3 Previously defined glycans are not associated with increased 
carbohydrate secretion 
To determine if the increase in carbohydrate secretion in response to α-
amylase involved the known glycan structures, the following mutants were 
tested alongside the wild-type strains, 11168H and 81-176. The kpsM mutant 
was included in these experiments to see whether any increase in secreted 
polysaccharide involves CPS expression.  Both waaC and waaF mutants were 
also included in these experiment to test whether any increase in 
carbohydrate secretion is due to LOS. Finally a spoT mutant was constructed 
(for construction of spoT mutant see Appendix 1) in order to see if the 
previously described CFW-binding polysaccharide was involved.  There was a 
significant increase in extracellular carbohydrate  when all strains were grown 
with 100 nM pancreatic α-amylase compared to bacteria grown without α-
amylase (Figure 3.3; 11168H, spoT, waaC and waaF p= 0.0001; 81-176 and 
kpsM p=0.001). Further, the magnitude of the increase was similar for all 
strains. 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 15 nM 50 nM 100 nM 500 nM 1 µM 100 µM
C
ar
b
o
h
yd
ra
te
 x
 1
0
-8
  µ
g/
cf
u
  
Concentration of α-amylase 
11168H
66 
 
 
Figure 3.3. Graph showing extracellular carbohydrate in C. jejuni strains grown in the 
presence (black bars) or absence (white bars) of 100 nM pancreatic α-amylase. Data 
shown is the mean and standard deviation from three independent experiments. 
 
 
3.2.4 Protein secretion is increased in response α-amylase 
To determine whether protein secretion was affected in response α-amylase, 
total protein assays were performed on each strain grown with and without the 
presence of 100 nM pancreatic α-amylase. An increase in the total secreted 
protein was observed in all the four strains grown on charcoal MHA 
supplemented with pancreatic α-amylase compared to growth without α-
amylase (Figure 3.4; 11168H, spoT, waaC and waaF p= 0.001; 81-176, kpsM 
p=0.0001). 
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Figure 3.4. Graph showing extracellular protein in C. jejuni strains grown in the 
presence (black bars) or absence (white bars) of 100 nM pancreatic α-amylase. Data 
shown is the mean and standard deviation from three independent experiments. 
 
3.2.5 Growth promotion by pancreatic α-amylase 
Since the colonies produced on amylase-containing plates were larger as well 
as being more mucoid, the growth of C. jejuni 11168H in the presence and 
absence of 100 nM hog pancreatic α-amylase was compared in Brucella broth 
and MEMα (Figure 3.5). In both cases, α-amylase supplementation resulted in 
an increased rate of C. jejuni growth. Furthermore there was a higher final 
culture density in both cultures, this increase was more pronounced in MEMα 
(Figure 3.5B). The generation time in Brucella broth was 256 minutes in 
comparison to Brucella broth supplemented with amylase which was reduced 
to 178 minutes. For bacteria grown in MEMα, the generation time was 248 
minutes, reduced to 172 minutes in MEMα supplemented with amylase. To 
assess if this response was specific to pancreatic α-amylase, α-amylase from 
A. oryzae was tested at a range of concentrations (100 nM, 1 µM and 100 µM) 
in both Brucella broth and MEM-α; this showed no effect on growth dynamics 
of C. jejuni 11168H. 
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Figure 3.5. Growth of C. jejuni 11168H at 37°C in (A) Brucella broth with (filled 
squares) and without (open triangles) 100 nM pancreatic α-amylase and (B) MEM α 
with (filled squares) and without (open triangles) 100 nM pancreatic α-amylase. The 
optical density (OD600) was measured at hourly intervals. Data shown is the mean 
and standard deviation from three independent experiments. 
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3.2.6 Reintroduction of mucoidy to clinical isolate 
 
The colony morphology of C. jejuni laboratory strains differs from clinical 
isolates, with these isolates being wet mucoid and translucent. Initially a 
clinical isolate C. jejuni JW1 was passaged to see if this would result in loss of 
mucoidy. The first culture shows wet, mucoid translucent colonies typical of 
clinical C. jejuni isolates. After repeated sub-culture, the colonies changed, 
and after the fourth passage the colonies were non-mucoid and smaller 
(Figure. 3.6D). Next, to see if mucoidy could be re-introduced, the isolate was 
recovered from the fourth sub-culture and grown on CHMA containing 100 µM 
α-amylase and, as shown in Figure 3.6E, the mucoidy of the colonies was 
restored. The same result was obtained with a second clinical strain.  
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Figure 3.6. Clinical C. jejuni JW1 isolate A-D sub-culture 1-4 on CMHA, E sub-culture 
5 on CMHA supplemented with 100 µM α-amylase. Scale bar represents 2.25 cm. 
 
3.2.7 Identity of the polysaccharide component of the EPM 
 
Preparations of EPM from C. jejuni 11168H and the kpsM mutant grown in the 
presence of 100 nM α-amylase were analysed using 1H and 13C-NMR and 
provided identical results  to an α-dextran standard (Figure 3.7). 
Furthermore, a number of 2D-NMR (COSY, HSQC & HMBC) were used to 
verify the identity of the EPM was an α-dextran. Monomer analysis 
71 
 
substantiated that glucose was the only monosaccharide present additionally 
analysis of the linkage showed the glucan to be composed entirely of 1,6-
glycosidic linkage. All the sugar analysis was conducted by Professor Andrew 
Laws, University of Huddersfield. 
 
Figure 3.7. 1H and 13C-NMR spectra of EPS isolated from C. jejuni 11168H and kpsM 
mutant grown with 100 nM α-amylase supplementation.  Both EPS samples showed 
identical spectra to a commercially available  α-dextran standard. 
 
 
3.2.8 Protein identification 
Preparations of EPM from C. jejuni 11168H grown in the presence and 
absence of 100 nM α-amylase were run on SDS-PAGE gel; equal 
concentrations of each sample were loaded into the well, the gel profiles 
shown are indicative of those seen in three independent experiments. 
Samples grown in the presence of amylase showed a substantially different 
profile in comparison with sample grown in the absence of amylase (Figure 
3.8). The bands were cut and analysed using LC-MS/MS and the hits are 
listed according to the 11168H database (Table 3.2).  
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Figure 3.8. Lane 1: 10-250 kDa protein ladder (NEB). Lane 2: Precipitate C. jejuni 
11168H grown in the absence of 100 nM α-amylase. Lane 3: Precipitate C. jejuni 
11168H grown in the presence of 100 nM α-amylase. Bands were excised from the 
SDS-PAGE gel shown, digested in-gel with trypsin and analysed by LC-MS/MS.  
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Table 3.2. Identities of extracellular proteins in C. jejuni grown in the presence (bands 2-11) and absence (band 1) of hog pancreatic α-amylase.  
 
 
 
Band 
No.
1
 
Accession 
number
2
 
Locus 
tag 
Protein identity
3
 Peptides 
matched
4
 
Coverage
5
 MW 
(kDa)
6
 
1 YP_002344650 Cj1259 Major outer membrane protein*† 6 30.7 45.6 
2 YP_002344856 Cj1476c Pyruvate ferredoxin/flavodoxin oxidoreductase 3 3.1 131.2 
3 YP_002344242 Cj0835c Bifunctional aconitate hydratase 2/2-
methylisocitrate dehydratase 
3 5.9 92.7 
 YP_002343725 Cj0284c Chemotaxis protein CheA*
#
 2 4.0 85.2 
  YP_002344890 Cj1511c Formate dehydrogenase, alpha subunit, 
selenocysteine-containing 
2 3.8 103.8 
4 YP_002343927 Cj0493 Elongation factor G*  11 23.2 76.6 
  YP_002343962 Cj0531 Isocitrate dehydrogenase, NADP-dependent 9 13.2 82.2 
  YP_002343704 Cj0262c Methyl-accepting chemotaxis protein* 8 18.3 72.7 
  YP_002343604 Cj0144 Methyl-accepting chemotaxis protein* 8 31.8 72.2 
  YP_002344885 Cj1506c Methyl-accepting chemotaxis protein* 4 6.6 77.3 
  YP_002343846 Cj0409 Fumarate reductase flavoprotein subunit 3 5.6 73.7 
  YP_002343589 Cj0129c OMP85 family outer membrane protein† 2 3.4 83.1 
  YP_002344625 Cj1234 Glycyl-tRNA synthetase subunit beta  2 3.9 76.4 
 5 YP_002344612 Cj1221 Chaperonin GroEL*
#
 8 22.2 57.8 
 YP_002344292 Cj0893c 30S ribosomal protein S1 6 16.5 62.7 
  YP_002344069 Cj0640c Aspartyl-tRNA synthetase 4 8.2 66.0 
 YP_002343950 Cj0518 Heat shock protein 90 4 8.9 69.5 
  YP_002344166 Cj0759 Molecular chaperone DnaK*  3 7.1 67.3 
  YP_002344331 Cj0933c Oxaloacetate decarboxylase, alpha subunit, 
putative 
3 6.8 65.7 
  YP_002344509 Cj1116c Cell division protein FtsH 3 6.2 70.9 
  YP_002343510  
 
Cj0039c GTP-binding protein TypA (BipA)  2 4.2 66.4 
  YP_002345014 Cj1645 Transketolase  2 3.6 69.5 
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 6 YP_002343565 Cj0105 F0F1 ATP synthase subunit alpha*  8 18.4 54.7 
 YP_002343547 Cj0087 Aspartate ammonia-lyase*  9 22.4 51.6 
  YP_002343829 Cj0392c Pyruvate kinase 5 12.7 53.7 
  YP_002344561 
 
Cj1170c 50 kDa outer membrane protein†  5 12.4 53.2 
  YP_002344588 Cj1197c Aspartyl/glutamyl-tRNA amidotransferase subunit B  4 11.2 52.8 
 YP_002344453 Cj1058c Inosine 5'-monophosphate dehydrogenase 3 8.5 52.0 
  YP_002343802 Cj0365c outer membrane channel protein CmeC* 3 7.7 55.3 
  YP_002344779 Cj1394 Adenylosuccinate lyase  2 5.9 51.2 
  YP_002343651 Cj0193c Trigger factor (peptidyl-prolyl cis/trans isomerase) 2 4.7 50.8 
  YP_002344106 Cj0688 Phosphate acetyltransferase
± 
 2 4.5 56.1 
  YP_002344408 Cj1013c cytochrome c biogenesis protein 2 2.2 123.3 
 7 YP_002343904 Cj0470 Elongation factor Tu*  9 31.1 43.5 
 YP_002343567 Cj0107 F0F1 ATP synthase subunit beta*  6 19.1 50.7 
  YP_002344581 Cj1190c Methyl-accepting chemotaxis protein 4 12.6 50.9 
  YP_002343552 Cj0092 Probable periplasmic protein* 3 9.2 49.1 
  YP_002343489 Cj0017c DsbB family disulfide bond formation protein* 3 7.1 56.6 
  YP_002344680 Cj1290c Biotin carboxylase 2 6.1 49.0 
  YP_002344228 Cj0821 UDP-N-acetylglucosamine pyrophosphorylase  2 8.6 47.8 
 8 YP_002344650 Cj1259 Major outer membrane protein*† 13 52.6 45.6 
 YP_002343964 Cj0533 Succinyl-CoA synthase, beta subunit 2 6.2 41.6 
 9 YP_002344802 Cj1419c Putative methyltransferase 5 21.2 29.6 
 YP_002343909 Cj0475 50S ribosomal protein L1  4 24.0 24.9 
  YP_002344152 Cj0734c CjaC, predicted periplasmic solute binding protein†  2 10.4 27.7 
10 YP_002344869 Cj1489c Cytochrome c oxidase, cbb3-type, subunit II* 2 10.9 24.8 
11 YP_002343573 Cj0113 Peptidoglycan-associated lipoprotein Omp18* 5 33.3 17.7 
       
 
1 Band number as shown on the SDS PAGE gel in Figure 3.8. 
2, 3 Accession number and protein identity as given in the C. jejuni NCTC 11168 re-annotated genome sequence database (Gundogdu et al., 2007). 
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4 Number of peptides observed in mass spectra matching to the protein in the database. 
5 Percentage amino acid coverage (peptides observed/theoretical from sequence data). 
6 Theoretical molecular weight (kDa) of proteins as given in the C. jejuni NCTC 11168 re-annotated genome sequence database. 
* Protein identified in outer membrane vesicles (Elmi et al., 2012). 
† Protein contains predicted N-terminal secretion signal. 
# Protein up-regulated in biofilms (Kalmokoff et al., 2006) 
± Demonstrated functional role in biofilms (Joshua et al., 2006). 
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3.3 Discussion 
The expression of a mucoid phenotype is not an uncommon phenomenon, a 
number of Gram-negative bacteria are able to express a mucoid phenotype, 
including B. cepacia, P. aeruginosa, V. cholera and V. parahaemolyticus, 
which is the result of EPM secretion (Bartholdson et al., 2008; Enos-Berlage 
and McCarter, 2000; Qiu et al., 2007). In the case of B. cepacia, the increased 
EPM production is due to interaction with onion skin which the organism 
encounters within its life cycle (Bartholdson et al., 2008). 
 
It has previously been shown that C. jejuni is able to recognise and respond to 
a number of biological compounds that it encounters in the human GI tract 
including constituent of bile DOC (Malik-Kale et al., 2008), neurotransmitter 
NE (Cogan et al., 2006) and mucin constituent MUC2 (Tu et al., 2008). The 
results of this chapter show that C. jejuni is also able to recognise mammalian 
pancreatic α-amylase specifically and responds with the production of exo-
polymers. 
 
The EPM expressed was shown to contain carbohydrate which was 
independent of previously characterised glycans in C. jejuni. The kpsM mutant 
which is CPS deficient,  waaC and waaF mutants which are LOS deficient all 
showed increases in carbohydrate secretion in response to α-amylase at wild-
type levels indicating that none of these glycans are involved. The fact that the 
spoT mutant (which is reported to over-express the CFW-reactive 
polysaccharide) only displays mucoidy in the presence of α-amylase, and 
shows similar levels of EPM as the wild-type strain, 11168H, in both the 
presence and absence of pancreatic amylase, clearly indicates that the CFW-
reactive polysaccharide is not involved in the response, highlighting that the 
EPM is composed of a novel polysaccharide.  
 
NMR analysis showed the polysaccharide component of the EPM consisted of 
1,6 linked glucose monomers, producing an α-dextran.  The polysaccharide 
component of many bacterial EPM’s retain backbone structures which are 
composed 1,3- or 1,4-β-linked hexose residues (Sutherland, 2001). These 
sequences exhibit a very rigid structure which are resistant to deformation and 
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are generally very poorly soluble. However polysaccharides of EPMs which 
are composed of 1,2-α- or 1,6-α-linkages observed in dextrans provide a more 
flexible structure (Sutherland, 2001).  Fast flow around a biofilm results in 
stresses around the biofilm and can lead to eventual detachment. Having 
visco-elastic flexible biofilm structures enables the bacteria to deform under 
the stresses placed upon them and thus remain attached (Young, 2006). This 
is presumably an advantage for an enteric bacterium such as C. jejuni which 
has to withstand significant peristalsis in the small intestine. 
 
C. jejuni is asaccharolytic and is unable to utilise glucose as a primary source 
of carbon, nevertheless genome sequencing and experimental data have 
identified homologues for the Embden-Meyerhof pathway, which provides both 
glycolysis and gluconeogenesis pathways. However, in C. jejuni these 
enzymes are considered to be predominately gluconeogenic (Mendz et al., 
1997).  Furthermore it has been determined that C. jejuni requires 
gluconeogenesis to produce glucose derived polysaccharides, such as the 
one observed in this study (Gaynor et al., 2004). 
 
The data presented in this chapter shows that the increase in extracellular 
proteins and the dextran secreted in response to pancreatic α-amylase, clearly 
demonstrates the EPM to be constituted of a mixture of protein and 
polysaccharide, however it would be advantageous to further extend this 
analysis to look for the presence of lipids and nucleic acids.  
 
The colony morphology of clinical C. jejuni isolates are wet and mucoid and 
differ considerably in comparison to laboratory strains such as C. jejuni 
11168H.  When fresh clinical isolates JW1 and JW2 were passaged mucoid 
morphology was lost and after the fourth passage resembled the non-mucoid 
small colonies of C. jejuni 11168H.  However, upon supplementation of α-
amylase into the growth medium, the original mucoidy observed was restored; 
this highlights the mucoid phenotype seen in response to α-amylase is 
clinically relevant and  mucoidy observed in fresh clinical isolates is due to 
recent exposure to α-amylase. This emphasises that C. jejuni laboratory 
strains commonly used in research have, in the sequence of consecutive in 
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vitro passage, become significantly differentiated from non-passaged clinical 
isolates; leading to current research performed with laboratory strains possibly 
missing important pathophysiological mechanisms and not being truly 
clinically relevant. 
 
As an example P. aeruginosa PAO1 which was first isolated by B.W. Holloway 
(1955) in Australia, has been passaged for decades and have become 
effectively non-pathogenic; studies using this strain has shown phenotypically 
diverse biofilm from different laboratory under the same conditions (Fux et al., 
2005). 
 
Another finding of this study is the ability of pancreatic α-amylase to promote 
growth of C. jejuni.  The results presented here have shown that 
supplementation of α-amylase results in increased growth kinetics in liquid 
culture.  Growth promotion by intestinal secretions has been documented 
previously; norepinephrine has been shown to significantly increase the rate of 
growth of C. jejuni (Cogan et al., 2009). Furthermore Helicobacter pylori 
exhibits growth promotion in response to gastrin a gastrointestinal hormone 
produced by g cells in the duodenum and in the pyloric antrum of the stomach 
(Chowers et al.,1999) 
 
It has been predicted that the concentration of pancreatic α-amylase in the 
human GI tract is between 5-15 nM, however this is considered an 
underestimate (Slaughter et al., 2000) and the actual value could be higher. 
Therefore the minimum concentration of α-amylase required for expression of 
the phenotype observed in this study was 100 nM is physiologically relevant. 
Interestingly hyperamylasia has been reported in clinical cases of severe 
campylobacterioses (Tositti et al., 2001; Peterson and Besendorfer, 2012). 
C. jejuni encounters both bile and pancreatic α-amylase at the same point in 
the small intestine, the pancreatic duct connects to the common bile duct 
before the hepatopancreatic ampulla, after which both ducts pierce the medial 
region of the duodenum. Malik-Kale et al. (2008) proposed that encountering 
DOC would prime C. jejuni to invade epithelial cells within the human GI tract, 
this idea of the bacterium using biological compounds as environmental 
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signals is supported by Tu et al. (2008) who suggested C. jejuni uses MUC2 
as an environmental cue to regulate expression of genes associated with 
pathogenicity. The results presented in this chapter indicate a similar role for 
pancreatic α-amylase. LC-MS/MS analysis showed the expression of a 
number of surface associated proteins specifically in bacteria grown in the 
presence of α-amylase. Interestingly a number of the identified proteins in the 
α-amylase grown bacteria, are secreted in outer membrane vesicles as shown 
by Elmi et al. (2012). The data set obtained shows a number of proteins 
involved chemotaxis such as transmembrane sensor proteins methyl-
accepting chemotaxis protein, which enables bacteria to detect concentrations 
of molecules extracellularly (Gestwicki et al., 2000).  Other proteins are 
involved in metabolism cycle of C. jejuni such as pyruvate 
ferredoxin/oxidoredctase and pyruvate kinase which is involved in glycolysis. 
Also, proteins such as CjaC which are components of ABC type transport 
systems and are involved in pathogenicity were identified (Pawalec et al., 
2000). 
This chapter has shown that C. jejuni is able to respond to specifically 
mammalian pancreatic α-amylase in response to which it produces a clinically 
relevant mucoid phenotype through secretion of exo-polymers composed of 
proteins and a dextran not previously described in C. jejuni.  
 
 
 
 
 
 
 
82 
 
Chapter 4: The role of Cj0511 in the response 
to α-amylase 
4.1 Introduction 
Pathogenic bacteria have a selection of factors which cause virulence either 
directly or indirectly. The ability of C. jejuni to persist in diverse environments 
that are experienced by the bacterium through its life cycle is due to its ability 
to adapt to these conditions. 
 
4.1.1 Bacterial Proteases 
 
Bacterial proteases are a group of enzymes which perform proteolysis, 
initiating protein catabolism through hydrolysis of peptide bonds which string 
together amino acids to make peptides. All living organisms produce 
proteases; they can be endopeptidases which cleave internal peptide bonds, 
or exo-peptidases which act on amino or carboxyl termini of proteins.  
Microbial proteases are can be divided into 6 groups based on the essential 
catalytic residue at their respective active site metalloproteases, serine, 
threonine, cysteine, aspartate and glutamic proteases.  
 
The majority of metalloproteases are zinc containing, zinc is an essential 
constituent of many proteins which a play a pivotal role in all aspects of 
metabolism across different phyla. They are ubiquitous and found in both 
Gram-negative and Gram-positive bacteria.  
 
4.1.2 Lon proteases 
A model organism in which peptidases have been studied is E. coli. Lon 
proteases are cytoplasmic serine proteases consisting of hexameric rings of 
single peptide chains carrying an ATPases domain and a chaperone activity 
domain. Lon recognises sequences abundant with aromatic residues which 
are exposed in unfolded proteins but concealed in folded proteins (Gur and 
Sauer, 2008). In E. coli these particular proteases degrade non-native proteins 
(Tsilibaris et al., 2006). 
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Lon proteases also play an important role in Salmonella typhimurium. Mutants 
that are deficient in the ability to express Lon displayed a phenotype that 
showed increased invasion of epithelial cells, increased expression of 
pathogenic proteins as well as stimulating apoptosis in macrophages. 
However, this did not lead to increased virulence in an animal model, with S. 
typhimurium mutants deficient in Lon requiring a 50% increase in lethal dose, 
and also showed decreased survival in response to oxidative stress (Takaya 
et al., 2002). 
 
4.1.3 Clp protease 
 
Another set of protease are Clp proteases, these consist of 2 heptameric rings 
of ClpP subunits flanked by hexameric rings of one Clp AtPases. Clp 
proteases are tubular shaped and the associated Clp ATPases are 
phylogentically determined, with Gram-negative bacteria generally having 
ClpA and ClpX, whereas the Gram-positive bacteria contain ClpX, ClpC and 
ClpE (Butler et al., 2006; Frees et al., 2004). In Listeria monocytogenes a 
foodborne pathogen, it has been suggested that ClpP play a fundamental role 
in degrading inhibitors of listeriolysin which is an essential virulence factor 
(Gaillot et al., 2000). Furthermore, mutation of clpC and clpP genes reduce 
transcription of actA-encoding proteins which initiate host actin polymerisation 
(Gaillot et al., 2000). Clp proteins play an active role in virulence of S. 
pneumonia, the causative agent of pneumonia, mutation of clpP results in 
significantly reduced survival in an intratracheal inoculation mice model (Kwon 
et al., 2004). 
 
4.1.4 HtrA proteases 
 
DegP also known more commonly as HtrA are highly conserved set of 
proteins which exhibit both in vivo proteolytic and chaperone activity. HtrA is 
localised in the periplasm of Gram-negative bacteria in comparison to ClpP 
and Lon that are ATP-dependent cytoplasmic peptidases (Meltzer et al., 
2008). In Gram-positive bacteria that do not have extramembranous 
compartments, HtrA is located at a single domain of the cellular membrane. 
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The predominant role of chaperone activity is to direct outer membrane 
proteins through the periplasm and proteolytic activity ensures degradation of 
unfolded periplasmic proteins (Rosch and Caparon, 2005). 
 
 
Investigations in in vivo virulence models have shown that mutation of htrA of 
S. typhimurium (Humphreys et al., 1999), Y. enterocolitica (Li et al., 1996) and 
L. monocytogenes (Yamamoto et al., 1996) show attenuated virulence. HtrA is 
involved in degradation of damaged proteins which build up during 
unfavourable conditions in the macrophages. Bacteria such as Y. 
enterocolitica are thus able to survive phagocytosis and other pathogens such 
as L. monocytogenes which are intracellular facultative survive within 
macrophages during infection by replicating. Within these environments the 
bacteria encounter a number of antimicrobial compounds such as reactive 
oxygen radicals, which in turn leads to unfolded damaged proteins amassing. 
 
4.1.5 FtsH Proteases 
 
FtsH proteins are located in the cytoplasmic membrane, they incorporate a 
core cystolic area and a transmembrane fragment situated at the N-terminus. 
These proteins are ubiquitous in eubacteria, and are essential for viability in 
some organisms. FtsH functions by degrading a number of mis-folded and 
transient membranous proteins. Staphylococcus aureus mutants that are FtsH 
deficient, when injected into mice exhibited lower recovery from lesions 
(Lithgow et al., 2004). 
 
4.1.6 Proteases in C. jejuni 
 
C. jejuni is an Epsilonproteobacteria and is distantly related to member of 
Gammaproteobacteria such E. coli which has been a model organism to study 
proteases. Scrutiny of the C. jejuni genome shows homologues for ClpA, ClpX 
and Lon that are found in E. coli (Hoskins et al., 1998). 
 
For C. jejuni, growth at high temperatures results in the accumulation of 
misfolded proteins and it has been shown both Lon and ClpP are both 
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required for growth under these conditions (Cohn et al., 2007). 
Characterisation of both clpP and lon mutants showed changes in 
phenotypes, such as lower levels of autoagglutination, decreased motility and 
decreased invasion of INT407 epithelial cells and it was concluded these 
proteases contribute to virulence of C. jejuni (Cohn et al., 2007). 
 
C. jejuni also maintains homologues of HtrA protease which is required for 
both heat and oxygen tolerance, and for interaction with human epithelial cells 
(Bronsted et al., 2005). Bronsted et al. (2005) showed that a C. jejuni htrA 
mutant exhibited reduced growth at 44°C and in the presence of puromycin, a 
peptide inhibitor, and further showed a reduced ability to adhere and invade 
INT407 epithelial cells.  
 
4.1.7 Cj0511 
 
Gene Cj0511 encodes a predicted product with similarity to tail-specific 
proteases. The amino acid sequence of Cj0511 shows the highest similarity to 
Bartonella bacilliformis peptidase CtpA, similar protease is found in Brucella 
suis and Burkholderia mallei and are required for survival within macrophages 
and for complete virulence in mice (Bandara et al., 2008; Bandara et al., 2005) 
In E. coli CtpA is a periplasmic protease and has been shown to be 
responsible for C-terminal processing of penicillin-binding protein 3 (PBP-3), 
furthermore it has been shown in vitro to degrade proteins with non-polar C 
termini (Hara et al., 1991). 
 
Mutation of the Cj0511 gene in C. jejuni 11168H resulted in reduced 
colonisation of chickens, this decrease seen in the chicken model was shown 
to be independent of any changes is flagella expression which appear in C. 
jejuni because of phase variation, with the mutant strain showing motility at 
wild-type levels (Personal communication Dr A. Karlyshev). Champion et al. 
(2010) showed that a Cj0511 mutant exhibited a reduced kill in G. mellonella 
model.  
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4.1.8 Outer membrane vesicles 
 
The mechanisms by which C. jejuni is able to deliver virulence factors into 
host cell remain unclear as the bacterium lacks the classical virulence-
associated secretion systems that are possessed by other enteric pathogens 
such as Salmonella spp., and uses a flagellar export system which Konkel et 
al. (2004) showed is necessary for the invasion of INT 407 epithelial cells. A 
number of Gram-negative bacteria, instead of secreting proteins into the 
surrounding environment, where they are liable to get broken down by host 
proteases, use outer membrane vesicles (OMVs) as a way of delivering active 
proteins and other biological products into the host cell (Ellis and Kuehn, 
2010).  
 
Utilising OMVs allows bacteria to secrete a number of virulence factors 
together rather than secrete them individually. OMVs have been shown to be 
involved in moderating host responses and delivering virulence factors for a 
number of Gram-negative bacteria (Lara-Tejero and Galan, 2001). OMVs are 
spherical nanostructures consisting of outer membrane proteins, LOS, 
phospholipids, and several periplasmic proteins and generally have a 
diameter between 10 to 500 nm (Kuehn and Kesty, 2005; Mashburn-Warren et 
al., 2008) However, C. jejuni OMVs differ in size and were found to be 
between 10-250 nm (Elmi et al., 2012) 
 
OMVs in C. jejuni were first described in 1982 by Logan and Trust and 
evidence of the biological importance of C. jejuni to OMVs has recently been 
determined with Lindmark et al. (2009) showing that active CDT is released 
inside OMVs by strain 81-176. Elmi et al. (2012) conducted proteome analysis 
on OMVs produced by C. jejuni 11168H and identified 151 including the 
protease HtrA and the predicted protease Cj0511.  
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4.1.9 Hypothesis 
 
Based on the findings of Elmi et al. (2012) who showed that the OMVs of C. 
jejuni contained Cj0511, it was postulated that this protease was involved in 
processing α-amylase as a signal for the response observed in Chapter 3. 
Therefore the hypothesis being addressed in this chapter is that Cj0511 
activity is necessary for the response seen when C. jejuni is grown in the 
presence of pancreatic α-amylase. To test this, a Cj0511 mutant was obtained 
(Campylobacter Resource Facility, LSHTM) and a complemented strain was 
constructed by insertion of a functional Cj0511 gene into Cj0046 under control 
of the pfdxA promoter by using plasmid pC46fdxA. Additionally recombinant 
Cj0511 was prepared by cloning and expression of a histidine-tagged protein 
in E. coli 
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4.2 Results 
4.2.1 Functional Cj0511 is required to increase carbohydrate secretion 
in response to α-amylase 
 
The mucoid phenotype, documented in Chapter 3, was not apparent when C. 
jejuni 11168H Cj0511 mutant was grown with α-amylase supplementation, as 
shown in figure 4.1 which shows11168H wild-type exhibiting a mucoid 
phenotype, and Cj0511 mutant exhibiting a non-mucoid phenotype; when both 
strains were grown on CMHA supplemented with 100 µM α-amylase.  
 
 
 
 
 
Figure 4.1 C. jejuni 11168H exhibiting a mucoid phenotype (Panel A) and 
Cj0511 mutant exhibiting a non-mucoid phenotype (Panel B) streaked on 
CMHA supplemented with 100 µM α-amylase. 
 
However, the lowest concentration that carbohydrate increase is exhibited is 
100 nM and this is not visible by eye, therefore a carbohydrate analysis was 
conducted to test if the Cj0511 mutant was able to express increased 
carbohydrate in response to rising concentrations of pancreatic α-amylase as 
exhibited by the wild-type strain. Furthermore the complemented Cj0511 strain 
(for complementation of Cj0511 see Appendix 2) was tested. The results 
A B 
89 
 
clearly show that Cj0511 was unable to express increased carbohydrate in 
response to increasing concentrations of amylase as exhibited by strain 
11168H, further to this the complemented strain exhibited an increase in 
carbohydrate secretion which was comparable to the wild-type strain (Figure 
4.2).  
 
 
Figure 4.2. Graph showing the amount of extracellular carbohydrate produced by C. 
jejuni 11168H, the Cj0511 mutant and the complemented strain in the presence of 
pancreatic α-amylase. Data shown is the mean and standard deviation from three 
independent experiments. 
 
4.2.3 Functional Cj0511 is required to grow on agar with α-amylase as 
the sole source of carbon 
 
As pancreatic amylase appears to increase the growth rate of C. jejuni as 
shown in Chapter 3, the question of whether the bacterium was able to use 
pancreatic enzymes as a carbon source was investigated.  Growth on a 
defined minimal medium (SAPI) was observed on plates supplemented with 
100 µM pancreatic α-amylase, as a positive control 20 mM sodium pyruvate 
was used, the results are summarised in Table 4.1. The wild-type strain and 
the Cj0511 complemented strain showed growth on SAPI when supplemented 
with pancreatic α-amylase; however no growth was observed by the Cj0511 
mutant in the presence of pancreatic α-amylase. All of the tested strain 
exhibited growth on sodium pyruvate. To test if the response was specific to 
pancreatic α-amylase growth  SAPI was supplemented with α- amylase from 
A. oryzae, pancreatic trypsin, porcine gastric mucin, bile, BSA and lactose at a 
range of concentrations; no growth by any of the strains was observed. 
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Further to this, no growth was observed on plates which were supplemented 
with microbial α-amylase. These results show that C. jejuni is able to grow on 
minimal defined medium containing pancreatic α-amylase as the sole source 
of carbon. The data also indicates that C. jejuni can use only pancreatic α-
amylase as a carbon source and not α-amylase from a microbial source, 
furthermore this ability is dependent on functional Cj0511. 
 
 Table 4.1. Growth of C. jejuni 11168H, the Cj0511 mutant and the complemented 
strain on SAPI medium containing different sole sources of carbon. 
 
 
 
 
 
 
 
 
 
 
4.2.4 Recombinant Cj0511 is proteolytically active 
 
To test if recombinant Cj0511 (For expression of recombinant protein see 
Appendix 3) has proteolytic activity, azocasein was used as a substrate and 
trypsin as a control. Azocasein is casein conjugated with an azo dye. When an 
active protease is incubated with azocasein, hydrolysis of the casein liberates 
the free dye into the supernatant which can be quantified by measuring 
Strain Hog α-
amylase 
α-
amylase 
from A. 
oryzae 
BSA Trypsin Mucin Bile Lactose Pyruvate 
11168H Yes No No No No No No Yes 
11168H 
Cj0511 
No No No No No No No Yes 
11168H 
Comp 
Yes No No No No No No Yes 
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absorption at 440 nm. Figure 4.3 shows trypsin exhibited higher activity when 
compared to an equal concentration of Cj0511. The results clearly show that 
Cj0511 exhibits proteolytic activity. 
 
 
 
 
Figure 4.3. Analysis of proteolytic activity of recombinant Cj0511 using azocaesin as 
substrate with equal concentrations of trypsin. 
 
 
 
 
 
 
 
 
 
4.2.5 Recombinant Cj0511 degrades α-amylase 
 
Final concentrations of 0,1,2,3 and 4 mg/ml recombinant Cj0511 were pre-
incubated at 37˚C with 5 µg/ml hog pancreatic α-amylase and then loaded into 
an agar plate containing starch. The resulting halos were visualised over white 
light as shown in Figure 4.4. The results show a dose-dependent decrease in 
the ability of α-amylase to hydrolyse starch. 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 0.05 0.1 0.15 0.2 0.25
O
D
 4
4
0
 
Concentration mg/ml 
Trypsin
Cj0511
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Nutrient agar plates containing 0.4 % (v/v) starch inoculated with A) 
Control 5 µg/ml hog pancreatic α-amylase. B) 1 mg/ml Cj0511, C) 2 mg/ml Cj0511, D) 
3 mg/ml Cj0511, E) 4 mg/ml Cj0511 pre-incubated with 5 µg/ml hog pancreatic α-
amylase at 37˚C. 
 
 
4.3 Discussion 
The study of proteases secreted by bacteria and their subsequent function in 
host environments is of significant importance. In general, proteases affect 
pathogenesis in two ways. They are involved in protein quality control which is 
necessary for the turnover of unfolded proteins produced in hostile 
environments within the host (Ingmer and Brondsted, 2009). There is evidence 
that suggests a conserved role in specific and controlled proteolysis of 
regulatory proteins in response to temporal, spatial or environmental stimuli 
A 
B 
E 
D 
C 
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(Ingmer and Brondsted, 2009).  These extra-cytoplasmic peptidases are 
attractive targets for the development of antimicrobial drugs. It has been 
highlighted that secreted peptidases are important virulence factors, C. jejuni 
produces a number of peptidases, of these Cj0511 has been found to be cell 
surface-associated (Prokhorova et al., 2006, Elmi et al., 2012). However the 
exact function of this protease has yet to be elucidated. Champion et al (2010) 
showed that a Cj0511 mutant was less toxic in G. mellonella model and 
concluded that the predicted protease-encoding gene warrants further 
investigation. 
 
This study has shown that induction of EPM in C. jejuni in response to α-
amylase (Chapter 3) requires a functioning Cj0511 gene. In contrast to the 
wild-type strain, C. jejuni 11168H, the Cj0511 mutant was unable to express 
increased levels of carbohydrate in response to α-amylase, however, when 
the mutant was complemented with a wild-type copy of Cj0511, wild-type 
response was restored. 
 
In chapter 3 it was shown that exposure to physiological concentrations of 
mammalian pancreatic α-amylase during growth in liquid culture promoted 
growth of C. jejuni 11168H. However, when mammalian pancreatic α-amylase 
was incorporated into SAPI agar as the sole source of exogenous carbon the 
Cj0511 mutant was unable to grow, whereas the wild-type strain did. 
Furthermore upon complementation of Cj0511 this ability to grow on α-
amylase-supplemented SAPI agar was restored. This data suggests that 
proteolytic activity of Cj0511 on α-amylase is required for C. jejuni to utilise α-
amylase    as a nutrient source. 
 
Subsequently recombinant Cj0511 was tested first for activity on azocaesin 
using trypsin as control, and determined the protein as proteolytically active. 
Secondly, pre-incubation of α-amylase with Cj0511 resulted in a reduction in 
the activity of α-amylase. The combination of caesinolytic activity and reduced 
amylase activity suggests that the reduction in amylase activity is due to 
proteolytic degradation of amylase.  
 
94 
 
The results show that C. jejuni is able to grow on agar with pancreatic α-
amylase as the sole source of carbon, the Cj0511 mutant was unable to do 
this, when the complemented strain was tested wildtype response was 
restored. This together with the proteolytic degradation of amylase suggests 
the ability to metabolise as an energy source is depended of Cj0511 activity. 
Tripeptide and dipeptide metabolism in E. coli K12 have been shown to begin 
by proteolytic breakdown and peptide uptake. The primary mode of uptake of 
these peptides in bacteria is via ATP binding cassette (ABC) transporters. The 
substrate-binding protein (SBP) of these transporters captures extracellular 
peptides and delivers them to membrane-bound components for transport. 
Bacterial peptide-binding SBPs that function in ABC transporters have evolved 
predominantly to function as generalists, recognising peptides of particular 
lengths but with low or no sequence specificity. However, within the peptide-
specific SBPs are examples that appear to have evolved subsequently to 
recognise specific peptides. C. jejuni contains homologues of a number of 
ABC transoprters and SBP; furthermore it also has homologues for 
tri/dipeptide transporters, making the above response feasible. 
 
This study shows that Cj0511 degrades pancreatic α-amylase. According to 
the MEROPS peptidase database (Sanger, UK) Cj0511 is predicted to be a C-
terminal processing peptidase and belongs to clan SK and family S41. 
Chlamydial protease-like activity factor (CPAF) from Chlamidya spp. is also in 
this family and it has been shown to be associated in the proteolysis of at least 
16 host proteins (Chen et al., 2012). Similar C-terminal proteases in 
organisms such as E. coli have been shown to be involved in the universal 
degradation of proteins tagged by a C-terminal sequence. Therefore based on 
the sequence homology shared between Cj0511 and the aforementioned 
proteases it can be assumed that Cj0511 functions in a similar fashion; 
processing pancreatic α-amylase to produce a C-terminal peptide that can be 
can be taken up by ABC transporters and recognised by C. jejuni. The finding 
that stable and proteolytically active Cj0511 can be expressed by E. coli is 
highly relevant as this will facilitate in future work with development of specific 
inhibitors. The study of bacterial proteases as future drug targets is promising. 
Slomiany et al. (1992) found successful treatment of H. pylori infection using 
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anti-ulcer drug ebrotidine was in part due to its strong inhibitory action of 
Helicobacter proteases involved in degrading gastric mucin, which is a growth 
promoter in H. pylori (Chowers et al., 1999).  
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Chapter 5: Biofilm Formation and Stress 
Survival  
5.1 Introduction 
5.1.1 History of biofilm formation 
 
In their natural environment bacteria are most commonly found in close 
contact with surfaces and form multicellular aggregates known as biofilms. A 
biofilm can be defined as a structured community of bacterial cells enclosed in 
a self-produced extracellular polymeric matrix (EPM) and adherent to an inert 
or living surface (Costerton et al.,1999). This tendency to exist as a 
multicellular community is comparable to other living cells which are capable 
of unicellular growth but reside within multicellular communities (Davey and 
O’Toole, 2000). The perception of unicellularity in bacteria is based on the 
pure culture paradigm, since bacteria can be diluted to a single cell and 
studied in liquid culture, which was advocated in the Koch’s postulates by Dr 
Robert Koch (Koch, 1876). The study of planktonic bacteria has become the 
standard method to study a variety of bacterial activities. 
  
The sessile mode of bacterial growth was not described until 1933, when 
Arthur Henrici, an American microbiologist studying fresh water bacteria 
stated , "It is quite evident that for the most part the water bacteria are not free 
floating organisms, but grow on submerged surfaces; they are of the benthos 
rather than the plancton"(Henrici 1933). Then in 1940 H. Heukelekian and A. 
Heller published their work in the Journal of Bacteriology, stating “Surfaces 
enable bacteria to develop in substrates otherwise too dilute for growth. 
Development takes place either as bacterial slime or colonial growth attached 
to surfaces" (Heukelekian and Heller. 1940) 
Ten years later it was reported that bacteria introduced into a bottle disappear 
from the liquid phase; concurrently there was a rapid increase in the number 
of bacteria attached to the surface of the bottles. This bacterial adhesion was 
accompanied by an increase in the amount of suspended organic material 
which was termed ‘mucilaginous’ in other words gelatinous or mucoid. Zobell 
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concluded that the bacteria attached themselves to the glass surface where 
they encountered a concentration of organic nutrients much higher than would 
have been found in the bulk fluid (Zobell, 1943). 
5.1.2 Growing biofilms in vitro 
 
Today there are a number of ways to grow biofilms and study them under 
laboratory conditions. The first method is culturing bacteria on solid agar. In 
the strictest sense a colony grown on an agar plate is a biofilm; they are 
colonies of bacteria growing attached to a solid surface.  
Another method, considered a gold standard for biofilm study, is continuous 
culture using a flow cell, in which a submerged biofilm is formed on the 
internal surface of the cell (Christensen et al., 1999). This method allows the 
biofilm to be tested against antimicrobials and other environmental stresses, 
and also allows analysis by confocal scanning laser microscopy (CSLM). The 
use of microscopy has allowed the determination of biofilm architecture and 
composition using a number of fluorescent staining methods (O’Toole and 
Kolter, 1998). Once the biofilm is formed it is stained with dyes such as crystal 
violet or safranin, which are subsequently solubilised, and the absorbance is 
taken as a measure of biofilm formation (O’Toole et al., 1999). 
 
The environment in which bacteria find themselves determines the 
architecture of the biofilm and this can vary greatly in response to miniscule 
changes in the ambient environment, for example it has been shown that 
biofilm formation by Bacillus subtilis strain 3610 varies on medium solidified 
with different concentrations of agar, the morphology of the biofilm decreases 
in size and structure as the concentration of agar increases (Branda et al., 
2006). 
 
Difference in biofilm architecture can arise from differences in constituents 
which make up the extracellular matrix or EPM. The EPM of biofilms has been 
shown to be composed of polysaccharide, protein and/or extracellular DNA as 
well as phospholipids (Davey and O’Toole, 2000; Chandra et al., 2001).  
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5.1.3 Biofilm Formation 
 
Biofilm formation can be divided into four stages: initial attachment, 
irreversible attachment, maturation and detachment (Watnick and Kolter, 
2000). 
 
Once a bacterium approaches the surface it is to attach to, van der Waals 
forces of attraction bring the bacterium close to the surface and are active at a 
distance of a few nanometres. Bacterial cell surfaces and the surfaces of 
many environmental surfaces possess a net negative electrostatic charge 
resulting in a repelling force as the bacterium move towards the surface; this 
is effective at a distance of 10 nm. Once the bacterium has closed the 
distance between itself and the surface to approximately 5 nm through 
secondary Gibbs free energy, receptors on the bacterial cell surface such as 
pili and adhesins begin to interact with the surface (Hermansson, 1999).   
 
When the bacterium is in such close proximity to the surface, the flow velocity 
is reduced resulting in a reduction in friction and turbulence which encourages 
attachment. Once this physical contact is achieved, the initial attachment 
which maybe a transient reversible attachment or a stable irreversible 
attachment occurs (Kolari, 2003). Once attachment has taken place, the 
pioneer bacteria that are the initial colonisers begin to recruit other bacteria 
through quorum sensing leading to the formation of microcolonies; these 
pioneer bacteria facilitate the arrival of other bacteria by providing more 
diverse adhesion sites.  Studies in Pseudomonas aeruginosa have shown that 
initial attachment causes the quorum sensing induction of genes responsible 
for the production of compounds found in the EPM for developing biofilms 
such as the genes of the alginate pathway. Alginate is a major component of 
EPM in this organism. It has been shown that attachment causes a major 
change in phenotypic expression in biofilm forming P. aeruginosa and may 
involve a change in expression of at least 30% of the genome (Davies et al., 
1998). 
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Once microcolonies are formed, the bacteria begin producing the EPM, which 
consist primarily of polysaccharides but can be composed of a mixture of 
extracellular protein and DNA. 
5.1.4 Role of the extracellular polymeric matrix (EPM) 
 
The structure and architecture of biofilm are provided by the EPM which, in 
many cases is highly hydrated and tightly bound to the underlying substratum. 
The structure of the matrix is heterogeneous within a bioflm and the formation 
of channels allows the transport of oxygen and essential nutrients to the cells 
present within the matrix (Lewandonski, 2000). 
It has been found that bacteria such as Klebsiella pneumonia present within a 
biofilm grow slower than bacteria in planktonic culture; this is due to changes 
in oxygen concentration and limited nutrients (Wentland et al., 1996). Cells 
detach from the biofilm as a result of either cell growth and division or the 
removal of biofilm aggregates that contain masses of cells. The 
microorganisms inside the biofilm matrix are able to avoid antimicrobial agents 
and in some cases a 100-fold increase in antibiotic concentration has been 
shown to be required to kill the biofilm organisms compared with that required 
to kill the same bacteria in planktonic form (Jefferson, 2004). 
There are three possible explanations for this phenomenon. The first is that 
the EPM impedes diffusion of, or chemically reacts with, the antimicrobial. 
Studies have shown the EPM of P. aeruginosa 579 composed mainly of 
acetylated β-D-mannuronic acid and α-L-guluronic acid is capable of binding 
tobramycin (Hoyle et al., 1992) 
 
Secondly, as bacteria present within a biofilm exhibit reduced growth rates, 
this minimises the rate at which antimicrobial agents are taken up into the cell. 
A study in Staphylococcus epidermidis found that ciprofloxacin activity was 
influenced by the cell cycle with daughter cells being more susceptible than 
other populations in the biofilm (DuGuid et al., 1992). The actions of antibiotics 
such as penicillin, which target cell wall synthesis, affect only bacteria which 
are growing. The depletion of substrates and accumulation of waste products 
which have an inhibitory effect results in bacteria entering a stationary phase 
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in which they are protected from antimicrobial killing, as demonstrated in E. 
coli with increasing generation times resulting in the bacteria showing 
increasing phenotypic tolerance to β-lactam antibiotics (Tuomanen et al., 
1986). These findings are further supported by direct visualisation of 
metabolically inactive regions within P. aeruginosa biofilms grown in 
continuous culture (Goto et al., 1999). 
 
Finally, the availability of oxygen may affect susceptibility. Tresse et al. (1995) 
demonstrated that agar enclosed E. coli demonstrate a decreased 
susceptibility to aminoglycoside antibiotics as a result of decreased uptake of 
the antibiotic by the oxygen-deprived cells (Tresse et al., 1995). 
5.1.5 C. jejuni biofilm EPM 
 
One of the major withstanding questions with regards to C. jejuni biofilms is 
the composition of the EPM. The EPM is what holds the biofilm together, 
providing structure and strength. In the case of C. jejuni biofilms, the best 
characterised polysaccharide, the CPS, is not involved in biofilm formation as 
shown by Joshua et al., (2005) who reported no reduction in the biofilm 
forming capacity of a C. jejuni NCTC 11168 kpsM mutant. KpsM consist of six 
putative trans-membrane regions and is situated in the inner membrane, and 
is a component of an ABC transporter involved in capsule transport through 
the inner membrane (Karlyshev et al., 2000). 
 
Another polysaccharide which has been described, is a calcoflour white 
(CFW) - reactive polysaccharide. CFW is a fluorescent stain which binds β1-3 
and β1-4 sugar linkages. McLennan et al. (2008) showed that C. jejuni biofilm 
produces a CFW-reactive polysaccharide; they found biofilm formation is up-
regulated in the absence of a stringent response, a stress response generally 
triggered by nutrient deprivation, which is governed by SpoT. When spoT was 
mutated, an increase in the level of CFW-binding polysaccharide was 
observed (McLennan et al., 2008). 
 
Furthermore, LOS and N- and O-linked glycoproteins have been shown to not 
be involved in biofilm formation. These are all glycans which have been ruled 
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out. McLennan et al (2008) tested a gne mutant and found no defect in biofilm 
formation. Gene gne encodes a bifunctional UDP-GlcNAc/Glc 4 epimerase 
involved in the synthesis of CPS, LOS, and N-linked carbohydrates 
(Bernatchez et al., 2005). 
 
5.1.6 Environmental stresses 
 
C. jejuni remains a paradox: in the laboratory it requires fastidious conditions 
to grow, however in its natural environment it is able to survive surprisingly 
well.  The ability of C. jejuni to transmit between hosts and cause diseases 
may be explained partly by the low infectious dose in comparison to other 
gastrointestinal pathogens such as Salmonella typhimurium and Vibrio 
cholerae (Schmid-Hemple and Frank, 2007). 
This may account for the bacterium’s ability to cause infection but does not 
explain how the bacterium is able to survive environmental stress. The 
stresses endured by C. jejuni from its natural reservoir in the chicken caeca to 
the GI tract of humans, is varied involving changes in temperature, pH and 
oxygen concentrations. 
 
Examples of proteins which have an integral role in the ability of C. jejuni to 
adapt to environmental changes include HtrA that prevents periplasmic 
proteins from aggregating by degrading proteins which are misfolded during 
stress (Li et al., 1996) Studies have shown transcription of dnaJ is up-
regulated when C. jejuni encounters temperature stress. DnaJ plays a 
significant role in the thermotolerance of C. jejuni by facilitating protein folding 
(Stintzi, 2003). 
 
Alternatively, mucoid growth of bacteria which can be defined as ‘biofilms’ 
have been shown to exhibit increased survival to environmental stresses. 
Mucoid strains of P. aeruginosa which are characterised by excessive 
amounts of the exo-polysaccharide alginate showed a significant increase in 
viability within chlorinated water in comparison to isogenic non-mucoid cells. 
When alginate was removed, survival was reduced (Grobe et al., 2001).  
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5.1.7 Hypothesis 
 
The hypotheses being addressed in this chapter are: 
1.  Induction of the EPM by exposure to pancreatic α-amylase promotes 
biofilm formation in C. jejuni.  
2. Induction of the EPM increases resistance to environmental stresses. 
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5.2 Results 
5.2.1 C. jejuni exhibits increased autoagglutination in response α-
amylase 
 
Autoagglutination (AAG) activity is thought to be a precursor for micro-colony 
formation and can be measured by assessing the reduction in absorbance at 
OD600 over time, because the suspended bacteria precipitate at the base of 
the cuvette after they agglutinate. Figure 5.1 shows that both C. jejuni 11168H 
and 81-176 wild-type strains grown in the presence (Chapter 2: 2.13) of 100 
nM α-amylase have higher rates of AAG than bacteria grown in the absence 
of α-amylase. 
 
Figure 5.1. Autoagglutination activity of C.jejuni 11168H and 81-176 grown in the 
presence and absence of 100 nM α-amylase. The optical density at 600 nm (OD600) 
measured at 6, 12, 24 and 48 hours. Results shown are means from three 
independent experiments. Errors bars represent standard deviation. 
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5.2.2 Quantification of biofilm formation using crystal violet (CV) 
staining 
 
The ability of C. jejuni strains to form biofilm on borosilicate glass test tubes at 
the liquid/gas interface was assessed in the presence and absence of 100 nM 
α-amylase. All the strains which were tested exhibited highly significant (p 
<0.001) increase in biofilm formation in the presence of α-amylase, with the 
exception of the Cj0511 mutant (Figure 5.2). The magnitude of the increase 
seen in biofilm formation in response to α-amylase by carbohydrate structure 
mutants (kpsM, spoT, waaC and waaF) was similar to reference strain 
11168H and strain 81-176, indicating that none of the known carbohydrate 
structures, capsule (kpsM), CFW binding polysaccharide (spoT) nor LOS 
(waaC and waaF) are involved in the response to α-amylase. Furthermore, 
these experiments definitively indicate that the ability of C. jejuni to form 
increased biofilm in response to amylase is dependent on Cj0511 as shown 
by the lack of response to amylase in the Cj0511 mutant and its restoration in 
the complemented strain; which showed a similar magnitude of increase as 
reference strain 11168H.  
 
Figure 5. 2. C. jejuni biofilms grown in the presence (black bars) and absence (white 
bars) of pancreatic α-amylase. Results are presented as the mean OD600 of 
solubilised CV in three independent experiments. Errors bars represent standard 
deviation. Statistical significance was analysed using students T-test (*** = p <0.001). 
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5.1.3 Biofilm analysis by CLSM reveals a three-dimensional structure 
 
Confocal laser scanning microscopy (CLSM) in conjunction with Live/Dead 
staining was used to visualise bacteria within an intact biofilm.  Forty eight 
hour old C. jejuni 11168H biofilms grown on glass coverslips in the presence 
or absence of 100 nM α-amylase were compared. Confocal image and model 
of biofilms in the absence of α-amylase show a scarce number of bacteria 
adhering to the coverslip surface and no significant depth of biofilm structure 
in the 3-D model (Figure 5.3A-C). In contrast biofilm grown in the presence of 
α-amylase show a large concentration of bacteria adhering in the form of 
microcolonies separated by dark regions which are probably water filled 
channels (Figure 5.3B). Construction of a 3-D model and subsequent analysis 
of the X-Z plane, clearly show the development of characteristic matrix 
structure which has a constant depth of 160 microns (Figure 5.3D). Images 
shown are representative of three independent experiments.  
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Figure 5.3. Confocal microscope images of Live/Dead stained C. jejuni 11168H 
biofilm attached to a glass coverslip at 48 hours images taken at x40 magnification A) 
11168H without hog pancreatic α-amylase, B) 11168H with 100 nM hog pancreatic α-
amylase. Graphical depiction of vertical density of biofilm C) 11168H without α-
amylase, D) 11168H with 100 nM α-amylase. The digitally manipulated 3D images 
and graphical representation of the biofilm were produced using ImageJ software 
(NIH, USA). Scale bar represent 10µm 
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5.1.4 Biofilm kinetics using a strain expressing green fluorescent protein 
(GFP) 
 
The increased biofilm observed in response to α-amylase suggests that the 
rate of growth of biofilm in the presence and absence of amylase may differ. 
Therefore biofilm formation in the presence and absence of 100 nM α-amylase 
was monitored by CLSM in a time course over 48 hours using a GFP-tagged 
strain of C. jejuni 11168H. At 3 hours (Figure. 3 A and F), no difference in the 
attachment of bacteria was seen with sparse attached cells being seen in both 
sample.  At 6 hours, the formation of microcolonies was observed on both sets 
of coverslips, with no evident differences observed. At 12 hours, there is a 
visible increase in the number of bacterial cells attached to the coverslip in the 
presence of α-amylase. At 24 hours the difference observed between the sets 
was clearly visible; the α-amylase supplemented culture had grown into a 
biofilm with a large biomass of cells attached to the surface, in comparison to 
sparse isolated clumps of attached cells observed in the biofilm grown without 
α-amylase. At 48 hours, there was further biomass accumulation in the 
presence of amylase. The image is indicative of a mature biofilm with large 
amounts of cellular biomass covering the surface of the coverslip. At this 
same time point the bacteria growing in the absence of amylase were 
beginning to show signs of biomass localisation and initial biofilm formation, 
however this is substantially lower and slower than the bacteria grown in the 
presence of α-amylase. Images shown are representative of three 
independent experiments.  
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Figure 5. 4. Kinetics of biofilm formation over 48 hours by GFP-tagged C. jejuni 
11168H. Images were taken using confocal microscopy x20 lens at time points 3, 6, 
12, 24 and 48 hours. Images A-E are grown in Brucella broth only and images F-J 
are supplemented with 100 nM hog pancreatic α-amylase. Scale bars represent 50 
µm. Images shown are representative of three independent experiments.  
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5.1.5 Electron microscopy show distinct differences in biofilm structure 
 
To validate the CV staining data, SEM was used to visualize biofilms of 
11168H in the presence and absence of α-amylase at the ultra-structural level. 
Biofilms were grown on polycarbonate filter disks placed on MHA plates, the 
disks were removed and placed on fresh plates every 24 hours for a total of 5 
days, and processed for SEM. The concentration of α-amylase was increased 
to 100 nM see if the structural differences in biofilm would increase and the 
time of 5 days was chosen to ensure that biofilm maturation was achieved. 
Figure 5.5 shows that biofilms grown in the presence of α-amylase show high 
density of cells attached to the polycarbonate surface in multiple layers with 
evidence of mucoid secretions between the cells (highlighted by red arrows). 
In contrast biofilm grown in absence of α-amylase show only sparse bacteria 
adhered to the polycarbonate surface, at identical magnifications. Images 
shown are representative of three independent experiments.  
 
 
 
 
 
 
 
 
 
 
Figure 5.5. SEM of 5-day biofilms formed on 0.2 µm polycarbonate filter disks placed on 
MHA with (A) and without (B) 100 nM pancreatic α-amylase. Images shown are 
representative of three independent experiments.  
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5.1.5 C. jejuni exhibits increased autoagglutination and biofilm 
formation in response to chicken pancreatic extract 
 
To test whether C. jejuni 11168H was able to respond to chicken pancreatic α-
amylase, autoagglutination and biofilm formation were examined. A crude 
chicken pancreas extract was prepared and tested. An increase in 
autoagglutination was observed with the crude pancreatic extract that was of 
similar magnitude to the increase apparent with pancreatic α-amylase (Figure 
5.6A). An increase in biofilm formation of similar magnitude (2.2-fold, 
p<0.0001) as the increase apparent with pancreatic α-amylase (Figure 5.6B) 
was also observed. As a control in both experiments, 0.05 M Tris pH 8.0 was 
supplemented into the growth medium as this was the buffer used to prepare 
the pancreatic extract. 
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Figure 5.6. A) Autoagglutination activity of C. jejuni 11168H in the presence of 70 
µg/ml α-amylase and 0.05 M Tris. The optical density at 600 nm (OD600) was 
measured at 6, 12, and 24 hours. Results shown are means from three independent 
experiments. Error bars represent standard deviation. B) C. jejuni biofilms grown in 
the presence and 70 µg/ml α-amylase, 0.05 M Tris and in Brucella broth. Results are 
presented as the mean OD600 of solubilised CV in three independent experiments. 
Error bars represent standard deviation. Statistical significance was calculated using 
students T-test (*** p <0.001). 
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5.3 Survival of environmental stresses  
5.3.1 EPM promotes increased survival under ambient conditions 
 
To determine if pre-exposure of C. jejuni to α-amylase promotes survival in 
ambient conditions, C. jejuni pre-exposed and non-exposed to 100 nM hog 
pancreatic α-amylase were suspended in broth and viable counts were 
performed. C. jejuni pre-exposed to α-amylase were able to survive 10 days 
longer under ambient conditions in comparison to non-mucoid cells (p<0.05; 
Figure 5.7).  
 
 
 
Figure 5.7. Survival of C. jejuni 11168H pre-exposed (filled square) or not pre-
exposed (open triangle) to α-amylase in Mueller-Hinton broth under aerobic 
conditions at room temperature. Results are mean counts of three independent 
experiments. Error bars represent standard deviation. Statistical significance is 
denoted by * (p<0.05) as determined by one way ANOVA. 
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5.3.2 EPM promotes increased survival at refrigeration temperature 
 
To determine if pre-exposure to α-amylase affects survival under refrigeration, 
bacteria exposed and not pre-exposed bacteria were incubated aerobically at 
4°C.  C. jejuni pre-exposed to α-amylase were able to survive 8 days longer 
than bacteria that were not pre-exposed, exhibiting significantly (p<0.05) lower 
susceptibility to refrigeration (Figure 5.8).  
 
Figure 5.8. Survival of C. jejuni 11168H pre-exposed (filled square) or not pre-
exposed (open triangles) to 100 nM hog pancreatic α-amylase in PBS under aerobic 
conditions at 4°C. Results are mean counts of three independent experiments. Error 
bars represent standard deviation. Statistical significance is denoted by * (p<0.05) as 
determined by one way ANOVA. 
 
5.3.3 EPM promotes resistance to high temperature  
To assess the effect of high temperature on bacteria pre-exposed or not to α-
amylase, C. jejuni grown in the presence and absence of 100 nM hog 
pancreatic α-amylase was suspended in PBS and incubated at 55°C, 60°C 
and 65°C. Bacteria pre-exposed to α-amylase showed significantly lower 
susceptibility to high temperature compared to bacteria that were not pre-
exposed (Figure 5.9). 
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Non-exposed cells exhibit greater total log reduction 7.8, when compared to 
pre-exposed bacteria which showed a log reduction of just 4.6 over 21 
minutes incubation at 55 °C (Figure 5.9 A).  
When incubated at 60°C, the rate of reduction for non-exposed cells was 1.0 
log per minute in comparison to 0.5 log per minute for pre-exposed cells. The 
difference between the two sets of cells was not significant at 3 minutes, 
however at later time points (6, 9, and 12 minutes), the difference in survival 
was significant (p<0.05; Figure 5.9 B). 
 At 65°C, the rate of reduction was increased to 1.5 log per minute for non-
exposed cells and 0.7 log per minute for pre-exposed bacteria. Again at 3 
minutes the difference between the two was considered non-significant, 
however at 6 minutes the difference was significant (p<0.05; Figure 5.9 C).  
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Figure 5.9. Survival of C. jejuni 11168H pre-exposed to α-amylase (filled squares) 
and with no pre-exposure (open triangles) in PBS under aerobic conditions at A) 
55°C, B) 60°C and C) 65°C. Results shown are the mean counts of three 
independent experiments. Error bars represent standard deviation. Statistical 
significance is denoted by * (p<0.05) as determined by one way ANOVA. 
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2.3.4 EPM promotes survival in acidic conditions 
 
To assess if pre-exposure to α-amylase affects survival under acidic 
conditions, bacteria were grown on agar in the presence or absence of 100 
nM hog pancreatic amylase, and suspended in PBS which was buffered to pH 
4.0 or pH 2.0. Bacteria pre-exposed to -amylase showed significantly 
(p<0.05) higher pH tolerance in comparison to bacteria that were unexposed. 
The rate of reduction at pH 4.0 for pre-exposed cells was 0.04 log per minute 
and 0.03 log per minute for unexposed cells (Figure 5.10 A). At pH 2.0 
unexposed cells showed a log reduction 0.077 per minute and for pre-
exposed cells a log reduction 0.044 per minute was observed (Figure 5.10 B).  
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Figure 5.10: Survival of C. jejuni 11168H pre-exposed (filled squares) or not pre-
exposed (open triangles) to 100 nM hog pancreatic in PBS under aerobic conditions 
at A) pH 4.0 B) pH 2.0. Results shown are the means viable counts in three 
independent experiments. Error bars represent standard deviation. Statistical 
significance is denoted by * (p<0.05) as determined by one way ANOVA. 
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5.3 Discussion 
 
One of the challenges in understanding the diseases caused by C. jejuni is 
how the bacterium is able to survive in the environment and be transmitted 
from host to host. One of the explanations put forward is that existing in a 
biofilm allows C. jejuni to survive stresses encountered in the environment 
(Reuter et al., 2010). However, there is little known about the factors which 
initiate C. jejuni biofilm formation, and determining these factors  is important 
for developing adequate control measures.  
The data presented in this chapter show that C. jejuni produces significantly 
more biofilm in response to pancreatic α-amylase using the crystal violet 
quantification method and this response is independent of the previously 
documented carbohydrate structures (CPS, LOS and CFW-binding 
polysaccharide). The data presented in Chapter 3 shows that exposure to 
pancreatic α-amylase induces the secretion of an EPM comprised of a novel 
α–dextran, whilst the results presented in this chapter show that this promotes 
formation of a biofilm. Furthermore the response to α-amylase requires 
Cj0511 activity, since the Cj0511 mutant showed no increase in biofilm 
formation in response to α-amylase, this in contrast with the complemented 
strain which showed a wild-type response. The Cj0511 mutant exhibited a 
slight increase in biofilm formation when grown without α-amylase in 
comparison to the wild-type strain. Although this increase was not significant, 
an explanation could be that production of the predicted extracellular protease 
may inhibit biofilm formation. It has been shown that extracellular proteases 
Aur and SspA of S. aureus inhibit biofilm formation, furthermore it has been 
suggested that protein-mediated biofilm formation is controlled by expression 
of extracellular proteases in S. aureus (Marti et al., 2010).   
It has been proposed that the ability of C. jejuni to survive harsh conditions in 
a biofilm is related to the area covered, thickness and architecture of biofilms 
(Trachoo and Frank 2002). When the architecture of the C. jejuni 11168H 
biofilm was assessed using CLSM; the biofilm formed in the presence α-
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amylase was approximately 8 times thicker, and showed a clear increase in 
biofilm across both X-Y and X-Z planes. 
Biofilm formation kinetics was monitored using a GFP-labelled C. jejuni strain. 
Once in the human small intestine C. jejuni encounters mechanical pressure 
through the intestine by peristalsis caused by smooth muscle and mesentery. 
This movement is not particularly fast, a typical peristaltic wave lasts only a 
few seconds and travelling a few centimetres per second (Young, 2006). The 
results presented here suggest that biofilm is formed significantly faster in 
response to physiological concentrations of α-amylase which would provide a 
considerable advantage in colonising the host. Furthermore studies have 
shown that strains isolated from humans and chicken, which are pre-exposed 
to α-amylase, form micro-colonies on smooth surfaces quickly during 
incubation and then the colonies progressively grow and form 
interconnections forming a mature biofilm similar to the results displayed in 
this study (Moe et al., 2009). 
The primary sequence between mammalian and avian pancreatic amylases 
are 80% identical, C. jejuni 11168H was able respond to chicken pancreatic 
extract which contained approximately 70 µg/ml α-amylase by significantly 
increasing both autoagglutination and biofilm formation.  This result is of 
considerable importance in two ways. Firstly, it is well known that C. jejuni is 
able to colonise the cecum of chickens in considerable numbers, forming in 
vivo biofilms would assist this process of colonisation and it has been 
suggested that biofilm formation is necessary for contamination of broiler meat 
with C. jejuni (Kudirkiene et al., 2012). Secondly C. jejuni excreted into the 
slaughterhouse environment by chickens are pre-exposed to α-amylase and 
thus, based on the data from this study, form increased biofilm. This is 
supported by findings showing that colonised chickens shed up to 107 C. jeuni 
CFU/g of faeces and these isolates along with exhibiting mucoidy have been 
shown to form biofilm faster and thicker (Mead et al., 1995; Moe et al., 2009). 
The ability of food borne pathogens to form biofilms on environmental 
surfaces is an important matter, C. jejuni has been shown to form biofilm on 
stainless steel, glass and polypropylene, and is subsequently more resistant 
to antimicrobials than planktonic cells (Neutres and Chen. 2009). Further to 
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this, C. jejuni has the ability to form attached biofilm on the surfaces of 
domestic and farming watering supplies and these attached bacteria could 
potentially act as an active reservoir of infection for humans and domestic 
animals (Reeser et al ., 2006). Biofilm formation in C. jejuni was first described 
by Joshua et al. (2005).  Existing as a biofilm allows organisms to withstand 
host immune responses such as phagocytosis and as a community they can 
endure changes in pH, temperature and starvation of nutrients (Jenkinson and 
Lamont, 2005). Joshua et al. (2005) showed that C. jejuni is able to form both 
attached and unattached biofilm. The unattached aggregates of biofilm known 
as ‘flocs’ are more resistant to ambient air  and may be important in survival 
and pathogenesis of the organism.  
 
Campylobacter spp. lack the genes encoding the RpoS global stress response 
mechanism, the oxidative stress response factor SoxRS (positive regulators 
for the response to superoxide stress) as well as other stress response factors 
such as Lrp (global regulator of metabolism), ProU (high affinity 
osmoregulatory uptake of compatible solutes), CspA (major cold shock 
protein) and RpoH (alternative sigma factor regulating the heat shock 
response) (Park, 2002; Nachamkin and Blaser, 2001).  
Studies have shown that acidic treatment at pH 4.5 has a significant 
bactericidal effect on C. jejuni, it has been recommended that the addition of 
organic acids in water supplies in poultry farms could significantly reduce the 
transmission of C. jejuni (Murphy et al., 2003). The data obtained in this study 
documents that C. jejuni secreting EPM are able to withstand acidic conditions 
at pH 4 and pH 2 significantly longer highlighting that current control measures 
using acidic treatment in domestic water supplies are inadequate. Further to 
this, decreased acid sensitivity which is promoted by EPM secretion is 
necessary to colonise the human GI tract, C. jejuni must pass the inhospitable 
acidic conditions of the stomach where pH values as low as 2.0 are present, 
and the emptying time for the stomach is approximately 2 hours (Smith, 2003). 
Therefore C. jejuni must be able to withstand an acidic pH of approximately 2 
for this amount of time if it is to reach its site of colonisation in the small 
intestine (Smith, 2003). EPM production in other bacteria such as by E. coli 
O157:H7 confer resistance to acidic stresses and it has been proposed that 
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this resistance allows the bacterium to persist in the GI tract (Mao et al., 
2006). A study by Murphy et al. (2003a) showed a novel stress response to 
acid stress by a natural C. jejuni isolate, in which extracellular proteins are 
accumulated on the surface of the bacterium protecting it from acid stress. In 
chapter 3 it was described that a significantly increased quantity of 
extracellular protein and carbohydrate secreted in response to α-amylase, 
from this we can deduce that these secretions play an active role in stress 
tolerance (Murphy et al., 2003a). 
Mesophilic bacteria such as C. jejuni must possess the capacity to resist cold 
temperatures (Panoff et al., 1999). These mechanisms are thought to be 
highly conserved; one method of tolerating chilled conditions is to alter the 
fatty acid composition in the outer membrane. Listeria spp. respond to cold 
conditions by increasing levels of branched fatty acids and Salmonella spp. 
increase levels of unsaturated fatty acids in cellular membranes (Russel, 
2002). Although a similar response has been observed in C. coli, this was not 
the case for C. jejuni; a study by Hazeleger et al. (1998) found no significant 
changes in fatty acid composition. 
Chilled storage is an important control measure in the food chain, studies 
have shown growth of C. jejuni at 31°C and ATP generation has been 
observed at temperatures as low as 4°C (Hazeleger et al.,1998). The FSA 
(2013) reported that 66% retail bought chicken are contaminated with C. 
jejuni, poultry is generally stored under refrigeration conditions and the ability 
to persist at such a low temperature would provide the bacterium with an 
advantage when transmitting from chicken to humans. C. jejuni 11168H grown 
in the presence of pancreatic α-amylase was shown to survive significantly 
longer in nutrient-deprived conditions at 4°C. This is supported by the view 
that existing within an EPM allows C. jejuni cells to survive starvation 
conditions and unfavourable temperatures (Reeser et al., 2007). 
 
It has been reported that high temperature treatment of C. jejuni at 50°C and 
60°C significantly reduces the bacterial load on the carcasses of chickens (Li 
et al., 2002). Specifically, treatment of broilers with hot water in slaughter 
houses is considered a means to eradicate C. jejuni in poultry, and this 
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method is reasonably successful when using it against C. jejuni not secreting 
EPM. However the results obtained in this chapter show that C. jejuni 
expressing the EPM exhibit a significantly lower susceptibility to heat 
treatment at 55°C, 60°C and 65°C. This ability to survive high temperature can 
explain why C. jejuni are able to survive and persist on broilers after heat 
treatment and inadequate cooking, playing an integral role in transmission of 
C. jejuni. 
 
The phenomenon of EPM expression and its relevance to stress survival is 
probably best described in P. aeruginosa, the bacteria is able to secrete 
extracellular alginate, which confers protection against many stresses such as 
desiccation changes in pH and chlorination. Bacteria expressing alginate 
reveal enhanced survival compared with isogenic non-alginate producing cells 
in chlorinated water. Removal of alginate from bacteria abolishes chlorine 
resistance; conversely the addition of alginate to washed cells enhances cell 
survival (Grobe et al., 2001). 
 
Another feature of cells secreting EPM is their ability to autoagglutinate. 
Agglutination of bacteria was discovered by Chartin Roger in 1889. 
Autoagglutination has been noted in a number of Gram-negative pathogens, 
including Vibrio cholerae, Neisseria gonorrhoeae, and Yersinia (Chiang et al., 
1995; Laird et al.,1980). Furthermore there is practical evidence of a 
correlation between autoagglutination and biofilm formation (Reuter et al., 
2010; Howard et al., 2009).  The data shows that bacteria grown in the 
presence of α-amylase, expressing the EPM, show an increased 
autoagglutination activity, which may play a role in increased virulence, a 
hypothesis which is addressed in the next chapter. 
 
In conclusion the findings of this chapter clearly show supplementation of 
physiological relevant concentrations of mammalian pancreatic α-amylase 
result in significant increase in the biofilm forming ability of C. jejuni, this 
increase in biofilm-forming ability is independent of all the major defined 
polysaccharide structures, additionally biofilm forming capacity was directly 
related to activity of Cj0511. The biofilm formed in response to α-amylase 
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formed quicker and was significantly thicker (8 times) in the X-Y and X-Z 
planes when assessed with CLSM. EPM producing C. jejuni, formed in 
response to α-amylase, were able to withstand environmental stresses such 
as changes in aerobic conditions, temperature and pH significantly longer than 
non-EPM producing cells.  
This chapter is the first description of C. jejuni responding to a gastrointestinal 
constituent, α-amylase by increasing formation of biofilm. The findings 
presented are pertinent when considering development of future control 
strategies, as the majority of current research would not account for the fact 
that C. jejuni expelled from chicken faeces into the environment in a broiler 
house will be expressing EPM and will be more resistant to stress than in vitro 
grown bacteria. 
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Chapter 6: Role of the EPM in interaction 
with eukaryotic cells 
6.1 Introduction 
The efforts to reduce Campylobacter infections in humans is unequivocally 
connected to a further understanding of the biology of the pathogen and 
particularly the virulence mechanisms contributing to colonisation and 
pathogenesis (Dasti et al., 2010). 
 
Despite the advances in the study of C. jejuni virulence through genome 
sequencing, the mechanisms by which C. jejuni colonises the host and causes 
disease are still relatively poorly understood in comparison to other enteric 
pathogens. A major reason for this is the lack of a practical animal model to 
study campylobacteriosis.  
 
6.1.1 Pathophysiology of C. jejuni infection 
 
Human infection begins after oral consumption of C. jejuni, with a low infective 
dose of 500 to 800 CFU (Berberian et al., 1994).  After consumption, the 
ingested bacteria pass through the acidic environment of the stomach where a 
large percentage of the bacteria are eradicated (Smith. 2003). However this 
can be affected by the buffering capacity of food. The bacteria which survive 
and pass into the small intestine have the ability to attach to the mucus which 
covers intestinal epithelial cells. At this point the bacteria are able to replicate 
within the intestinal environment. 
 
The outcome of this in humans can be two-fold: first, the bacteria can cause 
diarrheal disease, or the bacteria can remain in the intestine asymptomatically 
(Cawthraw et al., 2000). 
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6.1.2 Sources of C. jejuni infection 
 
Epidemiological studies have shown that the majority of C. jejuni infections 
arise from exposure to contaminated food especially undercooked or raw 
chicken (Friedman et al., 2003). Handling and ingesting raw undercooked 
poultry are predominately linked to C. jejuni infection; however infections can 
arise from drinking raw milk and consuming red meat, cattle and swine have 
been determined to maintain Campylobacter spp. Furthermore, untreated 
water has been determined as a potentially significant source of C. jejuni 
contamination, generally outbreaks are irregular but a number of 
epidemiological studies have traced the source of contamination back to water 
sources (Smith et al., 2005). An interesting phenomenon, particularly in water 
supply pipes on farms, is the formation of C. jejuni biofilms which act as a 
reservoir for C. jejuni to enter the human food chain.  Although the general 
consensus is that eating undercooked poultry meat is the most important 
cause of Campylobacteriosis (EFSA, 2010).  
 
6.1.3 Immune response to C. jejuni 
 
Intracellular C. jejuni have been observed in individuals suffering from 
campylobacteriosis, supporting the notion that C. jejuni invades epithelial cells 
in vivo as occurs in in vitro experiments with cell lines (van Spreeuwel et al., 
1985). 
 
However, the mechanism of invasion has not been elucidated, a difficulty 
exasperated by the variation among C. jejuni strains.  Many invasive bacteria 
use microfilament-dependent mechanisms of entry, however C. jejuni utilises 
microtubule and/or microfilment polymerisation which are required for 
maximum invasion (Monteville et al., 2003) 
 
When internalised, C. jejuni-containing vacuoles (CCV) have been shown to 
progress along microtubules to the perinuclear region of the cell by 
interactions with dynein (Hu and Kopecko, 1999). CCV allows C. jejuni to 
survive within epithelial cells allowing by averting delivery to lysosomes 
(Watson and Galan, 2008).  
128 
 
The responses of intestinal epithelial cells to C. jejuni is characterised by 
cytokine induction, particularly IL-8, a pro-inflammatory cytokine (Hickey et al., 
2000). The induction of IL‑8 results in the recruitment of dendritic cells, 
macrophages and neutrophils, the interaction between these cells and C. 
jejuni results in a considerable pro-inflammatory response (Hickey et al., 
2000). 
 
Infection of in vitro epithelial cell lines such as Caco‑2 and T84 results in the 
activation of ERK and p38 which are members of MAP kinase family proteins  
for T84 cells. ERK activation is essential for the stimulation of IL‑8. Similar 
observations have been observed with human intestinal tissue explants 
(MacCallum et al., 2005). Systemic diseases are rare in immunocompetent 
individuals (0.15%-0.8%), with diseases being restricted to the intestine in 
most cases (Kapperud et al., 1992; Skirrow et al., 1993).  
 
6.1.4 Colonisation and disease models 
 
According to Newell (2001), animal models for C. jejuni are required to: 
 
a) Confirm the identification and enable the characterization of putative 
bacterial virulence factors. 
b) Validate in vitro models of pathogenic mechanisms. 
c) Investigate the role of host mechanisms in the induction of clinical 
symptoms. 
d) Determine host immune responses and investigate surrogates of protective 
immunity. 
e) Measure and test the efficacy of therapeutic or prophylactic treatments such 
as vaccines or antibiotics. 
 
A variety of animal models have been proposed for study of C. jejuni-mediated 
diseases. These include the ferret model which was used by Bacon et al. 
(2001) to show that the phase variable CPS is a virulence factor. Other 
models include the rabbit ileal loop model which was first used by Everest et 
al. (1993) to examine pathological changes in ileal tissue after C. jejuni 
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infection, and  primates such as infant rhesus macaques (Macaca mulatta) 
and the New World monkey Aotus nancymae (Russell et al., 1993; Jones et 
al., 2006). However ethical concerns and inadequate representation of human 
campylobacteriosis have prevented the widespread application of these 
models.  
 
6.1.5 Chicken colonisation model 
 
C. jejuni is able to colonise the avian gastrointestinal tract, and the 
contamination of broiler chicken meat is a principal source of infection 
(Friedman et al., 2004). However, this colonisation is asymptomatic and is 
considered to be a commensal association with the host (Newell, 2001).   C. 
jejuni predominantly colonises the caecum of chicken, generally between 106 
to 108 cfu/g (Beery et al., 1988). This ability to successfully colonise the 
chicken gastrointestinal tract is a multifactorial process and the model has 
been used to elucidate colonisation and survival factors. 
 
Chicken colonisation models for C. jejuni are categorised into 2 groups: the 
first uses chicks that are up to 2 days old and the second uses chickens 
between 14 and 16 days old. The model has been used to determine 
colonisation factors, including motility, chemotaxis, two-component regulatory 
systems and oxidative and nitrosative stress responses (Lin et al., 2003; 
Raphael et al., 2005; Karlyshev et al., 2002; Bras et al.,1999; Atack and Kelly, 
2009). 
 
However this high level of colonisation does not result in a pathological 
inflammatory response and does not result in similar symptoms observed in 
humans. In vitro data has shown that C. jejuni  stimulates intracellular nitric 
oxide synthase, IL-1 and IL-6 by chicken macrophages and epithelial cells, 
furthermore heterophils are also stimulated in response to C. jejuni but 
epithelial invasion is not common (Bar-Shira and  Friedman, 2006). Although 
the above immune response has been observed, chickens have either 
developed tolerance or the response is diminished by an unknown 
mechanism. 
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6.1.6 Galleria mellonella infection model 
 
In 2010 Champion et al. reported that the larvae of G. mellonella, the Greater 
Wax Moth can be successfully infected by C. jejuni and this model can be 
utilised to screen for genes involved in virulence.  
 
Insect models of infection have been used as alternatives to mammalian 
models due to their cost effectiveness and non-requirement of ethical consent. 
The most commonly used invertebrate for infection is the nematode species 
Caenorhabditis elegans, which has been used to study Yersinia pathogenicity 
(Joshua et al., 2003). However, there are limitations when using the C. 
elegans model, as it is unable to survive at 37°C and it lacks functional 
homologues of the mammalian immune system such as phagocytic cells 
(Mylonakis et al., 2007). Using insect larvae overcomes these disadvantages 
because they can survive at 37°C and have structures known as haemocytes 
that function in a similar fashion to human phagocytic cells, are able to ingest 
bacterial pathogens and generate bactericidal compounds such as superoxide 
(Bergin et al., 2005). Senior et al. (2011) showed that C. jejuni can survive 
within G. mellonella causing significant damage to the gut of these larvae. 
 
6.1.4 Intestinal cell invasion model 
 
As an alternative to using whole animals to model campylobacteriosis, 
epithelial cell lines are utilised. Two cell lines are predominantly used to study 
C. jejuni infection: INT407 which is a human embryonic intestinal cell line, and 
the Caco-2 human colon adenocarcinoma line (Friis et al., 2005). 
 
These cells are used to assess the ability of C. jejuni to adhere to and invade 
the epithelial cells. Of the two cell lines, Caco-2 cells are considered 
favourable to study columnar shape, polarity, formation of tight junctions and 
expression of microvilli (Friis et al, 2005). 
 
It has been shown that data obtained from in vitro cell lines accurately mimics 
that obtained using animal models of infection. For example, mutation of 
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genes cheY and kpsM in strain 81-176 exhibited reduced virulence in a ferret 
disease model and these results corroborated with the findings of cell culture 
results showing reduced adherence and invasion (Yao et al, 1997; Bacon et 
al, 2001). 
 
Tissue culture models are also used to study bacterial translocation which is 
the first step in the passage of viable bacteria from the gastrointestinal (GI) 
tract to extraintestinal sites. C. jejuni has been shown to exhibit translocation 
across polarised epithelial cells and it has been determined that this process 
is important factor in pathogenesis (Louwen et al., 2012).  
 
6.1.5 Hypothesis 
 
The hypothesis being addressed in this chapter is that exposure of C. jejuni to 
physiologically-relevant concentration of mammalian pancreatic α-amylase 
results in an increase in virulence in the G. mellonella model and increased 
adhesion and interaction with Caco-2 cells, as well as increased colonisation 
in 21 day old chickens.  
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6.2 Results 
 
6.2.1 Exposure of C. jejuni to pancreatic -amylase results in increased 
kill in G. mellonella 
 
To establish if bacteria grown in the presence of pancreatic amylase show 
increased virulence in the G. mellonella model, the percentage of larval kill 
was assessed after 24 h of infection. Ten larvae were infected  with 
approximately 106 (CFUs) of C. jejuni strains 11168H, 81-176, the kpsM and 
Cj0511 mutants and the Cj0511 complemented strain, all of which had been 
cultured on MH agar with and without amylase. With the exception of the 
Cj0511 mutant, strains grown in the presence of amylase resulted in increased 
lethality (Figure 6.1). C. jejuni 11168H showed a mean kill of one out of 10 
larvae when grown in the absence of amylase, compared to a mean of 8.7 
when pre-exposed to amylase. C. jejuni 81-176 showed mean kills of 9.3 and 
2.3 out of ten larvae, respectively, when grown with or without amylase.  
Similar results were obtained with the kpsM mutant with a mean kill of 3.3 out 
of 10 larvae in the absence of amylase compared to 7.6 out of 10 in the 
presence of amylase as shown in figure 6.1. The Cj0511 mutant showed a 
mean kill of 3 when the inoculum was prepared without amylase compared to 
a mean of 4.6 when the bacteria were grown with amylase. The 
complemented strain displayed killing capacity similar to the wild-type strain 
11168H with a mean kill of 1.3 out of 10 larvae in the absence of amylase 
compared to 9.3 out of 10 in the presence of amylase. The control group 
which were injected with PBS showed no kill. 
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Figure 6.1. Killing capacity of Campylobacter jejuni grown on MH agar with (black 
bars) or without (white bars) 100 nM hog pancreatic α-amylase. 11168H, 81-176, 
kpsM mutant. Sets of ten G. mellonella larvae were used. Means of three 
experiments are shown and the error bars show the standard deviations. Statistical 
significance was analysed using students T-test (* p <0.05). 
 
6.2.2 Exposure to pancreatic amylase delays formation of coccoid forms 
in G. mellonella larvae 
 
In this study, GFP-labelled C. jejuni 11168H was injected into the right foreleg 
of the G. mellonella larvae. The haemocoel of infected larvae were collected, 
the autoflourescent hemocytes were removed by low speed centrifugation and 
examined by fluorescent microscopy.  
 
Figure 6.2 shows that C. jejuni 11168H-GFP grown on agar in the absence of 
α-amylase became coccoid at 3 hours (Figure 6.2B), whereas bacteria pre-
exposed to α-amylase remained the characteristic rod shape at 3 hours 
(Figure 6.2C) and exhibited coccoid shape only at 6 hours (Figure 6.2D). As a 
positive control 11168H-GFP was grown in Brucella broth and the fluorescent 
image of characteristic rod-shaped cells is shown Figure 6.2A. All hemolymph 
controls which are autoflourscent showed no fluorescence. Images shown are 
representative of three independent experiments. 
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Figure 6.2. C. jejuni 11168H-GFP interaction with G. mellonella larvae. A) C. jejuni 
11168H-GFP grown in Brucella broth for 16 h at 37 ̊C microaerobically. B) C. jejuni 
11168H-GFP grown without amylase, 3 h post infection. C) C. jejuni 11168H-GFP 
grown with 100 nM hog pancreatic α-amylase, 3 hour post infection, D) C. jejuni 
11168H-GFP grown with 100 nM pancreatic amylase, 6 hour post infection. Scale bar 
represents 10µm. Images taken at x40 magnification and are representative of three 
independent experiments. 
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6.2.3 Exposure of C. jejuni to pancreatic -amylase results in increased 
interaction and invasion of Caco-2 cells 
 
Interaction (adhesion and invasion) with human Caco-2 cells was assessed 
using C. jejuni 11168H, the Cj0511 mutant and the complemented strain 
grown on MH agar with and without 100 nM pancreatic α-amylase. 
Approximately 108 were added to a confluent monolayer of ~106 cells at an 
MOI 1:100.  
 
Both the wild-type and the complemented strains pre-exposed to amylase 
displayed a significantly (p<0.05) increased ability to interact with Caco-2 
cells, whereas the Cj0511 mutant showed no increase in interaction when pre-
exposed to amylase compared to unexposed bacteria (Figure 6.3A). The 
increase was the most pronounced in the early stage of the infection (3-fold 
increase at 3 hours). At 6 hours and 24 hours, the increase in the number of 
interacting bacteria caused by pre-exposure to amylase was 2-fold and 1.6-
fold, respectively.  
 
When invasion of Caco-2 cells was tested exclusively (Figure 6.3B), a 
significant (p<0.05) increase in the numbers of invading bacteria as a result of 
pre-exposure to amylase was observed at all-time points in the case of strains 
11168H and the complemented strain, whereas the Cj0511 mutant did not 
show an increase in response to amylase pre-exposure.  
 
 
 
 
 
 
 
 
136 
 
0.00E+00
5.00E+06
1.00E+07
1.50E+07
2.00E+07
2.50E+07
3.00E+07
3.50E+07
4.00E+07
4.50E+07
5.00E+07
11168H 3
hours
cj0511 3
hours
Complement
3 hours
11168H 6
hours
cj0511 6
hours
Complement
6 hours
11168H 24
hours
cj0511 24
hours
Complement
24 hours
C
FU
/m
l 
Interaction 
*** *** 
*** 
0.00E+00
5.00E+04
1.00E+05
1.50E+05
2.00E+05
2.50E+05
11168H 3
hours
cj0511 3
hours
Complement
3 hours
11168H 6
hours
cj0511 6
hours
Complement
6 hours
11168H 24
hours
cj0511 24
hours
Complement
24 hours
C
FU
/m
l 
Invasion 
*** 
*** 
*** 
* 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. A) Interaction B) invasion of Caco-2 cells by C.jejuni 11168H, the Cj0511 
mutant and the complemented strain grown on MH agar with (black bars) and without 
(white bars) 100 nM hog pancreatic α-amylase at 3 hours, 6 hours and 24 hours. 
Statistical significance was  analysed using students T-test (*** p <0.001). 
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6.2.5 C. jejuni pre-exposed to pancreatic -amylase exhibits increased 
translocation in T84 cells 
 
Translocation across polarised T84 cells by C. jejuni 11168H, the Cj0511 
mutant and the complemented strain was assessed after 8 hours of infection 
(Figure 6.4). The results showed that in both the wild-type and the 
complemented strain pre-exposure to α-amylase resulted in significantly 
(p<0.05) increased translocation of T84 cells compared to bacteria not pre-
exposed to α-amylase. However, the Cj0511 mutant did not show a significant 
increase in translocation in response to amylase pre-exposure. 
 
 
 
Figure 6.4.Translocation of T84 cells by at 8 hours. C. jejuni 11168H, the Cj0511 
mutant and its complemented strain were grown in the presence and absence of 100 
nM hog pancreatic amylase (*p<0.05). 
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6.2.6 C. jejuni pre-exposed to pancreatic -amylase exhibit increased 
colonisation of chickens 
 
To determine if pre-exposure to α-amylase would alter the ability of C. jejuni to 
colonise chickens, 21 day old broilers chickens were infected with C. jejuni 
11168H or the Cj0511 mutant which were grown in the presence and absence 
of α-amylase (Figure 6.5).  
 
The results showed no significant difference at day 4, however at day 7 strain 
11168H which was pre-exposed to α-amylase before infection showed a 
significant increase (p=0.005) with 11/15 birds colonised,  in comparison to the 
same strain not pre-exposed to α-amylase which colonised 5/15 birds. The 
Cj0511 mutant did not show a difference in colonisation when pre-exposed 
and not pre-exposed bacteria were compared (Figure 6.5A). 
 
Upon further examination, chickens infected with C. jejuni 11168H pre-
exposed to amylase showed a significant increase (p=0.03) in the numbers of 
colonising bacteria in the ileum at days 4 and 7, compared to the Cj0511 also 
pre-exposed to α-amylase (Figures 6.5B, 6.5C). 
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Figure 6.5. A. Number of birds from which Campylobacter was isolated from the 
ileum at 7 days post infection. C. jejuni was grown with (black bars) or without hog 
pancreatic α- amylase (white bars). Bars indicate significant difference between 
groups. n=15 birds per group. 
B. CFU of Campylobacter per gram of ileal contents in birds 4 days post infection. 
Bars indicate significant difference by Dunn's multiple comparison test. n=15 birds 
per group.  
C. CFU of Campylobacter per gram of ileal contents in birds 7 days post infection. 
Bars indicate significant difference by Dunn's multiple comparison test. n=15 birds 
per group. 
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6.3 Discussion 
 
The results of this study have shown that pre-exposure of C. jejuni to 
physiologically relevant concentrations of mammalian pancreatic -amylase 
results in increased virulence in the G. mellonella model. Both wild-type 
strains and the kpsM mutant showed increased virulence in response to 
amylase exposure indicating that the EPM is a virulence factor in this model. 
The Cj0511 mutant did not show an increase in virulence in response to 
amylase in contrast to the complemented strain which showed an increase 
similar to that of the wild-type. This indicates that Cj0511 activity is necessary 
for the response to amylase and is a virulence factor. 
  
Champion et al. (2010) reported that a Cj0511 mutant was significantly 
attenuated in killing G. mellonella in comparison to the wild-type C. jejuni 
strain 11168H, however the data reported here did not show a similar 
decrease for the Cj0511 mutant. This difference in results could be explained 
by the fact that Champion et al. (2010) used broth-grown bacteria whereas 
here the bacteria were grown on agar, a factor shown by Champion et al. 
(2010) to influence virulence in the G. mellonella model.   
 
One of the main advantages of using the G. mellonella model is the 
resemblance between the vertebrate and invertebrate innate immune 
systems, which can be exploited. Kemp and Massey (2007) showed that G. 
mellonella have a cuticle which functions in a similar way to mammalian skin, 
operating as a physical barrier which, when breached, results in the induction 
of humoral immune response with the release of factors such as antimicrobial 
peptides. Furthermore, G. mellonella induces a cellular response to invading 
microorganisms, and hemocytes phagocytose bacteria in similar fashion to 
human neutrophils (Kemp and Massey, 2007). Therefore, using such a model 
allows us to predict how C. jejuni would behave in the human GI tract. A study 
by Senior et al. (2011) showed that upon entry into the larvae, C.jejuni begins 
to undergo a change to a coccoid shape after 3 hours. The reason for the 
change of C. jejuni from being rod shaped to coccoid has been debated 
however the consensus is that it is a response to oxidative stress and nutrient 
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deprivation and coccoid forms are therefore a degenerative state and are 
likely candidates for viable but non-culturable cells (Harvey and Leach 1998; 
Hudock et al., 2005). Interestingly a study by Beumer et al. (1992) concluded 
that oral administration of coccoid C. jejuni to mice and human volunteers 
resulted in none of the symptoms associated with C. jejuni infection. The 
findings described in this chapter show that C.jejuni 11168H-GFP which was 
grown in the absence of amylase was coccoid at 3 hours, however the C.jejuni 
11168H-GFP grown in the presence of amylase were still rod shaped at 3 
hours and became coccoid by 6 hours. This indicates that EPM-secreting cells 
are able to withstand oxidative stresses, nutrient deprivation and action of 
hematocyes and maintain its characteristic shape for a longer period of time 
longer in vivo allowing leading to increased virulence.  
 
The Caco-2 intestinal cell model was used to determine interaction and 
invasion of epithelial cells. The findings show that pre-exposure of C. jejuni to 
physiologically relevant concentrations of α-amylase significantly increased 
both interaction and invasion. It was also demonstrated that the protease, 
Cj0511, is necessary for the response. The Cj0511 mutant when grown 
without pancreatic α-amylase, showed no major difference in interaction with 
Caco-2 cells when compared to the wild-type strain; however when invasion of 
epithelial cells, a distinct reduction in the density of bacteria invading Caco-2 
cells was observed. In many cases it has been suggested that secreted 
extracellular proteases assist in tissue invasion through breaking down 
extracellular matrix proteins and polysaccharides, allowing bacteria to invade 
deeper. 
 
It was previously shown that induction of EPM results in significantly increased 
autoagglutination and biofilm formation (chapter 5) are both markers for 
virulence.  Micro-colony formation is a perquisite for biofilm formation, in vitro 
data obtained by Haddock et al. (2010) showed microcolony formation on 
human intestinal tissue, and concluded this to be a principal step in the ability 
of C. jejuni to cause diarrhoea in humans (Haddock et al., 2010). The results 
obtained in this chapter clearly highlight that induction of EPM through 
exposure to α-amylase results in significantly higher rates of adherent cells, 
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emphasising that biofilm formation by C. jejuni in vivo is an important step in 
the bacterium to cause disease, furthermore it underscores the fact that 
exposure to α-amylase is a significant and necessary step in the ability to 
colonise eukaryotic cells. 
  
The invasiveness of C. jejuni is an important virulence determinant, supported 
by a number of studies using animal models such as the chicken embryo, 
hamster and piglet (Field et al., 1986; Humphrey et al. 1986; Babakhani et al., 
1993).  
 
The data obtained here shows an increased invasion by EPM-producing 
bacteria, this increase was significant however the magnitude of change 
observed was not as high as the magnitude of change observed with 
interaction. This brings to light the EPM secretion predominantly assists 
adhesion and not invasion directly of eukaryotic cells, and this increased 
attachment subsequently results in increased invasion.  
 
A study by Everest et al. (1992) found isolates recovered from patients 
suffering from inflammatory colitis showed significantly higher levels of 
invasiveness than isolates from patients suffering from non-inflammatory 
campylobacteriosis. Furthermore, it has been determined that clinical isolates 
show increased invasion when compared to environmental isolates (Newell et 
al., 1985). An explanation for this can be found in the fact that clinical isolates 
have been exposed to pancreatic α-amylase prior to excretion in faeces, it is a 
well-known phenomenon that clinical isolates exhibit mucoidy, a response 
highlighted previously in Chapter 3. Chapter 3 described that mucoidy was 
associated with exposure to pancreatic α-amylase and is therefore the 
phenotype that would be expressed in vivo, mucoidy has been definitively 
associated with increased virulence in C. jejuni (Babakhani, 1993). 
Substantiating that EPM induction is vital for the pathogenesis seen clinically. 
Whereas environmental strains are unlikely to encounter pancreatic amylase 
and thus do not express EPM in their life cycle and thus exhibit reduced 
virulence. 
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Translocation is a mechanism of virulence used by a number of 
enteropathogens such as Salmonella sp., Yersinia sp., Shigella sp. and 
Listeria sp. to propagate within the host. The exact mechanism by which C. 
jejuni undergoes translocation is not known, however there is evidence that it 
requires a functional flagellum and requires de novo protein synthesis (Bras 
and Ketley, 1999; Finlay and Falkow, 1997). The wild-type strain 11168H pre-
exposed to pancreatic amylase showed significantly more translocation across 
T84 cells than the unexposed bacteria. When the Cj0511 mutant pre-exposed 
to amylase was tested it did not show a significant increase in translocation in 
comparison to the mutant grown in the absence of amylase, however the 
complementation of this gene resulted in restoration of the response seen in 
the wild-type. The first step to translocation is bacterial adhesion to the colonic 
cells (Bras and Ketley, 1999); our data has shown that bacteria grown with 
amylase supplementation show greater interaction and thus adhesion to 
Caco-2 epithelial cells. Based on this we can assume that greater number of 
bacteria adhering to the cells would result in an increased number of 
translocating bacteria. 
 
The data presented in this chapter has also shown that C. jejuni 11168H 
grown with 100 µM amylase, showed a significantly increased ability to 
colonise 21-day old chickens. This again underlines the fact that EPM 
induction via exposure to amylase is essential to forming an attachment to 
eukaryotic cells, as described in chapter 5 it was demonstrated that C. jejuni is 
also able to respond to chicken pancreatic extract containing amylase, by 
increasing autoagglutination and biofilm formation by secretion of EPM;  A 
number of studies have shown increased colonisation after in vivo passaging 
through chicks (Sang et al., 1989; Cawthraw et al., 1996) and  in fact 
enhanced colonisation has been shown by even inadequately colonising 
isolates after several in vivo passages (Stern et al., 1988). These studies 
suggest that passaging through a chicken and thus exposing the bacteria to 
pancreatic α-amylase would induce EPM secretion; validating that EPM 
induction is paramount to successful colonisation in chickens. As in the 
environment C. jejuni encounters a number of environmental stresses in the 
chicken intestinal tract, which inhibits optimal growth (Hermans et al., 2011). 
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However the consistent nature of colonisation of the chicken GI tract by C. 
jejuni point towards the bacterium having regulatory systems that confer 
protection towards a hostile environment within and outside the host. The 
exact mechanism by which C. jejuni is able to maintain itself within this hostile 
environment has not been previously elucidated, however this study is the first 
to demonstrate the role of EPM in conferring protection of C. jejuni to  stresses  
as shown in Chapter 5. This protective mechanism is expected to be the same 
within the chicken caeca, allowing the bacteria to resist stresses and colonise, 
indeed analysis of five C. jejuni isolate obtained from chickens have been 
shown to be covered by dextrans (Personal communication Dr E. Allan).  
 
In summary the data shown in this chapter illustrates bacteria grown in the 
presence of physiological-relevant concentrations of pancreatic α-amylase 
show significantly increased virulence in the G. mellonella and cell culture 
models; as well as significantly increased colonisation of 21 day old chickens. 
Based on the results of this chapter it can be concluded that current research 
conducted using laboratory strains are not truly representative of the 
phenotypes found in vivo and therefore the virulence data obtained is not 
accurately demonstrating pathogenicity; however supplementing growth 
media with pancreatic amylase and thus inducing EPM would allow 
researchers to more accurately study C. jejuni virulence. Another finding of 
this chapter is the validation of the G. mellonella model with in vitro Caco-2 
epithelial cell assays in both cases bacteria grown with α-amylase 
supplementation showed similar increase in virulence, in the case of G. 
mellonella an increased kill was observed over 24 hours in comparison to 
increased interaction and invasion of Caco-2 cells. 
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Chapter 7: Final Discussion  
7.1 Significance of the study 
 
This study has generated results that have a considerable impact on the 
understanding of C. jejuni biology. The data presented in this thesis shows, for 
the first time, that C. jejuni is able to detect the presence of physiological 
concentrations of pancreatic α-amylase and responds by secretion of EPM.  
This response resulted in a change in colony morphology to a mucoid 
phenotype through the secretion of EPM which includes the secretion of 
extracellular proteins and a novel polysaccharide that consists of 1,6-linked 
glucose residues, producing an α-dextran. Bacteria such as B. cepacia 
(Bartholdson et al., 2008), E. faecalis (Battone et al., 1998) , S. pneumoniae 
(Allegrucci and Sauer, 2007)  and P. aeruginosa (Friedl et al., 1992) all have 
the ability to express mucoidy. Some bacteria such as B. cepacia and P. 
aeruginosa express mucoidy through secretion of an EPM (Cérantola et al., 
2006; Bartholdson et al., 2008; Tielen et al., 2010). These EPM can consist of 
either polysaccharide, extracellular proteins, DNA and lipids, in some cases 
the EPM can be a combination of all these substrates (Costerton et al., 1995).   
Secretion of EPM is a prerequisite to biofilm formation and has been observed 
in a number of enteric bacteria, such as V. cholerae (Yildiz and Schoolnik, 
1999), H. pylori (Stark et al., 1999) and S. typhimurium (Ledeboer and Jones. 
2005). Existing encased within EPM provides a number of advantages to 
bacteria including the ability to evade immune responses. For example, in P. 
aeruginosa which when expressing mucoidy through secretion of alginate 
shows significantly reduced killing by macrophages (Leid et al., 2005).  
The results of this study further show C. jejuni pre-exposed to α-amylase and 
thus expressing EPM exhibit increased virulence in a G. mellonella model and 
increased colonisation of chickens. These results could be explained by the 
enhanced ability of C. jejuni to form a biofilm in vivo, a conclusion supported 
by data showing increased biofilm formation in response to chicken pancreatic 
α-amylase in this study. Haddock et al. (2010) described the formation of C. 
jejuni micro-colonies and biofilms on human intestinal tissue obtained from 
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biopsies; they concluded that this was an essential step in causing diarrhoeal 
disease in humans. A study by Purdy and Watnick (2011) discovered biofilm 
formation was necessary for V. cholerae to colonise the intestine of 
arthropods, which are the environmental host for the organism.  
 
One of the major challenges regarding control of C. jejuni transmission is the 
ability of the bacterium to persist in broiler houses and colonise chicken caeca 
in such high numbers. These bacteria are able to withstand hot water, acid 
and chemical treatment, data presented here shows that C. jejuni is able to 
respond to chicken pancreatic amylase by increasing autoagglutination and 
biofilm formation. Therefore C. jejuni excreted in the faeces of chickens would 
have been pre-exposed to amylase and producing EPM. The results of this 
study query many of the suggested control strategies. Studies had previously 
suggested using organic acids to treat water supplies in poultry farms to 
reduce transmission of C. jejuni, with treatment at pH 4.5 showing a significant 
bactericidal effect (Murphy et al., 2003). The data reported here shows that 
EPM-expressing C. jejuni exhibit significantly increased resistance to acid 
stress at pH 4.0 and pH 2.0. EPM production in other bacteria such as by E. 
coli O157:H7 confer resistance to acid stress and it has been proposed that 
this resistance allows the bacterium to persist in the GI tract (Mao et al., 
2006). Studies of EPM production by Bifidobacteria have shown that bacteria 
expressing EPM exhibit increased resistance to bile salts and low pH (Alp and 
Aslim, 2010).  Furthermore it has been suggested high temperature treatment 
at 50°C and 60°C significantly reduces the C. jejuni load on the carcasses of 
chickens (Li et al., 2002). However the data obtained here showed that C. 
jejuni expressing EPM exhibit a significantly lower susceptibility to heat 
treatment at 55°C, 60°C and 65°C.  
 
Cold storage is another stress endured by C. jejuni and the FSA (2013) have 
recently reported that 66% retail bought chicken are contaminated with C. 
jejuni. The United States Department of Agriculture (USDA) as well as the 
FSA recommend all poultry to be refrigerated at 4°C.  This study has shown 
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that C. jejuni expressing EPM is able to survive significantly longer in nutrient 
deprived conditions at 4°C. Expression of EPM also increases survival at 
refrigeration temperatures in E. coli O157:H7, another food-borne pathogen, 
compared to bacteria which do not express the EPM (Lee and Chen. 2004). 
The phenomenon of EPM expression and its relevance to stress survival is 
probably best described in P. aeruginosa, the bacteria is able to secrete 
extracellular alginate, which confers protection against many stresses such as 
desiccation, changes in pH and chlorination. Bacteria expressing alginate 
reveal enhanced survival compared with isogenic non-alginate producing cells 
in chlorinated water. Removal of alginate from bacteria abolishes chlorine 
resistance; and the addition of alginate to washed cells enhances cell survival 
(Grobe et al., 2001) 
Data obtained here has shown fresh clinical isolates of C. jejuni exhibit a 
mucoid phenotype as a result of exposure to pancreatic α-amylase. Mucoidy 
has been conclusively associated with increased virulence in C. jejuni 
(Babakhani, 1993). Furthermore, clinical strains, which would have 
encountered amylase in the human GI tract, show increased invasion when 
compared to environmental isolates (Newell et al., 1985). 
Standardised in vitro bacterial growth conditions contrast significantly from the 
complex and fluctuating conditions seen in vivo, regardless of this the majority 
of research is conducted using reference strains which become adapted to 
laboratory conditions through decades of passaging. Reference strains such 
as C. jejuni NCTC 11168 which was originally isolated from the faeces of a 
diarrheic patient in 1977 by Martin Skirrow have been passaged for well over 
three decades. Through this successive in vitro passaging, the bacterium has 
significantly changed from the original clinical equivalent and lost many of the 
pathophysiological mechanisms that are present in clinical strains. This is 
highlighted by the reduced interactions of laboratory C. jejuni strains with 
intestinal epithelial cells, with invasion being reported at less than one per 
cent, which is not accurate when compared to clinical data (Friis et al., 2005).  
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To understand the biology of C. jejuni it is imperative that researchers attempt 
to simulate the natural environment of the host as accurately as possible, as 
shown by this study.  
Research has been conducted using secretions found in the GI tract and the 
results have been fascinating. When C. jejuni was cultured with NE, growth 
rate, motility and invasion of Caco-2 cells were increased in comparison with 
cultures grown in the absence of NE. Additionally, these bacteria produced 
extensive breakdown and disruption of cell monolayers, indicating that this 
may contribute to the epithelial destruction that is characteristic of severe 
campylobacteriosis (Cogan et al., 2007). Another study by Quoc et al. (2008) 
concluded that C. jejuni utilizes MUC2 a constituent of mucin as an 
environmental signal to control expression of genes associated with 
pathogenicity. Furthermore, Malik-Kale et al. (2008) showed that culturing C. 
jejuni with DOC activates pathogenic behaviour by exhibiting an increase in 
epithelial cell invasion; the study concluded that interaction with DOC 
prepares the bacterium to invade cells though activating the production of Cia 
proteins. In another gastrointestinal bacterium, H. pylori, gastrin at 
physiological concentrations has been shown to promote growth in vitro 
(Chowers et al., 1999).   
 
7.2 Further work 
Further work is necessary to extend and build upon the data presented in this 
study.  Although it was determined that Cj0511 activity is vital for the 
bacterium to respond to α-amylase, the molecular mechanisms behind 
recognition of α-amylase and elucidating the signal transduction pathway need 
to be investigated. This could be done through screening a C. jejuni 
transposon mutagenesis library on CHMA agar supplemented with and 
without pancreatic α-amylase to check for conformity of phenotype on both 
sets of plates, with colonies not showing mucoidy in response to amylase 
being further characterised. A mutagenesis library could be constructed using 
a mariner transposon based system which has a recognition sequence of TA 
and would provide a good degree of genome coverage; it has previously been 
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demonstrated to produce random in vivo transposon mutagenesis of C. jejuni 
(Golden et al., 2000).  
With the discovery that the C. jejuni EPM consists partly of a dextran it would 
be advantageous to assess whether commercially available dextranases have 
the ability to degrade the EPM, this in turn would lead to the possibility of 
incorporating such enzymes into treatment of C. jeuni in commercial broiler 
houses to make the bacteria more susceptible to the already used control 
treatments such as using scalding water to wash chicken carcasses after 
slaughter. Furthermore the optimum pH range for dextranase activity is pH 
5.0-6.0, with the lower end of the range more preferable, this would be ideal to 
incorporate into acidic treatment of water to treat chicken faeces, which would 
inevitably contain C. jejuni pre-exposed to α-amylase and thus expressing 
EPM. 
The results of this study have demonstrated that activity of secreted protease 
Cj0511 is essential for C. jejuni to respond to pancreatic α-amylase, a 
valuable therapeutic measure would be to inhibit the activity of Cj0511. The 
finding that stable and proteolytic active Cj0511-His protein can be expressed 
by E. coli is highly relevant as this will facilitate in future work with 
development of specific inhibitors. The study of bacterial proteases as future 
drug targets is promising.  Slomiany et al. (1992) found successful treatment 
of H. pylori infection using anti-ulcer drug ebrotidine was in part due to a 
strong inhibitory action on Helicobacter proteases involved in degrading 
gastric mucin, which is a growth promoter in H. pylori (Chowers et al., 1999).  
Protease inhibitors have been used to treat viral infections such as hepatitis 
and HIV, Saquinavir an antiretroviral drug that was the first approved protease 
inhibitor for the treatment of HIV inhibits the function of both HIV-1 and HIV-2 
proteases. 
 
Protein–protein interactions play an integral role in the majority of biological 
processes, developing small molecule inhibitors to proteases are appealing 
opportunities for therapeutic intervention. Recently, it was shown in mice that 
inhibition of lethal factor protease activity from Bacillus anthracis can protect 
against anthrax infection (Moayeri et al., 2013). Developing similar inhibitors to 
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Cj0511 would be valuable tools in the development of future control measures 
for C. jejuni. 
In summary, the data generated in this thesis has improved our understanding 
of C. jejuni biology in particular it has highlighted that pancreatic α-amylase 
acts as a signal for initiating pathogenic behaviour and changing to a 
phenotype which promotes survival. Furthermore, this study has elucidated 
the relevance of Cj0511 activity in the ability of C. jejuni to persist in the food 
chain and cause disease, this in combination with the identification of a α-
dextran as the main component of C. jejuni EPM are useful for the 
development of effective control measures against C. jejuni. The data from 
this PhD has also emphasised the importance of simulating the host intestinal 
environment as closely as possible when studying C. jejuni to allow novel 
insights into pathogenic mechanisms. 
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Appendix 1  
A1.1. Purity of hog pancreatic α-amylase preparation 
 
Preparations of hog pancreatic α-amylase (Sigma cat no. 10080) dissolved in 
dH20 at concentration of 1 mg/ml were analysed by Dr Karen Homer (Kings 
College). Samples were run on SDS-PAGE gel (Figure A1.1)., the gel profile 
shown is indicative of those seen in three independent experiments The 
bands were cut and analysed using LC-MS/MS and the hits are listed 
according to the UniprotKB/SwissProt database from EBI. The data showed 
only pancreatic α-amylase as the sole protein present in the sample (Table 
A1.1).  
 
Figure A1.1. Lane 1: 10-250 kDa protein ladder (NEB). Lane 2: hog pancreatic α-
amylase. Bands were excised from the SDS-PAGE gel shown, digested in-gel with 
trypsin and analysed by LC-MS/MS. 
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Table A1.1. Identity of protein present hog pancreatic α-amylase preparation (Sigma-
Aldrich) 
 
1 Band number as shown on the SDS PAGE gel in Figure 3.8. 
2, 3 Accession number and protein identity as given in the the UniprotKB/SwissProt 
database from EBI. 
4 Number of peptides observed in mass spectra matching to the protein in the 
database. 
5 Percentage amino acid coverage (peptides observed/theoretical from sequence 
data). 
6 Theoretical molecular weight (kDa) 
 
  
Band 
No.
1
 
Accession 
number
2
 
Protein identity
3
 Peptides 
matched
4
 
Coverage
5
 MW (kDa)
6
 
1 P00690 Pancreatic alpha-amylase 6 40 57.1 
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Appendix 2 
 
A2.1 Construction of spoT mutant 
A spoT mutant of C. jejuni 11168H was generated. This mutant was 
constructed by insertion of a ~1.4 kb fragment carrying the kanamycin-
resistance gene, (aphA-3) into a unique BglII site in the spoT gene on the C. 
jejuni 11168H chromosome. The entire cloning strategy is shown in Figure 
A2.1.  
175 
 
 
 
Figure A2.1. Graphical representation of the construction of C.jejuni 11168H spoT 
mutant. First, part of the spoT gene flanking the BglII site was amplified and cloned 
into vector pGEM-T-easy, generating pWJ1. Next the kanr cassette was cut from 
pJMK30 and inserted into pWJ1 at the BglII site. The resulting plasmid is pWJ2. 
Finally this vector was transformed into C. jejuni NCTC 11168 and the kanr cassette 
was inserted into the spoT gene in the chromosome via double cross-over 
recombination.  
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A2.2 Amplification of the spoT gene fragment 
Nucleotides 968 bp to 2174 bp of the spoT gene were amplified from C. jejuni 
11168H genomic DNA using primers WJ1 and WJ2. This fragment was 
designated spoT. The PCR product was analysed on an agarose gel as shown 
in Figure A2.2. 
                                                
Figure A2.2. Gel electrophoresis of PCR product spoT, expected size of product: 
1207bp. 
 
A2.3 Cloning of spoT into pGEM-T-easy 
The PCR product of spoT was purified and ligated into vector pGEM-T-easy. 
The ligation mix was transformed into E. coli JM109. Four white colonies were 
selected and checked for the insertion of spoT by PCR using primers WJ1 and 
WJ2 (Figure A2.3). All the 4 plasmids produced a product of the expected 
size; one was selected and designated pWJ1. 
 
 
 
 
 
 
 
 
 
 
 
 
spoT 1000bp 
1650bp 
177 
 
                                              1     2       3       4       5       6 
 
Figure A2.3. Gel electrophoresis of PCR samples amplified pGEM-T-easy 
transformants. Lane 1, 1 kb marker (New England Biolabs); lane 2, pGEM-T_easy 
negative control; lanes 3-6, plasmid from transformants.  (negative control, the 
second lane) and purified plasmids (lane 3-6). PCR product from the expected clone 
is 1207bp. 
 
 
A2.4 Insertion of kanr cassette into pWJ1 
A 1.4 kb BamHI fragment carrying the kanr gene aphA-3 was cut from plasmid 
pJMK30 (Figure A2.4). The 1.4 kb DNA fragment was gel-purified and ligated 
to BglII-digested pWJ1. The ligation mix was transformed into E. coli JM109. 
Five transformants were selected and analysed by PCR using primers WJ1 
and WJ2. The PCR product generated by WJ1/WJ2 from the vector containing 
the kanr cassette is ~ 2.6 kb (right). All five clones showed a band ~ 2.6kb, 
indicating that aphA-3 had been inserted. A second PCR was used to identify 
clones that contained aphA-3 in the same transcriptional orientation as spoT 
(data not shown). The plasmid with the insertion of kanr cassette was 
designated pWJ2. 
 
 
 
 
 
 
 
 
 
 
 
1650bp 
1000bp 
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1      2      3      4      5      6      7 
                                                    
Figure A2.4. Gel electrophoresis of pJMK30 BamHI digests. B. Lane 1 contains a 1 
kb ladder (New England Biolabs) PCR samples amplified from lane 2, control pWJ1; 
lanes 3-7, and purified plasmids (lane 3-7). PCR product from the expected clone is 
~2.6kb. 
 
 
A2.5 Integration of kanr cassette into C. jejuni 11168H 
chromosome 
Plasmid pWJ2 was electroporated into C. jejuni 11168H. Genomic DNA was 
purified from kanamycin resistant transformants, and analyzed by PCR using 
primers WJ1 and WJ3 to check the insertion and orientation of kanr cassette. 
WJ3 is located in the kanr cassette and is 500bp and 900bp to each end. The 
expected mutants with kanr cassette inserted in a right direction will be able to 
generate a PCR product around 1.1kb (600bp of spoT and 500bp of kanr 
gene). Figure A2.5 shows the amplified PCR product from genomica DNA of 
five transformants. All the five transformants displayed the expected DNA 
bands at about 1.1kb. This strain was named C. jejuni 11168H spoT mutant. 
 
1       2     3     4     5     6 
  
Figure A2.5. Gel electrophoresis of PCR samples amplified from chromosome DNA 
of five  
1kb 
3kb 
2kb 
1kb 
Kanr 
cassette 1.5kb 
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Appendix 3 
 
A3.1 Complementation of the Cj0511 mutant using 
pC46fdxA 
The C. jejuni 11168H Cj0511 mutant was complemented by insertion of a 
functional Cj0511 gene into pseudogene Cj0046 under control of the fdxA 
promoter by using plasmid pC46fdxA (Figure A3.1).  
 
Figure A3.1. pCfdxA vector used for insertion of wildtype gene Cj0511. Expression is 
controlled by PfdxA to allow over expression of Cj0511. 
 
  
pCfdxA
3986 bp
cat
PfdxA
BclI (1437)
BsmBI (3878)
ClaI (630)
NcoI (1754)
NdeI (2933)
NheI (1463)
SacI (2927)
SphI (1773)
EcoRI (1739)
EcoRI (2958)
HindIII (521)
HindIII (999)
NotI (1748)
NotI (2951)
PvuII (2691)
PvuII (3071)
SpeI (833)SpeI (2964)
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A3.2 Amplification of the Cj0511gene 
The Cj0511 gene (~1.3 kb) was amplified from C. jejuni 11168H genomic 
DNA. To enable formation of complementary ends for ligation the restriction 
site BsmBI was added to the 5’ ends: Figure A3.2 shows a gel image of the 
PCR product (lane 3), which is at the expected size of 1.3 kb.  
 
    
 
 
 
 
 
 
Figure A3.2. Gel electrophoresis of PCR of Cj0511, expected size of the product is 
1346 bp 
 
 
A3.3 Cloning of Cj0511 into pCfdxA 
The PCR product (amplified Cj0511) was digested with BsmBI, mixed with 
similarly digested pCfdxA and ligated. The ligation mix was transformed into 
E. coli JM109. For confirmation that the Cj0511 gene was inserted into 
pCfdxA, plasmids were purified from chloramphenicol resistant E. coli 
transformants, and digested with BsmBI generating two fragments. One 
fragment of ~3.9 kb was of the plasmid backbone and the other a fragment of 
~1.3 kb (Figure A3.3).  
 
 
1 kb 
1.5 kb 
181 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.3. Gel electrophoresis of BsmBI restriction digest of Cj0511 cloned into 
pCfdxA, expected digestion pattern: two fragments of 3926 bp and 1328 bp. Lane 1: 
1kb DNA ladder (NEB). Lane 2: negative control. Lanes 3-8: Digested pCfdxA-Cj0511 
five individual transformants. 
 
 
A3.4 Orientation of the Cj0511 insertion 
To determine the orientation of the Cj0511 gene insertion in pCfdxA was 
correct with respect to PfdxA promoter, PCR amplifications from the pCfdxA-
Cj0511 plasmids were done using a forward primer specific for the fdxA 
promoter on PcfdxA facing the BsmBI cloning site (PcfdxA F) and a reverse 
primer specific to the 3’ end of the Cj0511 gene (WJ10 R) as shown in Figure 
A3.4. 
 
 
 
1.5 kb 
4 kb 
3 kb 
 1               2                3                  4                  5                    
6                7                8   8 
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Figure A3.4. Gel electrophoresis ofPCR products amplified from pCfdxA-Cj0511 
transformants. Lane 1: 1kb DNA ladder (NEB). Lane 2-7: pCfdxA-Cj0511 fragments. 
Expected product product size 1427 bp. 
 
 
The plasmid with Cj0511 gene inserted in the correct orientation was 
designated pWJ4 and subsequently electroporated into the C. jejuni 11168H 
Cj0511 mutant. The insertion of the promoter-gene fragment into Cj0046 was 
confirmed by PCR using primers specific for Cj0511 (WJ10F and WJ10R) in 
combination with primers specific for sequences flanking Cj0046 in the 
genome (WJ11 and WJ12) (Figure. A3.5).  
 
1.5 kb 
1 kb 
   1       2      3      4     5     6       7 
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Figure A3.5. Gel electrophoresis of PCR products. Lane 1: 1kb DNA ladder (NEB). 
Lane 2: negative control. Lane 3: PCR product of WJ12 and WJ10R generate a 
product of 3255 bp. Lane 4: PCR product of WJ11 and WJ10F generate a product of 
2396 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
2 kb 
4 kb 
3 kb 
184 
 
Appendix 4 
A4.1 Cj0511 recombinant protein expression  
Genomic DNA from C. jejuni 11168H was used to amplify gene Cj0511 using 
primers CJ1AF and CJ1AR (Figure A4.1). The amplified fragment was 
directionally cloned into the pET151/D-TOPO® vector expression system (not 
shown). The vector adds an N-terminal His6 tag, a V5 epitope and a tobacco 
etch virus (TEV) protease cleavage site to the expressed recombinant protein. 
Correct cloning was verified by sequencing the DNA construct obtained by re-
amplifying Cj0511 from the ligated pET151/D-TOPO vector using standard 
primers for T7 promoters (data not shown). 
 
 
Figure A4.1. Gel electrophoresis of PCR products. Lane 1: 1kb DNA ladder (NEB). 
Lane 2: PCR product of CJ1AF and CJ1AR generate a product of 1355 bp 
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A4.2 Expression and Purification 
The resulting plasmid pWJ3 was transformed into E. coli BL21 StarTM (DE3) 
One Shot®. Figure A4.2 shows SDS-PAGE analysis of different protein 
factions; in lane seven the over expressed 48 kDa recombinant Cj0511His 
protein band can be seen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.2. Coomassie stained 10% SDS PAGE. Lane 1: 10-250 kDa ladder (NEB). 
Lane 2: Unexpressed initial fraction. Lane 3: Unexpressed wash fraction. Lane 4: 
Unexpressed eluted fraction. Lane 5. Expressed initial fraction. Lane 6: Expressed 
wash fraction. Lane 7: Expressed eluted fraction containing purified recombinant 
Cj0511 of 48 kDa. 
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